The	O
Structural	O
Basis	O
of	O
Coenzyme	B-chemical
A	I-chemical
Recycling	O
in	O
a	O
Bacterial	B-taxonomy_domain
Organelle	O

Bacterial	B-taxonomy_domain
Microcompartments	B-complex_assembly
(	O
BMCs	B-complex_assembly
)	O
are	O
proteinaceous	O
organelles	O
that	O
encapsulate	O
critical	O
segments	O
of	O
autotrophic	O
and	O
heterotrophic	O
metabolic	O
pathways	O
;	O
they	O
are	O
functionally	O
diverse	O
and	O
are	O
found	O
across	O
23	O
different	O
phyla	O
.	O

The	O
majority	O
of	O
catabolic	B-protein_state
BMCs	B-complex_assembly
(	O
metabolosomes	B-complex_assembly
)	O
compartmentalize	O
a	O
common	O
core	O
of	O
enzymes	O
to	O
metabolize	O
compounds	O
via	O
a	O
toxic	O
and	O
/	O
or	O
volatile	O
aldehyde	B-chemical
intermediate	O
.	O

The	O
core	O
enzyme	O
phosphotransacylase	B-protein_type
(	O
PTAC	B-protein_type
)	O
recycles	O
Coenzyme	B-chemical
A	I-chemical
and	O
generates	O
an	O
acyl	B-chemical
phosphate	I-chemical
that	O
can	O
serve	O
as	O
an	O
energy	O
source	O
.	O

The	O
PTAC	B-protein_type
predominantly	O
associated	O
with	O
metabolosomes	B-complex_assembly
(	O
PduL	B-protein_type
)	O
has	O
no	O
sequence	O
homology	O
to	O
the	O
PTAC	B-protein_type
ubiquitous	O
among	O
fermentative	B-taxonomy_domain
bacteria	I-taxonomy_domain
(	O
Pta	B-protein_type
).	O

Here	O
,	O
we	O
report	O
two	O
high	O
-	O
resolution	O
PduL	B-protein_type
crystal	B-evidence
structures	I-evidence
with	B-protein_state
bound	I-protein_state
substrates	I-protein_state
.	O

The	O
PduL	B-protein_type
fold	B-structure_element
is	O
unrelated	O
to	O
that	B-structure_element
of	O
Pta	B-protein_type
;	O
it	O
contains	O
a	O
dimetal	B-site
active	I-site
site	I-site
involved	O
in	O
a	O
catalytic	O
mechanism	O
distinct	O
from	O
that	O
of	O
the	O
housekeeping	B-protein_state
PTAC	B-protein_type
.	O

Accordingly	O
,	O
PduL	B-protein_type
and	O
Pta	B-protein_type
exemplify	O
functional	O
,	O
but	O
not	O
structural	O
,	O
convergent	O
evolution	O
.	O

The	O
PduL	B-protein_type
structure	B-evidence
,	O
in	O
the	O
context	O
of	O
the	O
catalytic	O
core	O
,	O
completes	O
our	O
understanding	O
of	O
the	O
structural	O
basis	O
of	O
cofactor	O
recycling	O
in	O
the	O
metabolosome	B-complex_assembly
lumen	O
.	O

This	O
study	O
describes	O
the	O
structure	B-evidence
of	O
a	O
novel	O
phosphotransacylase	B-protein_type
enzyme	O
that	O
facilitates	O
the	O
recycling	O
of	O
the	O
essential	O
cofactor	O
acetyl	B-chemical
-	I-chemical
CoA	I-chemical
within	O
a	O
bacterial	B-taxonomy_domain
organelle	O
and	O
discusses	O
the	O
properties	O
of	O
the	O
enzyme	O
'	O
s	O
active	B-site
site	I-site
and	O
how	O
it	O
is	O
packaged	O
into	O
the	O
organelle	O
.	O

In	O
metabolism	O
,	O
molecules	O
with	O
“	O
high	O
-	O
energy	O
”	O
bonds	O
(	O
e	O
.	O
g	O
.,	O
ATP	B-chemical
and	O
Acetyl	B-chemical
~	I-chemical
CoA	I-chemical
)	O
are	O
critical	O
for	O
both	O
catabolic	O
and	O
anabolic	O
processes	O
.	O

The	O
phosphotransacylase	B-protein_type
(	O
Pta	B-protein_type
)	O
enzyme	O
catalyzes	O
the	O
conversion	O
between	O
acyl	B-chemical
-	I-chemical
CoA	I-chemical
and	O
acyl	B-chemical
-	I-chemical
phosphate	I-chemical
.	O

This	O
reaction	O
directly	O
links	O
an	O
acyl	B-chemical
-	I-chemical
CoA	I-chemical
with	O
ATP	B-chemical
generation	O
via	O
substrate	O
-	O
level	O
phosphorylation	O
,	O
producing	O
short	B-chemical
-	I-chemical
chain	I-chemical
fatty	I-chemical
acids	I-chemical
(	O
e	O
.	O
g	O
.,	O
acetate	B-chemical
),	O
and	O
also	O
provides	O
a	O
path	O
for	O
short	B-chemical
-	I-chemical
chain	I-chemical
fatty	I-chemical
acids	I-chemical
to	O
enter	O
central	O
metabolism	O
.	O

Due	O
to	O
this	O
key	O
function	O
,	O
Pta	O
is	O
conserved	B-protein_state
across	O
the	O
bacterial	B-taxonomy_domain
kingdom	I-taxonomy_domain
.	O

Recently	O
,	O
a	O
new	O
type	O
of	O
phosphotransacylase	B-protein_type
was	O
described	O
that	O
shares	O
no	O
evolutionary	O
relation	O
to	O
Pta	B-protein_type
.	O

This	O
enzyme	O
,	O
PduL	B-protein_type
,	O
is	O
exclusively	B-protein_state
associated	O
with	O
organelles	O
called	O
bacterial	B-taxonomy_domain
microcompartments	B-complex_assembly
,	O
which	O
are	O
used	O
to	O
catabolize	O
various	O
compounds	O
.	O

Not	O
only	O
does	O
PduL	B-protein_type
facilitate	O
substrate	O
level	O
phosphorylation	O
,	O
but	O
it	O
also	O
is	O
critical	O
for	O
cofactor	O
recycling	O
within	O
,	O
and	O
product	O
efflux	O
from	O
,	O
the	O
organelle	O
.	O

We	O
solved	B-experimental_method
the	O
structure	B-evidence
of	O
this	O
convergent	B-protein_state
phosphotransacylase	B-protein_type
and	O
show	O
that	O
it	O
is	O
completely	O
structurally	O
different	O
from	O
Pta	B-protein_type
,	O
including	O
its	O
active	B-site
site	I-site
architecture	O
.	O

Bacterial	B-taxonomy_domain
Microcompartments	B-complex_assembly
(	O
BMCs	B-complex_assembly
)	O
are	O
organelles	O
that	O
encapsulate	O
enzymes	O
for	O
sequential	O
biochemical	O
reactions	O
within	O
a	O
protein	O
shell	B-structure_element
.	O

The	O
shell	B-structure_element
is	O
typically	O
composed	O
of	O
three	O
types	O
of	O
protein	O
subunits	O
,	O
which	O
form	O
either	O
hexagonal	B-protein_state
(	O
BMC	B-complex_assembly
-	I-complex_assembly
H	I-complex_assembly
and	O
BMC	B-complex_assembly
-	I-complex_assembly
T	I-complex_assembly
)	O
or	O
pentagonal	B-protein_state
(	O
BMC	B-complex_assembly
-	I-complex_assembly
P	I-complex_assembly
)	O
tiles	O
that	O
assemble	O
into	O
a	O
polyhedral	B-protein_state
shell	B-structure_element
.	O

The	O
facets	O
of	O
the	O
shell	B-structure_element
are	O
composed	O
primarily	O
of	O
hexamers	B-oligomeric_state
that	O
are	O
typically	O
perforated	O
by	O
pores	B-site
lined	O
with	O
highly	B-protein_state
conserved	I-protein_state
,	O
polar	B-protein_state
residues	B-structure_element
that	O
presumably	O
function	O
as	O
the	O
conduits	O
for	O
metabolites	O
into	O
and	O
out	O
of	O
the	O
shell	B-structure_element
.	O

The	O
vitamin	B-complex_assembly
B12	I-complex_assembly
-	I-complex_assembly
dependent	I-complex_assembly
propanediol	I-complex_assembly
-	I-complex_assembly
utilizing	I-complex_assembly
(	I-complex_assembly
PDU	I-complex_assembly
)	I-complex_assembly
BMC	I-complex_assembly
was	O
one	O
of	O
the	O
first	O
functionally	O
characterized	O
catabolic	B-protein_state
BMCs	B-complex_assembly
;	O
subsequently	O
,	O
other	O
types	O
have	O
been	O
implicated	O
in	O
the	O
degradation	O
of	O
ethanolamine	B-chemical
,	O
choline	B-chemical
,	O
fucose	B-chemical
,	O
rhamnose	B-chemical
,	O
and	O
ethanol	B-chemical
,	O
all	O
of	O
which	O
produce	O
different	O
aldehyde	B-chemical
intermediates	O
(	O
Table	O
1	O
).	O

More	O
recently	O
,	O
bioinformatic	B-experimental_method
studies	I-experimental_method
have	O
demonstrated	O
the	O
widespread	O
distribution	O
of	O
BMCs	B-complex_assembly
among	O
diverse	O
bacterial	B-taxonomy_domain
phyla	I-taxonomy_domain
and	O
grouped	O
them	O
into	O
23	O
different	O
functional	O
types	O
.	O

The	O
reactions	O
carried	O
out	O
in	O
the	O
majority	O
of	O
catabolic	B-protein_state
BMCs	B-complex_assembly
(	O
also	O
known	O
as	O
metabolosomes	B-complex_assembly
)	O
fit	O
a	O
generalized	O
biochemical	O
paradigm	O
for	O
the	O
oxidation	O
of	O
aldehydes	B-chemical
(	O
Fig	O
1	O
).	O

This	O
involves	O
a	O
BMC	B-complex_assembly
-	O
encapsulated	O
signature	O
enzyme	O
that	O
generates	O
a	O
toxic	O
and	O
/	O
or	O
volatile	O
aldehyde	B-chemical
that	O
the	O
BMC	B-complex_assembly
shell	B-structure_element
sequesters	O
from	O
the	O
cytosol	O
.	O

The	O
aldehyde	B-chemical
is	O
subsequently	O
converted	O
into	O
an	O
acyl	B-chemical
-	I-chemical
CoA	I-chemical
by	O
aldehyde	B-protein_type
dehydrogenase	I-protein_type
,	O
which	O
uses	O
NAD	B-chemical
+	I-chemical
and	O
CoA	B-chemical
as	O
cofactors	O
.	O

These	O
two	O
cofactors	O
are	O
relatively	O
large	O
,	O
and	O
their	O
diffusion	O
across	O
the	O
protein	B-structure_element
shell	I-structure_element
is	O
thought	O
to	O
be	O
restricted	O
,	O
necessitating	O
their	O
regeneration	O
within	O
the	O
BMC	B-complex_assembly
lumen	O
.	O

NAD	B-chemical
+	I-chemical
is	O
recycled	O
via	O
alcohol	B-protein_type
dehydrogenase	I-protein_type
,	O
and	O
CoA	B-chemical
is	O
recycled	O
via	O
phosphotransacetylase	B-protein_type
(	O
PTAC	B-protein_type
)	O
(	O
Fig	O
1	O
).	O

The	O
final	O
product	O
of	O
the	O
BMC	B-complex_assembly
,	O
an	O
acyl	B-chemical
-	I-chemical
phosphate	I-chemical
,	O
can	O
then	O
be	O
used	O
to	O
generate	O
ATP	B-chemical
via	O
acyl	B-protein_type
kinase	I-protein_type
,	O
or	O
revert	O
back	O
to	O
acyl	B-chemical
-	I-chemical
CoA	I-chemical
by	O
Pta	B-protein_type
for	O
biosynthesis	O
.	O

Collectively	O
,	O
the	O
aldehyde	B-protein_type
and	I-protein_type
alcohol	I-protein_type
dehydrogenases	I-protein_type
,	O
as	O
well	O
as	O
the	O
PTAC	B-protein_type
,	O
constitute	O
the	O
common	O
metabolosome	B-complex_assembly
core	O
.	O

General	O
biochemical	O
model	O
of	O
aldehyde	B-protein_state
-	I-protein_state
degrading	I-protein_state
BMCs	B-complex_assembly
(	O
metabolosomes	B-complex_assembly
)	O
illustrating	O
the	O
common	O
metabolosome	B-complex_assembly
core	O
enzymes	O
and	O
reactions	O
.	O

Substrates	O
and	O
cofactors	O
involving	O
the	O
PTAC	B-protein_type
reaction	O
are	O
shown	O
in	O
red	O
;	O
other	O
substrates	O
and	O
enzymes	O
are	O
shown	O
in	O
black	O
,	O
and	O
other	O
cofactors	O
are	O
shown	O
in	O
gray	O
.	O

Characterized	O
and	O
predicted	O
catabolic	B-protein_state
BMC	B-complex_assembly
(	O
metabolosome	B-complex_assembly
)	O
types	O
that	O
represent	O
the	O
aldehyde	B-chemical
-	O
degrading	O
paradigm	O
(	O
for	O
definition	O
of	O
types	O
see	O
Kerfeld	O
and	O
Erbilgin	O
).	O

Name	O
PTAC	B-protein_type
Type	O
Sequestered	O
Aldehyde	B-chemical
PDU	B-complex_assembly
*	O
PduL	B-protein_type
propionaldehyde	B-chemical
EUT1	B-complex_assembly
PTA_PTB	B-protein_type
acetaldehyde	B-chemical
EUT2	B-complex_assembly
PduL	B-protein_type
acetaldehyde	B-chemical
ETU	B-complex_assembly
None	O
acetaldehyde	B-chemical
GRM1	B-complex_assembly
/	I-complex_assembly
CUT	I-complex_assembly
PduL	B-protein_type
acetaldehyde	B-chemical
GRM2	B-complex_assembly
PduL	B-protein_type
acetaldehyde	B-chemical
GRM3	B-complex_assembly
*,	I-complex_assembly
4	I-complex_assembly
PduL	B-protein_type
propionaldehyde	B-chemical
GRM5	B-complex_assembly
/	I-complex_assembly
GRP	I-complex_assembly
PduL	B-protein_type
propionaldehyde	B-chemical
PVM	B-complex_assembly
*	O
PduL	B-protein_type
lactaldehyde	B-chemical
RMM1	B-complex_assembly
,	I-complex_assembly
2	I-complex_assembly
None	O
unknown	O
SPU	B-complex_assembly
PduL	B-protein_type
unknown	O

*	O
PduL	B-protein_type
from	O
these	O
functional	O
types	O
of	O
metabolosomes	B-complex_assembly
were	O
purified	O
in	O
this	O
study	O
.	O

The	O
activities	O
of	O
core	O
enzymes	O
are	O
not	O
confined	O
to	O
BMC	B-complex_assembly
-	O
associated	O
functions	O
:	O
aldehyde	B-protein_type
and	I-protein_type
alcohol	I-protein_type
dehydrogenases	I-protein_type
are	O
utilized	O
in	O
diverse	O
metabolic	O
reactions	O
,	O
and	O
PTAC	B-protein_type
catalyzes	O
a	O
key	O
biochemical	O
reaction	O
in	O
the	O
process	O
of	O
obtaining	O
energy	O
during	O
fermentation	O
.	O

The	O
concerted	O
functioning	O
of	O
a	O
PTAC	B-protein_type
and	O
an	O
acetate	B-protein_type
kinase	I-protein_type
(	O
Ack	B-protein_type
)	O
is	O
crucial	O
for	O
ATP	B-chemical
generation	O
in	O
the	O
fermentation	O
of	O
pyruvate	B-chemical
to	O
acetate	B-chemical
(	O
see	O
Reactions	O
1	O
and	O
2	O
).	O

Both	O
enzymes	O
are	O
,	O
however	O
,	O
not	O
restricted	O
to	O
fermentative	B-taxonomy_domain
organisms	I-taxonomy_domain
.	O

They	O
can	O
also	O
work	O
in	O
the	O
reverse	O
direction	O
to	O
activate	O
acetate	B-chemical
to	O
the	O
CoA	B-chemical
-	I-chemical
thioester	I-chemical
.	O

This	O
occurs	O
,	O
for	O
example	O
,	O
during	O
acetoclastic	O
methanogenesis	O
in	O
the	O
archaeal	B-taxonomy_domain
Methanosarcina	B-taxonomy_domain
species	I-taxonomy_domain
.	O

Reaction	O
1	O
:	O
acetyl	B-chemical
-	I-chemical
S	I-chemical
-	I-chemical
CoA	I-chemical
+	O
Pi	B-chemical
←→	O
acetyl	B-chemical
phosphate	I-chemical
+	O
CoA	B-chemical
-	I-chemical
SH	I-chemical
(	O
PTAC	B-protein_type
)	O

Reaction	O
2	O
:	O
acetyl	B-chemical
phosphate	I-chemical
+	O
ADP	B-chemical
←→	O
acetate	B-chemical
+	O
ATP	B-chemical
(	O
Ack	B-protein_type
)	O

The	O
canonical	O
PTAC	B-protein_type
,	O
Pta	B-protein_type
,	O
is	O
an	O
ancient	O
enzyme	O
found	O
in	O
some	O
eukaryotes	B-taxonomy_domain
and	O
archaea	B-taxonomy_domain
,	O
and	O
widespread	O
among	O
the	O
bacteria	B-taxonomy_domain
;	O
90	O
%	O
of	O
the	O
bacterial	B-taxonomy_domain
genomes	O
in	O
the	O
Integrated	O
Microbial	O
Genomes	O
database	O
contain	O
a	O
gene	O
encoding	O
the	O
PTA_PTB	B-protein_type
phosphotransacylase	I-protein_type
(	O
Pfam	O
domain	O
PF01515	B-structure_element
).	O

Pta	B-protein_type
has	O
been	O
extensively	O
characterized	O
due	O
to	O
its	O
key	O
role	O
in	O
fermentation	O
.	O

More	O
recently	O
,	O
a	O
second	O
type	O
of	O
PTAC	B-protein_type
without	O
any	O
sequence	O
homology	O
to	O
Pta	B-protein_type
was	O
identified	O
.	O

This	O
protein	O
,	O
PduL	B-protein_type
(	O
Pfam	O
domain	O
PF06130	B-structure_element
),	O
was	O
shown	O
to	O
catalyze	O
the	O
conversion	O
of	O
propionyl	B-chemical
-	I-chemical
CoA	I-chemical
to	O
propionyl	B-chemical
-	I-chemical
phosphate	I-chemical
and	O
is	O
associated	O
with	O
a	O
BMC	B-complex_assembly
involved	O
in	O
propanediol	O
utilization	O
,	O
the	O
PDU	B-complex_assembly
BMC	I-complex_assembly
.	O

Both	O
pduL	B-gene
and	O
pta	B-gene
genes	O
can	O
be	O
found	O
in	O
genetic	O
loci	O
of	O
functionally	O
distinct	O
BMCs	B-complex_assembly
,	O
although	O
the	O
PduL	B-protein_type
type	O
is	O
much	O
more	O
prevalent	O
,	O
being	O
found	O
in	O
all	O
but	O
one	O
type	O
of	O
metabolosome	B-gene
locus	I-gene
:	O
EUT1	B-gene
(	O
Table	O
1	O
).	O

Furthermore	O
,	O
in	O
the	O
Integrated	O
Microbial	O
Genomes	O
Database	O
,	O
91	O
%	O
of	O
genomes	O
that	O
encode	O
PF06130	B-structure_element
also	O
encode	O
genes	O
for	O
shell	O
proteins	O
.	O

As	O
a	O
member	O
of	O
the	O
core	O
biochemical	O
machinery	O
of	O
functionally	O
diverse	O
aldehyde	B-protein_state
-	I-protein_state
oxidizing	I-protein_state
metabolosomes	B-complex_assembly
,	O
PduL	B-protein_type
must	O
have	O
a	O
certain	O
level	O
of	O
substrate	O
plasticity	O
(	O
see	O
Table	O
1	O
)	O
that	O
is	O
not	O
required	O
of	O
Pta	B-protein_type
,	O
which	O
has	O
generally	O
been	O
observed	O
to	O
prefer	O
acetyl	B-chemical
-	I-chemical
CoA	I-chemical
.	O
PduL	B-protein_type
from	O
the	O
PDU	B-complex_assembly
BMC	I-complex_assembly
of	O
Salmonella	B-species
enterica	I-species
favors	O
propionyl	B-chemical
-	I-chemical
CoA	I-chemical
over	O
acetyl	B-chemical
-	I-chemical
CoA	I-chemical
,	O
and	O
it	O
is	O
likely	O
that	O
PduL	B-protein_type
orthologs	O
in	O
functionally	O
diverse	O
BMCs	B-complex_assembly
would	O
have	O
substrate	O
preferences	O
for	O
other	O
CoA	B-chemical
derivatives	O
.	O

Another	O
distinctive	O
feature	O
of	O
BMC	B-protein_state
-	I-protein_state
associated	I-protein_state
PduL	B-protein_type
homologs	O
is	O
an	O
N	O
-	O
terminal	O
encapsulation	B-structure_element
peptide	I-structure_element
(	O
EP	B-structure_element
)	O
that	O
is	O
thought	O
to	O
“	O
target	O
”	O
proteins	O
for	O
encapsulation	O
by	O
the	O
BMC	B-complex_assembly
shell	B-structure_element
.	O

EPs	B-structure_element
are	O
frequently	O
found	O
on	O
BMC	B-protein_type
-	I-protein_type
associated	I-protein_type
proteins	I-protein_type
and	O
have	O
been	O
shown	O
to	O
interact	O
with	O
shell	O
proteins	O
.	O

EPs	B-structure_element
have	O
also	O
been	O
observed	O
to	O
cause	O
proteins	O
to	O
aggregate	O
,	O
and	O
this	O
has	O
recently	O
been	O
suggested	O
to	O
be	O
functionally	O
relevant	O
as	O
an	O
initial	O
step	O
in	O
metabolosome	B-complex_assembly
assembly	O
,	O
in	O
which	O
a	O
multifunctional	O
protein	O
core	O
is	O
formed	O
,	O
around	O
which	O
the	O
shell	B-structure_element
assembles	O
.	O

Of	O
the	O
three	O
common	O
metabolosome	B-complex_assembly
core	O
enzymes	O
,	O
crystal	B-evidence
structures	I-evidence
are	O
available	O
for	O
both	O
the	O
alcohol	B-protein_type
and	I-protein_type
aldehyde	I-protein_type
dehydrogenases	I-protein_type
.	O

In	O
contrast	O
,	O
the	O
structure	B-evidence
of	O
PduL	B-protein_type
,	O
the	O
PTAC	B-protein_type
found	O
in	O
the	O
vast	O
majority	O
of	O
catabolic	B-protein_state
BMCs	B-complex_assembly
,	O
has	O
not	O
been	O
determined	O
.	O

This	O
is	O
a	O
major	O
gap	O
in	O
our	O
understanding	O
of	O
metabolosome	B-complex_assembly
-	O
encapsulated	O
biochemistry	O
and	O
cofactor	O
recycling	O
.	O

Moreover	O
,	O
it	O
will	O
be	O
useful	O
for	O
guiding	O
efforts	O
to	O
engineer	O
novel	O
BMC	B-complex_assembly
cores	O
for	O
biotechnological	O
applications	O
.	O

The	O
primary	O
structure	O
of	O
PduL	B-protein_type
homologs	O
is	O
subdivided	O
into	O
two	O
PF06130	B-structure_element
domains	O
,	O
each	O
roughly	O
80	B-residue_range
residues	I-residue_range
in	I-residue_range
length	I-residue_range
.	O

No	O
available	O
protein	O
structures	O
contain	O
the	O
PF06130	B-structure_element
domain	O
,	O
and	O
homology	B-experimental_method
searches	I-experimental_method
using	O
the	O
primary	O
structure	O
of	O
PduL	B-protein_type
do	O
not	O
return	O
any	O
significant	O
results	O
that	O
would	O
allow	O
prediction	O
of	O
the	O
structure	B-evidence
.	O

Moreover	O
,	O
the	O
evident	O
novelty	O
of	O
PduL	B-protein_type
makes	O
its	O
structure	B-evidence
interesting	O
in	O
the	O
context	O
of	O
convergent	O
evolution	O
of	O
PTAC	B-protein_type
function	O
;	O
to	O
-	O
date	O
,	O
only	O
the	O
Pta	B-protein_type
active	B-site
site	I-site
and	O
catalytic	O
mechanism	O
is	O
known	O
.	O

Here	O
we	O
report	O
high	O
-	O
resolution	O
crystal	B-evidence
structures	I-evidence
of	O
a	O
PduL	B-protein_type
-	I-protein_type
type	I-protein_type
PTAC	I-protein_type
in	O
both	O
CoA	B-protein_state
-	I-protein_state
and	O
phosphate	B-protein_state
-	I-protein_state
bound	I-protein_state
forms	O
,	O
completing	O
our	O
understanding	O
of	O
the	O
structural	O
basis	O
of	O
catalysis	O
by	O
the	O
metabolosome	B-complex_assembly
common	O
core	O
enzymes	O
.	O

We	O
propose	O
a	O
catalytic	O
mechanism	O
analogous	O
but	O
yet	O
distinct	O
from	O
the	O
ubiquitous	O
Pta	B-protein_type
enzyme	O
,	O
highlighting	O
the	O
functional	O
convergence	O
of	O
two	O
enzymes	O
with	O
completely	O
different	O
structures	O
and	O
metal	O
requirements	O
.	O

We	O
also	O
investigate	O
the	O
quaternary	O
structures	O
of	O
three	O
different	O
PduL	B-protein_type
homologs	O
and	O
situate	O
our	O
findings	O
in	O
the	O
context	O
of	O
organelle	O
biogenesis	O
in	O
functionally	O
diverse	O
BMCs	B-complex_assembly
.	O

Structure	B-experimental_method
Determination	I-experimental_method
of	O
PduL	B-protein_type

We	O
cloned	B-experimental_method
,	I-experimental_method
expressed	I-experimental_method
,	I-experimental_method
and	I-experimental_method
purified	I-experimental_method
three	O
different	O
PduL	B-protein_type
homologs	O
from	O
functionally	O
distinct	O
BMCs	B-complex_assembly
(	O
Table	O
1	O
):	O
from	O
the	O
well	O
-	O
studied	O
pdu	B-gene
locus	I-gene
in	O
S	B-species
.	I-species
enterica	I-species
Typhimurium	I-species
LT2	I-species
(	O
sPduL	B-protein
),	O
from	O
the	O
recently	O
characterized	O
pvm	B-gene
locus	I-gene
in	O
Planctomyces	B-species
limnophilus	I-species
(	O
pPduL	B-protein
),	O
and	O
from	O
the	O
grm3	B-gene
locus	I-gene
in	O
Rhodopseudomonas	B-species
palustris	I-species
BisB18	I-species
(	O
rPduL	B-protein
).	O

While	O
purifying	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
sPduL	B-protein
,	O
we	O
observed	O
a	O
tendency	O
to	O
aggregation	O
as	O
described	O
previously	O
,	O
with	O
a	O
large	O
fraction	O
of	O
the	O
expressed	O
protein	O
found	O
in	O
the	O
insoluble	O
fraction	O
in	O
a	O
white	O
,	O
cake	O
-	O
like	O
pellet	O
.	O

Remarkably	O
,	O
after	O
removing	B-experimental_method
the	O
N	O
-	O
terminal	O
putative	O
EP	B-structure_element
(	O
27	B-residue_range
amino	I-residue_range
acids	I-residue_range
),	O
most	O
of	O
the	O
sPduLΔEP	B-mutant
protein	O
was	O
in	O
the	O
soluble	O
fraction	O
upon	O
cell	O
lysis	O
.	O

Similar	O
differences	O
in	O
solubility	O
were	O
observed	O
for	O
pPduL	B-protein
and	O
rPduL	B-protein
when	O
comparing	O
EP	B-protein_state
-	I-protein_state
truncated	I-protein_state
forms	O
to	O
the	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
protein	O
,	O
but	O
none	O
were	O
quite	O
as	O
dramatic	O
as	O
for	O
sPduL	B-protein
.	O
We	O
confirmed	O
that	O
all	O
homologs	O
were	O
active	B-protein_state
(	O
S1a	O
and	O
S1b	O
Fig	O
).	O

Among	O
these	O
,	O
we	O
were	O
only	O
able	O
to	O
obtain	O
diffraction	B-evidence
-	I-evidence
quality	I-evidence
crystals	I-evidence
of	O
rPduL	B-protein
after	O
removing	B-experimental_method
the	O
N	O
-	O
terminal	O
putative	O
EP	B-structure_element
(	O
33	B-residue_range
amino	I-residue_range
acids	I-residue_range
,	O
also	O
see	O
Fig	O
2a	O
)	O
(	O
rPduLΔEP	B-mutant
).	O

Truncated	B-protein_state
rPduLΔEP	B-mutant
had	O
comparable	O
enzymatic	O
activity	O
to	O
the	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
enzyme	O
(	O
S1a	O
Fig	O
).	O

Structural	O
overview	O
of	O
R	B-species
.	I-species
palustris	I-species
PduL	B-protein_type
from	O
the	O
grm3	B-gene
locus	I-gene
.	O

(	O
a	O
)	O
Primary	O
and	O
secondary	O
structure	O
of	O
rPduL	B-protein
(	O
tubes	O
represent	O
α	B-structure_element
-	I-structure_element
helices	I-structure_element
,	O
arrows	O
β	B-structure_element
-	I-structure_element
sheets	I-structure_element
and	O
dashed	O
line	O
residues	O
disordered	O
in	O
the	O
structure	B-evidence
.	O

The	O
first	B-residue_range
33	I-residue_range
amino	I-residue_range
acids	I-residue_range
are	O
present	O
only	O
in	O
the	O
wildtype	O
construct	O
and	O
contains	O
the	O
predicted	O
EP	B-structure_element
alpha	B-structure_element
helix	I-structure_element
,	O
α0	B-structure_element
);	O
the	O
truncated	B-protein_state
rPduLΔEP	B-mutant
that	O
was	O
crystallized	B-experimental_method
begins	O
with	O
M	B-residue_name
-	O
G	B-residue_name
-	O
V	B-residue_name
.	O
Coloring	O
is	O
according	O
to	O
structural	O
domains	O
(	O
domain	B-structure_element
1	I-structure_element
D36	B-residue_range
-	I-residue_range
N46	I-residue_range
/	O
Q155	B-residue_range
-	I-residue_range
C224	I-residue_range
,	O
blue	O
;	O
loop	B-structure_element
insertion	I-structure_element
G61	B-residue_range
-	I-residue_range
E81	I-residue_range
,	O
grey	O
;	O
domain	B-structure_element
2	I-structure_element
R47	B-residue_range
-	I-residue_range
F60	I-residue_range
/	O
E82	B-residue_range
-	I-residue_range
A154	I-residue_range
,	O
red	O
).	O

Metal	B-site
coordination	I-site
residues	I-site
are	O
highlighted	O
in	O
light	O
blue	O
and	O
CoA	B-site
contacting	I-site
residues	I-site
in	O
magenta	O
,	O
residues	O
contacting	O
the	O
CoA	B-chemical
of	O
the	O
other	O
chain	O
are	O
also	O
outlined	O
.	O

(	O
b	O
)	O
Cartoon	O
representation	O
of	O
the	O
structure	B-evidence
colored	O
by	O
domains	O
and	O
including	O
secondary	O
structure	B-evidence
numbering	O
.	O

Coenzyme	B-chemical
A	I-chemical
is	O
shown	O
in	O
magenta	O
sticks	O
and	O
Zinc	B-chemical
(	O
grey	O
)	O
as	O
spheres	O
.	O

We	O
collected	B-experimental_method
a	I-experimental_method
native	I-experimental_method
dataset	I-experimental_method
from	O
rPduLΔEP	B-mutant
crystals	B-evidence
diffracting	O
to	O
a	O
resolution	O
of	O
1	O
.	O
54	O
Å	O
(	O
Table	O
2	O
).	O

Using	O
a	O
mercury	B-experimental_method
-	I-experimental_method
derivative	I-experimental_method
crystal	I-experimental_method
form	O
diffracting	O
to	O
1	O
.	O
99	O
Å	O
(	O
Table	O
2	O
),	O
we	O
obtained	O
high	O
quality	O
electron	B-evidence
density	I-evidence
for	O
model	O
building	O
and	O
used	O
the	O
initial	O
model	O
to	O
refine	O
against	O
the	O
native	O
data	O
to	O
Rwork	B-evidence
/	O
Rfree	B-evidence
values	O
of	O
18	O
.	O
9	O
/	O
22	O
.	O
1	O
%.	O

There	O
are	O
two	O
PduL	B-protein_type
molecules	O
in	O
the	O
asymmetric	O
unit	O
of	O
the	O
P212121	O
unit	O
cell	O
.	O

We	O
were	O
able	O
to	O
fit	O
all	O
of	O
the	O
primary	O
structure	O
of	O
PduLΔEP	B-mutant
into	O
the	O
electron	B-evidence
density	I-evidence
with	O
the	O
exception	O
of	O
three	O
amino	O
acids	O
at	O
the	O
N	O
-	O
terminus	O
and	O
two	O
amino	O
acids	O
at	O
the	O
C	O
-	O
terminus	O
(	O
Fig	O
2a	O
);	O
the	O
model	O
is	O
of	O
excellent	O
quality	O
(	O
Table	O
2	O
).	O

A	O
CoA	B-chemical
cofactor	O
as	O
well	O
as	O
two	O
metal	O
ions	O
are	O
clearly	O
resolved	O
in	O
the	O
density	B-evidence
(	O
for	O
omit	B-evidence
maps	I-evidence
of	O
CoA	B-chemical
see	O
S2	O
Fig	O
).	O

Structurally	O
,	O
PduL	B-protein_type
consists	O
of	O
two	O
domains	B-structure_element
(	O
Fig	O
2	O
,	O
blue	O
/	O
red	O
),	O
each	O
a	O
beta	B-structure_element
-	I-structure_element
barrel	I-structure_element
that	O
is	O
capped	O
on	O
both	O
ends	O
by	O
short	O
α	B-structure_element
-	I-structure_element
helices	I-structure_element
.	O

β	B-structure_element
-	I-structure_element
Barrel	I-structure_element
1	I-structure_element
consists	O
of	O
the	O
N	O
-	O
terminal	O
β	B-structure_element
strand	I-structure_element
and	O
β	B-structure_element
strands	I-structure_element
from	O
the	O
C	B-structure_element
-	I-structure_element
terminal	I-structure_element
half	I-structure_element
of	O
the	O
polypeptide	O
chain	O
(	O
β1	B-structure_element
,	O
β10	B-structure_element
-	I-structure_element
β14	I-structure_element
;	O
residues	O
37	B-residue_range
–	I-residue_range
46	I-residue_range
and	O
155	B-residue_range
–	I-residue_range
224	I-residue_range
).	O

β	B-structure_element
-	I-structure_element
Barrel	I-structure_element
2	I-structure_element
consists	O
mainly	O
of	O
the	O
central	O
segment	O
of	O
primary	O
structure	O
(	O
β2	B-structure_element
,	O
β5	B-structure_element
–	I-structure_element
β9	I-structure_element
;	O
residues	O
47	B-residue_range
–	I-residue_range
60	I-residue_range
and	O
82	B-residue_range
–	I-residue_range
154	I-residue_range
)	O
(	O
Fig	O
2	O
,	O
red	O
),	O
but	O
is	O
interrupted	O
by	O
a	O
short	B-structure_element
two	I-structure_element
-	I-structure_element
strand	I-structure_element
beta	I-structure_element
sheet	I-structure_element
(	O
β3	B-structure_element
-	I-structure_element
β4	I-structure_element
,	O
residues	O
61	B-residue_range
–	I-residue_range
81	I-residue_range
).	O

This	O
β	B-structure_element
-	I-structure_element
sheet	I-structure_element
is	O
involved	O
in	O
contacts	O
between	O
the	O
two	O
domains	O
and	O
forms	O
a	O
lid	O
over	O
the	O
active	B-site
site	I-site
.	O

Residues	O
in	O
this	O
region	O
(	O
Gln42	B-residue_name_number
,	O
Pro43	B-residue_name_number
,	O
Gly44	B-residue_name_number
),	O
covering	O
the	O
active	B-site
site	I-site
,	O
are	O
strongly	B-protein_state
conserved	I-protein_state
(	O
Fig	O
3	O
).	O

This	O
structural	O
arrangement	O
is	O
completely	O
different	O
from	O
the	O
functionally	O
related	O
Pta	B-protein_type
,	O
which	O
is	O
composed	O
of	O
two	O
domains	B-structure_element
,	O
each	O
consisting	O
of	O
a	O
central	O
flat	O
beta	B-structure_element
sheet	I-structure_element
with	O
alpha	B-structure_element
-	I-structure_element
helices	I-structure_element
on	O
the	O
top	O
and	O
bottom	O
.	O

Primary	O
structure	O
conservation	O
of	O
the	O
PduL	B-protein_type
protein	O
family	O
.	O

Sequence	O
logo	O
calculated	O
from	O
the	O
multiple	B-experimental_method
sequence	I-experimental_method
alignment	I-experimental_method
of	O
PduL	B-protein_type
homologs	O
(	O
see	O
Materials	O
and	O
Methods	O
),	O
but	O
not	B-protein_state
including	I-protein_state
putative	O
EP	B-structure_element
sequences	O
.	O

Residues	O
100	O
%	O
conserved	O
across	O
all	O
PduL	B-protein_type
homologs	O
in	O
our	O
dataset	O
are	O
noted	O
with	O
an	O
asterisk	O
,	O
and	O
residues	O
conserved	O
in	O
over	O
90	O
%	O
of	O
sequences	O
are	O
noted	O
with	O
a	O
colon	O
.	O

The	O
sequences	O
aligning	O
to	O
the	O
PF06130	B-structure_element
domain	O
(	O
determined	O
by	O
BLAST	O
)	O
are	O
highlighted	O
in	O
red	O
and	O
blue	O
.	O

The	O
position	O
numbers	O
shown	O
correspond	O
to	O
the	O
residue	O
numbering	O
of	O
rPduL	B-protein
;	O
note	O
that	O
some	O
positions	O
in	O
the	O
logo	O
represent	O
gaps	O
in	O
the	O
rPduL	B-protein
sequence	O
.	O

There	O
are	O
two	O
PduL	B-protein_type
molecules	O
in	O
the	O
asymmetric	O
unit	O
forming	O
a	O
butterfly	B-protein_state
-	I-protein_state
shaped	I-protein_state
dimer	B-oligomeric_state
(	O
Fig	O
4c	O
).	O

Consistent	O
with	O
this	O
,	O
results	O
from	O
size	B-experimental_method
exclusion	I-experimental_method
chromatography	I-experimental_method
of	O
rPduLΔEP	B-mutant
suggest	O
that	O
it	O
is	O
a	O
dimer	B-oligomeric_state
in	O
solution	O
(	O
Fig	O
5e	O
).	O

The	O
interface	B-site
between	O
the	O
two	O
chains	O
buries	O
882	O
Å2	O
per	O
monomer	B-oligomeric_state
and	O
is	O
mainly	O
formed	O
by	O
α	B-structure_element
-	I-structure_element
helices	I-structure_element
2	I-structure_element
and	I-structure_element
4	I-structure_element
and	O
parts	O
of	O
β	B-structure_element
-	I-structure_element
sheets	I-structure_element
12	I-structure_element
and	I-structure_element
14	I-structure_element
,	O
as	O
well	O
as	O
a	O
π	O
–	O
π	O
stacking	O
of	O
the	O
adenine	B-chemical
moiety	O
of	O
CoA	B-chemical
with	O
Phe116	B-residue_name_number
of	O
the	O
adjacent	O
chain	O
(	O
Fig	O
4c	O
).	O

The	O
folds	O
of	O
the	O
two	O
chains	O
in	O
the	O
asymmetric	O
unit	O
are	O
very	O
similar	O
,	O
superimposing	B-experimental_method
with	O
a	O
rmsd	B-evidence
of	O
0	O
.	O
16	O
Å	O
over	O
2	O
,	O
306	O
aligned	O
atom	O
pairs	O
.	O

The	O
peripheral	O
helices	B-structure_element
and	O
the	O
short	B-structure_element
antiparallel	I-structure_element
β3	I-structure_element
–	I-structure_element
4	I-structure_element
sheet	I-structure_element
mediate	O
most	O
of	O
the	O
crystal	O
contacts	O
.	O

Details	O
of	O
active	B-site
site	I-site
,	O
dimeric	B-oligomeric_state
assembly	O
,	O
and	O
sequence	O
conservation	O
of	O
PduL	B-protein_type
.	O

(	O
a	O
,	O
b	O
)	O
Proposed	O
active	B-site
site	I-site
of	O
PduL	B-protein_type
with	O
relevant	O
residues	O
shown	O
as	O
sticks	O
in	O
atom	O
coloring	O
(	O
nitrogen	B-chemical
blue	O
,	O
oxygen	B-chemical
red	O
,	O
sulfur	B-chemical
yellow	O
),	O
zinc	B-chemical
as	O
grey	O
colored	O
spheres	O
and	O
coordinating	O
ordered	O
water	B-chemical
molecules	O
in	O
red	O
.	O

Distances	O
between	O
atom	O
centers	O
are	O
indicated	O
in	O
Å	O
.	O
(	O
a	O
)	O
Coenzyme	B-chemical
A	I-chemical
containing	O
,	O
(	O
b	O
)	O
phosphate	B-protein_state
-	I-protein_state
bound	I-protein_state
structure	B-evidence
.	O

(	O
c	O
)	O
View	O
of	O
the	O
dimer	B-oligomeric_state
in	O
the	O
asymmetric	O
unit	O
from	O
the	O
side	O
,	O
domains	B-structure_element
1	I-structure_element
and	I-structure_element
2	I-structure_element
colored	O
as	O
in	O
Fig	O
2	O
and	O
the	O
two	O
chains	O
differentiated	O
by	O
blue	O
/	O
red	O
versus	O
slate	O
/	O
firebrick	O
.	O

The	O
asterisk	O
and	O
double	O
arrow	O
marks	O
the	O
location	O
of	O
the	O
π	O
–	O
π	O
interaction	O
between	O
F116	B-residue_name_number
and	O
the	O
CoA	B-chemical
base	O
of	O
the	O
other	O
dimer	B-oligomeric_state
chain	O
.	O

(	O
d	O
)	O
Surface	O
representation	O
of	O
the	O
structure	B-evidence
with	O
indicated	O
conservation	O
(	O
red	O
:	O
high	O
,	O
white	O
:	O
intermediate	O
,	O
yellow	O
:	O
low	O
).	O

Size	B-experimental_method
exclusion	I-experimental_method
chromatography	I-experimental_method
of	O
PduL	B-protein_type
homologs	O
.	O

(	O
a	O
)–(	O
c	O
):	O
Chromatograms	B-evidence
of	O
sPduL	B-protein
(	O
a	O
),	O
rPduL	B-protein
(	O
b	O
),	O
and	O
pPduL	B-protein
(	O
c	O
)	O
with	O
(	O
orange	O
)	O
or	O
without	O
(	O
blue	O
)	O
the	O
predicted	O
EP	B-structure_element
,	O
post	O
-	O
nickel	B-experimental_method
affinity	I-experimental_method
purification	I-experimental_method
,	O
applied	O
over	O
a	O
preparative	O
size	O
exclusion	O
column	O
(	O
see	O
Materials	O
and	O
Methods	O
).	O

(	O
d	O
)–(	O
f	O
):	O
Chromatograms	B-evidence
of	O
sPduL	B-protein
(	O
d	O
),	O
rPduL	B-protein
(	O
e	O
),	O
and	O
pPduL	B-protein
(	O
f	O
)	O
post	O
-	O
preparative	O
size	B-experimental_method
exclusion	I-experimental_method
chromatography	I-experimental_method
with	O
different	O
size	O
fractions	O
separated	O
,	O
applied	O
over	O
an	O
analytical	O
size	O
exclusion	O
column	O
(	O
see	O
Materials	O
and	O
Methods	O
).	O

All	O
chromatograms	B-evidence
are	O
cropped	O
to	O
show	O
only	O
the	O
linear	O
range	O
of	O
separation	O
based	O
on	O
standard	O
runs	O
,	O
shown	O
in	O
black	O
squares	O
with	O
a	O
dashed	O
linear	O
trend	O
line	O
.	O

Active	B-site
Site	I-site
Properties	O

CoA	B-chemical
and	O
the	O
metal	O
ions	O
bind	O
between	O
the	O
two	O
domains	O
,	O
presumably	O
in	O
the	O
active	B-site
site	I-site
(	O
Figs	O
2b	O
and	O
4a	O
).	O

To	O
identify	O
the	O
bound	O
metals	O
,	O
we	O
performed	O
an	O
X	B-experimental_method
-	I-experimental_method
ray	I-experimental_method
fluorescence	I-experimental_method
scan	I-experimental_method
on	O
the	O
crystals	B-evidence
at	O
various	O
wavelengths	O
(	O
corresponding	O
to	O
the	O
K	O
-	O
edges	O
of	O
Mn	B-chemical
,	O
Fe	B-chemical
,	O
Co	B-chemical
,	O
Ni	B-chemical
,	O
Cu	B-chemical
,	O
and	O
Zn	B-chemical
).	O

There	O
was	O
a	O
large	O
signal	O
at	O
the	O
zinc	O
edge	O
,	O
and	O
we	O
tested	O
for	O
the	O
presence	O
of	O
zinc	B-chemical
by	O
collecting	B-experimental_method
full	I-experimental_method
data	I-experimental_method
sets	I-experimental_method
before	I-experimental_method
and	I-experimental_method
after	I-experimental_method
the	I-experimental_method
Zn	I-experimental_method
K	I-experimental_method
-	I-experimental_method
edge	I-experimental_method
(	I-experimental_method
1	I-experimental_method
.	I-experimental_method
2861	I-experimental_method
and	I-experimental_method
1	I-experimental_method
.	I-experimental_method
2822	I-experimental_method
Å	I-experimental_method
,	O
respectively	O
).	O

The	O
large	O
differences	O
between	O
the	O
anomalous	O
signals	O
confirm	O
the	O
presence	O
of	O
zinc	B-chemical
at	O
both	O
metal	O
sites	O
(	O
S3	O
Fig	O
).	O

The	O
first	O
zinc	B-chemical
ion	O
(	O
Zn1	B-chemical
)	O
is	O
in	O
a	O
tetrahedral	O
coordination	O
state	O
with	O
His48	B-residue_name_number
,	O
His50	B-residue_name_number
,	O
Glu109	B-residue_name_number
,	O
and	O
the	O
CoA	B-chemical
sulfur	B-chemical
(	O
Fig	O
4a	O
).	O

The	O
second	O
(	O
Zn2	B-chemical
)	O
is	O
in	O
octahedral	O
coordination	O
by	O
three	O
conserved	B-protein_state
histidine	B-residue_name
residues	O
(	O
His157	B-residue_name_number
,	O
His159	B-residue_name_number
and	O
His204	B-residue_name_number
)	O
as	O
well	O
as	O
three	O
water	B-chemical
molecules	O
(	O
Fig	O
4a	O
).	O

The	O
nitrogen	O
atom	O
coordinating	O
the	O
zinc	B-chemical
is	O
the	O
Nε	O
in	O
each	O
histidine	B-residue_name
residue	O
,	O
as	O
is	O
typical	O
for	O
this	O
interaction	O
.	O

When	O
the	O
crystals	B-experimental_method
were	I-experimental_method
soaked	I-experimental_method
in	O
a	O
sodium	B-chemical
phosphate	I-chemical
solution	O
for	O
2	O
d	O
prior	O
to	O
data	O
collection	O
,	O
the	O
CoA	B-chemical
dissociates	O
,	O
and	O
density	B-evidence
for	O
a	O
phosphate	B-chemical
molecule	O
is	O
visible	O
at	O
the	O
active	B-site
site	I-site
(	O
Table	O
2	O
,	O
Fig	O
4b	O
).	O

The	O
phosphate	B-protein_state
-	I-protein_state
bound	I-protein_state
structure	B-evidence
aligns	B-experimental_method
well	O
with	O
the	O
CoA	B-protein_state
-	I-protein_state
bound	I-protein_state
structure	B-evidence
(	O
0	O
.	O
43	O
Å	O
rmsd	B-evidence
over	O
2	O
,	O
361	O
atoms	O
for	O
the	O
monomer	B-oligomeric_state
,	O
0	O
.	O
83	O
Å	O
over	O
5	O
,	O
259	O
aligned	O
atoms	O
for	O
the	O
dimer	B-oligomeric_state
).	O

The	O
phosphate	B-chemical
contacts	O
both	O
zinc	B-chemical
atoms	O
(	O
Fig	O
4b	O
)	O
and	O
replaces	O
the	O
coordination	O
by	O
CoA	B-chemical
at	O
Zn1	B-chemical
;	O
the	O
coordination	O
for	O
Zn2	B-chemical
changes	O
from	O
octahedral	O
with	O
three	O
bound	O
waters	B-chemical
to	O
tetrahedral	O
with	O
a	O
phosphate	B-chemical
ion	O
as	O
one	O
of	O
the	O
ligands	O
(	O
Fig	O
4b	O
).	O

Conserved	B-protein_state
Arg103	B-residue_name_number
seems	O
to	O
be	O
involved	O
in	O
maintaining	O
the	O
phosphate	B-chemical
in	O
that	O
position	O
.	O

The	O
two	O
zinc	B-chemical
atoms	O
are	O
slightly	O
closer	O
together	O
in	O
the	O
phosphate	B-protein_state
-	I-protein_state
bound	I-protein_state
form	O
(	O
5	O
.	O
8	O
Å	O
vs	O
6	O
.	O
3	O
Å	O
),	O
possibly	O
due	O
to	O
the	O
bridging	O
effect	O
of	O
the	O
phosphate	B-chemical
.	O

An	O
additional	O
phosphate	B-chemical
molecule	O
is	O
bound	O
at	O
a	O
crystal	O
contact	O
interface	O
,	O
perhaps	O
accounting	O
for	O
the	O
14	O
Å	O
shorter	O
c	O
-	O
axis	O
in	O
the	O
phosphate	B-protein_state
-	I-protein_state
bound	I-protein_state
crystal	O
form	O
(	O
Table	O
2	O
).	O

Oligomeric	O
States	O
of	O
PduL	B-protein_type
Orthologs	O
Are	O
Influenced	O
by	O
the	O
EP	B-structure_element

Interestingly	O
,	O
some	O
of	O
the	O
residues	O
important	O
for	O
dimerization	O
of	O
rPduL	B-protein
,	O
particularly	O
Phe116	B-residue_name_number
,	O
are	O
poorly	B-protein_state
conserved	I-protein_state
across	O
PduL	B-protein_type
homologs	O
associated	O
with	O
functionally	O
diverse	O
BMCs	B-complex_assembly
(	O
Figs	O
4c	O
and	O
3	O
),	O
suggesting	O
that	O
they	O
may	O
have	O
alternative	O
oligomeric	O
states	O
.	O

We	O
tested	O
this	O
hypothesis	O
by	O
performing	O
size	B-experimental_method
exclusion	I-experimental_method
chromatography	I-experimental_method
on	O
both	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
and	O
truncated	O
variants	O
(	O
lacking	B-protein_state
the	O
EP	B-structure_element
,	O
ΔEP	B-mutant
)	O
of	O
sPduL	B-protein
,	O
rPduL	B-protein
,	O
and	O
pPduL	B-protein
.	O
These	O
three	O
homologs	O
are	O
found	O
in	O
functionally	O
distinct	O
BMCs	B-complex_assembly
(	O
Table	O
1	O
).	O

It	O
has	O
been	O
proposed	O
that	O
the	O
catabolic	B-protein_state
BMCs	B-complex_assembly
may	O
assemble	O
in	O
a	O
core	O
-	O
first	O
manner	O
,	O
with	O
the	O
luminal	O
enzymes	O
(	O
signature	O
enzyme	O
,	O
aldehyde	B-protein_type
,	I-protein_type
and	I-protein_type
alcohol	I-protein_type
dehydrogenases	I-protein_type
and	O
the	O
BMC	B-complex_assembly
PTAC	B-protein_type
)	O
forming	O
an	O
initial	O
bolus	O
,	O
or	O
prometabolosome	O
,	O
around	O
which	O
a	O
shell	B-structure_element
assembles	O
.	O

Given	O
the	O
diversity	O
of	O
signature	O
enzymes	O
(	O
Table	O
1	O
),	O
it	O
is	O
plausible	O
that	O
PduL	B-protein_type
orthologs	O
may	O
adopt	O
different	O
oligomeric	O
states	O
that	O
reflect	O
the	O
differences	O
in	O
the	O
proteins	O
being	O
packaged	O
with	O
them	O
in	O
the	O
organelle	O
lumen	O
.	O

We	O
found	O
that	O
not	O
only	O
did	O
the	O
different	O
orthologs	O
appear	O
to	O
assemble	O
into	O
different	O
oligomeric	O
states	O
,	O
but	O
that	O
quaternary	O
structure	O
was	O
dependent	O
on	O
whether	O
or	O
not	O
the	O
EP	B-structure_element
was	O
present	O
.	O

Full	B-protein_state
-	I-protein_state
length	I-protein_state
sPduL	B-protein
was	O
unstable	O
in	O
solution	O
—	O
precipitating	O
over	O
time	O
—	O
and	O
eluted	O
throughout	O
the	O
entire	O
volume	O
of	O
a	O
size	O
exclusion	O
column	O
,	O
indicating	O
it	O
was	O
nonspecifically	O
aggregating	O
.	O

However	O
,	O
when	O
the	O
putative	O
EP	B-structure_element
(	O
residues	O
1	B-residue_range
–	I-residue_range
27	I-residue_range
)	O
was	O
removed	B-experimental_method
(	O
sPduL	B-mutant
ΔEP	I-mutant
),	O
the	O
truncated	B-protein_state
protein	O
was	O
stable	O
and	O
eluted	O
as	O
a	O
single	O
peak	O
(	O
Fig	O
5a	O
)	O
consistent	O
with	O
the	O
size	O
of	O
a	O
monomer	B-oligomeric_state
(	O
Fig	O
5d	O
,	O
blue	O
curve	O
).	O

In	O
contrast	O
,	O
both	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
rPduL	B-protein
and	O
pPduL	B-protein
appeared	O
to	O
exist	O
in	O
two	O
distinct	O
oligomeric	O
states	O
(	O
Fig	O
5b	O
and	O
5c	O
respectively	O
,	O
orange	O
curves	O
),	O
one	O
form	O
of	O
the	O
approximate	O
size	O
of	O
a	O
dimer	B-oligomeric_state
and	O
the	O
second	O
,	O
a	O
higher	O
molecular	O
weight	O
oligomer	B-oligomeric_state
(~	O
150	O
kDa	O
).	O

Upon	O
deletion	B-experimental_method
of	O
the	O
putative	O
EP	B-structure_element
(	O
residues	O
1	B-residue_range
–	I-residue_range
47	I-residue_range
for	O
rPduL	B-protein
,	O
and	O
1	B-residue_range
–	I-residue_range
20	I-residue_range
for	O
pPduL	B-protein
),	O
there	O
was	O
a	O
distinct	O
change	O
in	O
the	O
elution	O
profiles	O
(	O
Fig	O
5b	O
and	O
5c	O
respectively	O
,	O
blue	O
curves	O
).	O

pPduLΔEP	B-mutant
eluted	O
as	O
two	O
smaller	O
forms	O
,	O
possibly	O
corresponding	O
to	O
a	O
trimer	B-oligomeric_state
and	O
a	O
monomer	B-oligomeric_state
.	O

In	O
contrast	O
,	O
rPduLΔEP	B-mutant
eluted	O
as	O
one	O
smaller	O
oligomer	O
,	O
possibly	O
a	O
dimer	B-oligomeric_state
.	O

We	O
also	O
analyzed	O
purified	O
rPduL	B-protein
and	O
rPduLΔEP	B-mutant
by	O
size	B-experimental_method
exclusion	I-experimental_method
chromatography	I-experimental_method
coupled	O
with	O
multiangle	B-experimental_method
light	I-experimental_method
scattering	I-experimental_method
(	O
SEC	B-experimental_method
-	I-experimental_method
MALS	I-experimental_method
)	O
for	O
a	O
complementary	O
approach	O
to	O
assessing	O
oligomeric	O
state	O
.	O

SEC	B-experimental_method
-	I-experimental_method
MALS	I-experimental_method
analysis	O
of	O
rPdulΔEP	B-mutant
is	O
consistent	O
with	O
a	O
dimer	B-oligomeric_state
(	O
as	O
observed	O
in	O
the	O
crystal	B-evidence
structure	I-evidence
)	O
with	O
a	O
weighted	B-evidence
average	I-evidence
(	I-evidence
Mw	I-evidence
)	I-evidence
and	I-evidence
number	I-evidence
average	I-evidence
(	I-evidence
Mn	I-evidence
)	I-evidence
of	I-evidence
the	I-evidence
molar	I-evidence
mass	I-evidence
of	O
58	O
.	O
4	O
kDa	O
+/−	O
11	O
.	O
2	O
%	O
and	O
58	O
.	O
8	O
kDa	O
+/−	O
10	O
.	O
9	O
%,	O
respectively	O
(	O
S4a	O
Fig	O
).	O

rPduL	B-protein
full	B-protein_state
length	I-protein_state
runs	O
as	O
Mw	B-evidence
=	O
140	O
.	O
3	O
kDa	O
+/−	O
1	O
.	O
2	O
%	O
and	O
Mn	B-evidence
=	O
140	O
.	O
5	O
kDa	O
+/−	O
1	O
.	O
2	O
%.	O

This	O
corresponds	O
to	O
an	O
oligomeric	O
state	O
of	O
six	B-oligomeric_state
subunits	I-oligomeric_state
(	O
calculated	O
molecular	B-evidence
weight	I-evidence
of	O
144	O
kDa	O
).	O

Collectively	O
,	O
these	O
data	O
strongly	O
suggest	O
that	O
the	O
N	O
-	O
terminal	O
EP	B-structure_element
of	O
PduL	B-protein_type
plays	O
a	O
role	O
in	O
defining	O
the	O
quaternary	O
structure	O
of	O
the	O
protein	O
.	O

The	O
BMC	B-complex_assembly
shell	B-structure_element
not	O
only	O
sequesters	O
specific	O
enzymes	O
but	O
also	O
their	O
cofactors	O
,	O
thereby	O
establishing	O
a	O
private	O
cofactor	O
pool	O
dedicated	O
to	O
the	O
encapsulated	O
reactions	O
.	O

In	O
catabolic	B-protein_state
BMCs	B-complex_assembly
,	O
CoA	B-chemical
and	O
NAD	B-chemical
+	I-chemical
must	O
be	O
continually	O
recycled	O
within	O
the	O
organelle	O
(	O
Fig	O
1	O
).	O

Homologs	O
of	O
the	O
predominant	O
cofactor	O
utilizer	O
(	O
aldehyde	B-protein_type
dehydrogenase	I-protein_type
)	O
and	O
NAD	B-chemical
+	I-chemical
regenerator	O
(	O
alcohol	B-protein_type
dehydrogenase	I-protein_type
)	O
have	O
been	O
structurally	O
characterized	O
,	O
but	O
until	O
now	O
structural	O
information	O
was	O
lacking	O
for	O
PduL	B-protein_type
,	O
which	O
recycles	O
CoA	B-chemical
in	O
the	O
organelle	O
lumen	O
.	O

Curiously	O
,	O
while	O
the	O
housekeeping	B-protein_state
Pta	B-protein_type
could	O
provide	O
this	O
function	O
,	O
and	O
indeed	O
does	O
so	O
in	O
the	O
case	O
of	O
one	O
type	O
of	O
ethanolamine	B-complex_assembly
-	I-complex_assembly
utilizing	I-complex_assembly
(	I-complex_assembly
EUT	I-complex_assembly
)	I-complex_assembly
BMC	I-complex_assembly
,	O
the	O
evolutionarily	O
unrelated	O
PduL	B-protein_type
fulfills	O
this	O
function	O
for	O
the	O
majority	O
of	O
metabolosomes	B-complex_assembly
using	O
a	O
novel	O
structure	B-evidence
and	O
active	B-site
site	I-site
for	O
convergent	O
evolution	O
of	O
function	O
.	O

The	O
Tertiary	O
Structure	O
of	O
PduL	B-protein_type
Is	O
Formed	O
by	O
Discontinuous	O
Segments	O
of	O
Primary	O
Structure	O

The	O
structure	B-evidence
of	O
PduL	B-protein_type
consists	O
of	O
two	B-structure_element
β	I-structure_element
-	I-structure_element
barrel	I-structure_element
domains	I-structure_element
capped	O
by	O
short	B-structure_element
alpha	I-structure_element
helical	I-structure_element
segments	I-structure_element
(	O
Fig	O
2b	O
).	O

The	O
two	O
domains	O
are	O
structurally	O
very	O
similar	O
(	O
superimposing	B-experimental_method
with	O
a	O
rmsd	B-evidence
of	O
1	O
.	O
34	O
Å	O
(	O
over	O
123	O
out	O
of	O
320	O
/	O
348	O
aligned	O
backbone	O
atoms	O
,	O
S5a	O
Fig	O
).	O

However	O
,	O
the	O
amino	O
acid	O
sequences	O
of	O
the	O
two	O
domains	O
are	O
only	O
16	O
%	O
identical	O
(	O
mainly	O
the	O
RHxH	B-structure_element
motif	I-structure_element
,	O
β2	B-structure_element
and	O
β10	B-structure_element
),	O
and	O
34	O
%	O
similar	O
.	O

Our	O
structure	B-evidence
reveals	O
that	O
the	O
two	O
assigned	O
PF06130	B-structure_element
domains	O
(	O
Fig	O
3	O
)	O
do	O
not	O
form	O
structurally	O
discrete	O
units	O
;	O
this	O
reduces	O
the	O
apparent	O
sequence	O
conservation	O
at	O
the	O
level	O
of	O
primary	O
structure	O
.	O

One	O
strand	B-structure_element
of	O
the	O
domain	B-structure_element
1	I-structure_element
beta	B-structure_element
barrel	I-structure_element
(	O
shown	O
in	O
blue	O
in	O
Fig	O
2	O
)	O
is	O
contributed	O
by	O
the	O
N	O
-	O
terminus	O
,	O
while	O
the	O
rest	O
of	O
the	O
domain	O
is	O
formed	O
by	O
the	O
residues	O
from	O
the	O
C	B-structure_element
-	I-structure_element
terminal	I-structure_element
half	I-structure_element
of	O
the	O
protein	B-protein_type
.	O

When	O
aligned	B-experimental_method
by	O
structure	B-evidence
,	O
the	O
β1	B-structure_element
strand	I-structure_element
of	O
the	O
first	B-structure_element
domain	I-structure_element
(	O
Fig	O
2a	O
and	O
2b	O
,	O
blue	O
)	O
corresponds	O
to	O
the	O
final	B-structure_element
strand	I-structure_element
of	O
the	O
second	B-structure_element
domain	I-structure_element
(	O
β9	B-structure_element
),	O
effectively	O
making	O
the	O
domains	O
continuous	O
if	O
the	O
first	O
strand	O
was	O
transplanted	O
to	O
the	O
C	O
-	O
terminus	O
.	O

Refined	O
domain	O
assignment	O
based	O
on	O
our	O
structure	B-evidence
should	O
be	O
able	O
to	O
predict	O
domains	O
of	O
PF06130	B-structure_element
homologs	O
much	O
more	O
accurately	O
.	O

The	O
closest	O
structural	O
homolog	O
of	O
the	O
PduL	B-protein_type
barrel	B-structure_element
domain	I-structure_element
is	O
a	O
subdomain	O
of	O
a	O
multienzyme	O
complex	O
,	O
the	O
alpha	B-structure_element
subunit	I-structure_element
of	O
ethylbenzene	B-protein_type
dehydrogenase	I-protein_type
(	O
S5b	O
Fig	O
,	O
rmsd	B-evidence
of	O
2	O
.	O
26	O
Å	O
over	O
226	O
aligned	O
atoms	O
consisting	O
of	O
one	O
beta	B-structure_element
barrel	I-structure_element
and	O
one	O
capping	B-structure_element
helix	I-structure_element
).	O

In	O
contrast	O
to	O
PduL	B-protein_type
,	O
there	O
is	O
only	O
one	O
barrel	B-structure_element
present	O
in	O
ethylbenzene	B-protein_type
dehydrogenase	I-protein_type
,	O
and	O
there	O
is	O
no	O
comparable	O
active	B-site
site	I-site
arrangement	O
.	O

The	O
PduL	B-protein_type
signature	O
primary	O
structure	O
,	O
two	O
PF06130	B-structure_element
domains	O
,	O
occurs	O
in	O
some	O
multidomain	O
proteins	O
,	O
most	O
of	O
them	O
annotated	O
as	O
Acks	B-protein_type
,	O
suggesting	O
that	O
PduL	B-protein_type
may	O
also	O
replace	O
Pta	B-protein_type
in	O
variants	O
of	O
the	O
phosphotransacetylase	B-protein_type
-	O
Ack	B-protein_type
pathway	O
.	O

These	O
PduL	B-protein_type
homologs	O
lack	B-protein_state
EPs	B-structure_element
,	O
and	O
their	B-protein_type
fusion	O
to	O
Ack	B-protein_type
may	O
have	O
evolved	O
as	O
a	O
way	O
to	O
facilitate	O
substrate	O
channeling	O
between	O
the	O
two	O
enzymes	O
.	O

Implications	O
for	O
Metabolosome	B-complex_assembly
Core	O
Assembly	O

For	O
BMC	B-complex_assembly
-	O
encapsulated	O
proteins	O
to	O
properly	O
function	O
together	O
,	O
they	O
must	O
be	O
targeted	O
to	O
the	O
lumen	O
and	O
assemble	O
into	O
an	O
organization	O
that	O
facilitates	O
substrate	O
/	O
product	O
channeling	O
among	O
the	O
different	O
catalytic	B-site
sites	I-site
of	O
the	O
signature	O
and	O
core	O
enzymes	O
.	O

The	O
N	B-structure_element
-	I-structure_element
terminal	I-structure_element
extension	I-structure_element
on	O
PduL	B-protein_type
homologs	O
may	O
serve	O
both	O
of	O
these	O
functions	O
.	O

The	B-structure_element
extension	I-structure_element
shares	O
many	O
features	O
with	O
previously	O
characterized	O
EPs	B-structure_element
:	O
it	O
is	O
present	O
only	O
in	O
homologs	O
associated	O
with	O
BMC	B-gene
loci	I-gene
,	O
and	O
it	O
is	O
predicted	O
to	O
form	O
an	O
amphipathic	B-protein_state
α	B-structure_element
-	I-structure_element
helix	I-structure_element
.	O

Moreover	O
,	O
its	O
removal	B-experimental_method
affects	O
the	O
oligomeric	O
state	O
of	O
the	O
protein	O
.	O

EP	B-structure_element
-	O
mediated	O
oligomerization	O
has	O
been	O
observed	O
for	O
the	O
signature	O
and	O
core	O
BMC	B-complex_assembly
enzymes	O
;	O
for	O
example	O
,	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
propanediol	B-protein_type
dehydratase	I-protein_type
and	O
ethanolamine	B-protein_type
ammonia	I-protein_type
-	I-protein_type
lyase	I-protein_type
(	O
signature	O
enzymes	O
for	O
PDU	B-complex_assembly
and	O
EUT	B-complex_assembly
BMCs	I-complex_assembly
)	O
subunits	O
are	O
also	O
insoluble	O
,	O
but	O
become	O
soluble	O
upon	O
removal	O
of	O
the	O
predicted	O
EP	B-structure_element
.	O

sPduL	B-protein
has	O
also	O
previously	O
been	O
reported	O
to	O
localize	O
to	O
inclusion	O
bodies	O
when	O
overexpressed	B-experimental_method
;	O
we	O
show	O
here	O
that	O
this	O
is	O
dependent	O
on	O
the	O
presence	O
of	O
the	O
EP	B-structure_element
.	O

This	O
propensity	O
of	O
the	O
EP	B-structure_element
to	O
cause	O
proteins	O
to	O
form	O
complexes	O
(	O
Fig	O
5	O
)	O
might	O
not	O
be	O
a	O
coincidence	O
,	O
but	O
could	O
be	O
a	O
necessary	O
step	O
in	O
the	O
assembly	O
of	O
BMCs	B-complex_assembly
.	O

Structured	O
aggregation	O
of	O
the	O
core	O
enzymes	O
has	O
been	O
proposed	O
to	O
be	O
the	O
initial	O
step	O
in	O
metabolosome	B-complex_assembly
assembly	O
and	O
is	O
known	O
to	O
be	O
the	O
first	O
step	O
of	O
β	O
-	O
carboxysome	O
biogenesis	O
,	O
where	O
the	O
core	O
enzyme	O
Ribulose	B-protein_type
Bisphosphate	I-protein_type
Carboxylase	I-protein_type
/	I-protein_type
Oxygenase	I-protein_type
(	O
RuBisCO	B-protein_type
)	O
is	O
aggregated	O
by	O
the	O
CcmM	B-protein_type
protein	O
.	O

Likewise	O
,	O
CsoS2	B-protein_type
,	O
a	O
protein	O
in	O
the	O
α	B-complex_assembly
-	I-complex_assembly
carboxysome	I-complex_assembly
core	O
,	O
also	O
aggregates	O
when	O
purified	O
and	O
is	O
proposed	O
to	O
facilitate	O
the	O
nucleation	O
and	O
encapsulation	O
of	O
RuBisCO	B-protein_type
molecules	O
in	O
the	O
lumen	O
of	O
the	O
organelle	O
.	O

This	O
role	O
for	O
EPs	B-structure_element
in	O
BMC	B-complex_assembly
assembly	O
is	O
in	O
addition	O
to	O
their	O
interaction	O
with	O
shell	O
proteins	O
.	O

Moreover	O
,	O
the	O
PduL	B-protein_type
crystal	B-evidence
structures	I-evidence
offer	O
a	O
clue	O
as	O
to	O
how	O
required	O
cofactors	O
enter	O
the	O
BMC	B-complex_assembly
lumen	O
during	O
assembly	O
.	O

Free	O
CoA	B-chemical
and	O
NAD	B-chemical
+/	I-chemical
H	B-chemical
could	O
potentially	O
be	O
bound	O
to	O
the	O
enzymes	O
as	O
the	O
core	O
assembles	O
and	O
is	O
encapsulated	O
.	O

Our	O
PduL	B-protein_type
crystals	B-evidence
contained	O
CoA	B-chemical
that	O
was	O
captured	O
from	O
the	O
Escherichia	B-species
coli	I-species
cytosol	O
,	O
indicating	O
that	O
the	O
“	O
ground	O
state	O
”	O
of	O
PduL	B-protein_type
is	O
in	O
the	O
CoA	B-protein_state
-	I-protein_state
bound	I-protein_state
form	O
;	O
this	O
could	O
provide	O
an	O
elegantly	O
simple	O
means	O
of	O
guaranteeing	O
a	O
1	O
:	O
1	O
ratio	O
of	O
CoA	B-complex_assembly
:	I-complex_assembly
PduL	I-complex_assembly
within	O
the	O
metabolosome	B-complex_assembly
lumen	O
.	O

Active	B-site
Site	I-site
Identification	O
and	O
Structural	O
Insights	O
into	O
Catalysis	O

The	O
active	B-site
site	I-site
of	O
PduL	B-protein_type
is	O
formed	O
at	O
the	O
interface	B-site
of	O
the	O
two	O
structural	O
domains	B-structure_element
(	O
Fig	O
2b	O
).	O

As	O
expected	O
,	O
the	O
amino	O
acid	O
sequence	O
conservation	O
is	O
highest	O
in	O
the	O
region	O
around	O
the	O
proposed	O
active	B-site
site	I-site
(	O
Fig	O
4d	O
);	O
highly	B-protein_state
conserved	I-protein_state
residues	O
are	O
also	O
involved	O
in	O
CoA	B-chemical
binding	O
(	O
Figs	O
2a	O
and	O
3	O
,	O
residues	O
Ser45	B-residue_name_number
,	O
Lys70	B-residue_name_number
,	O
Arg97	B-residue_name_number
,	O
Leu99	B-residue_name_number
,	O
His204	B-residue_name_number
,	O
Asn211	B-residue_name_number
).	O

All	O
of	O
the	O
metal	B-site
-	I-site
coordinating	I-site
residues	I-site
(	O
Fig	O
2a	O
)	O
are	O
absolutely	B-protein_state
conserved	I-protein_state
,	O
implicating	O
them	O
in	O
catalysis	O
or	O
the	O
correct	O
spatial	O
orientation	O
of	O
the	O
substrates	O
.	O

Arg103	B-residue_name_number
,	O
which	O
contacts	O
the	O
phosphate	B-chemical
(	O
Fig	O
4b	O
),	O
is	O
present	O
in	O
all	O
PduL	B-protein_type
homologs	O
.	O

The	O
close	O
resemblance	O
between	O
the	O
structures	O
binding	O
CoA	B-chemical
and	O
phosphate	B-chemical
likely	O
indicates	O
that	O
no	O
large	O
changes	O
in	O
protein	O
conformation	O
are	O
involved	O
in	O
catalysis	O
,	O
and	O
that	O
our	O
crystal	B-evidence
structures	I-evidence
are	O
representative	O
of	O
the	O
active	B-protein_state
form	O
.	O

The	O
native	O
substrate	O
for	O
the	O
forward	O
reaction	O
of	O
rPduL	B-protein
and	O
pPduL	B-protein
,	O
propionyl	B-chemical
-	I-chemical
CoA	I-chemical
,	O
most	O
likely	O
binds	O
to	O
the	O
enzyme	O
in	O
the	O
same	O
way	O
at	O
the	O
observed	O
nucleotide	B-chemical
and	O
pantothenic	B-chemical
acid	I-chemical
moiety	O
,	O
but	O
the	O
propionyl	O
group	O
in	O
the	O
CoA	B-chemical
-	I-chemical
thioester	I-chemical
might	O
point	O
in	O
a	O
different	O
direction	O
.	O

There	O
is	O
a	O
pocket	B-site
nearby	O
the	O
active	B-site
site	I-site
between	O
the	O
well	B-protein_state
-	I-protein_state
conserved	I-protein_state
residues	O
Ser45	B-residue_name_number
and	O
Ala154	B-residue_name_number
,	O
which	O
could	O
accommodate	O
the	O
propionyl	O
group	O
(	O
S6	O
Fig	O
).	O

A	O
homology	B-experimental_method
model	I-experimental_method
of	O
sPduL	B-protein
indicates	O
that	O
the	O
residues	O
making	O
up	O
this	O
pocket	B-site
and	O
the	O
surrounding	O
active	B-site
site	I-site
region	O
are	O
identical	O
to	O
that	O
of	O
rPduL	B-protein
,	O
which	O
is	O
not	O
surprising	O
,	O
because	O
these	O
two	O
homologs	O
presumably	O
have	O
the	O
same	O
propionyl	B-chemical
-	I-chemical
CoA	I-chemical
substrate	O
.	O

The	O
homology	B-experimental_method
model	I-experimental_method
of	O
pPduL	B-protein
also	O
has	O
identical	O
residues	O
making	O
up	O
the	O
pocket	B-site
,	O
but	O
with	O
a	O
key	O
difference	O
in	O
the	O
vicinity	O
of	O
the	O
active	B-site
site	I-site
:	O
Gln77	B-residue_name_number
of	O
rPduL	B-protein
is	O
replaced	O
by	O
a	O
tyrosine	B-residue_name
(	O
Tyr77	B-residue_name_number
)	O
in	O
pPduL	B-protein
.	O
The	O
physiological	O
substrate	O
of	O
pPduL	B-protein
(	O
Table	O
1	O
)	O
is	O
thought	O
to	O
be	O
lactyl	B-chemical
-	I-chemical
CoA	I-chemical
,	O
which	O
contains	O
an	O
additional	O
hydroxyl	O
group	O
relative	O
to	O
propionyl	B-chemical
-	I-chemical
CoA	I-chemical
.	O
The	O
presence	O
of	O
an	O
aromatic	B-protein_state
residue	B-structure_element
at	O
this	O
position	O
may	O
underlie	O
the	O
substrate	O
preference	O
of	O
the	O
PduL	B-protein_type
enzyme	O
from	O
the	O
pvm	B-gene
locus	I-gene
.	O

Indeed	O
,	O
in	O
the	O
majority	O
of	O
PduLs	B-protein_type
encoded	O
in	O
pvm	B-gene
loci	I-gene
,	O
Gln77	B-residue_name_number
is	O
substituted	O
by	O
either	O
a	O
Tyr	B-residue_name
or	O
Phe	B-residue_name
,	O
whereas	O
it	O
is	O
typically	O
a	O
Gln	B-residue_name
or	O
Glu	B-residue_name
in	O
PduLs	B-protein_type
in	O
all	O
other	O
BMC	B-complex_assembly
types	O
that	O
degrade	O
acetyl	B-chemical
-	I-chemical
or	O
propionyl	B-chemical
-	I-chemical
CoA	I-chemical
.	O
A	O
comparison	B-experimental_method
of	O
the	O
PduL	B-protein_type
active	B-site
site	I-site
to	O
that	O
of	O
the	O
functionally	O
identical	O
Pta	B-protein_type
suggests	O
that	O
the	O
two	O
enzymes	O
have	O
distinctly	O
different	O
mechanisms	O
.	O

The	O
catalytic	O
mechanism	O
of	O
Pta	B-protein_type
involves	O
the	O
abstraction	O
of	O
a	O
thiol	O
hydrogen	O
by	O
an	O
aspartate	B-residue_name
residue	O
,	O
resulting	O
in	O
the	O
nucleophilic	O
attack	O
of	O
thiolate	O
upon	O
the	O
carbonyl	O
carbon	O
of	O
acetyl	B-chemical
-	I-chemical
phosphate	I-chemical
,	O
oriented	O
by	O
an	O
arginine	B-residue_name
and	O
stabilized	O
by	O
a	O
serine	B-residue_name
—	O
there	O
are	O
no	O
metals	O
involved	O
.	O

In	O
contrast	O
,	O
in	O
the	O
rPduL	B-protein
structure	B-evidence
,	O
there	O
are	O
no	O
conserved	O
aspartate	B-residue_name
residues	O
in	O
or	O
around	O
the	O
active	B-site
site	I-site
,	O
and	O
the	O
only	O
well	B-protein_state
-	I-protein_state
conserved	I-protein_state
glutamate	B-residue_name
residue	O
in	O
the	O
active	B-site
site	I-site
is	O
involved	O
in	O
coordinating	O
one	O
of	O
the	O
metal	O
ions	O
.	O

These	O
observations	O
strongly	O
suggest	O
that	O
an	O
acidic	B-protein_state
residue	B-structure_element
is	O
not	O
directly	O
involved	O
in	O
catalysis	O
by	O
PduL	B-protein_type
.	O
Instead	O
,	O
the	O
dimetal	B-site
active	I-site
site	I-site
of	O
PduL	B-protein_type
may	O
create	O
a	O
nucleophile	O
from	O
one	O
of	O
the	O
hydroxyl	O
groups	O
on	O
free	O
phosphate	B-chemical
to	O
attack	O
the	O
carbonyl	O
carbon	O
of	O
the	O
thioester	O
bond	O
of	O
an	O
acyl	B-chemical
-	I-chemical
CoA	I-chemical
.	O
In	O
the	O
reverse	O
direction	O
,	O
the	O
metal	O
ion	O
(	O
s	O
)	O
could	O
stabilize	O
the	O
thiolate	O
anion	O
that	O
would	O
attack	O
the	O
carbonyl	O
carbon	O
of	O
an	O
acyl	B-chemical
-	I-chemical
phosphate	I-chemical
;	O
a	O
similar	O
mechanism	O
has	O
been	O
described	O
for	O
phosphatases	B-protein_type
where	O
hydroxyl	O
groups	O
or	O
hydroxide	O
ions	O
can	O
act	O
as	O
a	O
base	O
when	O
coordinated	O
by	O
a	O
dimetal	B-site
active	I-site
site	I-site
.	O

Our	O
structures	B-evidence
provide	O
the	O
foundation	O
for	O
studies	O
to	O
elucidate	O
the	O
details	O
of	O
the	O
catalytic	O
mechanism	O
of	O
PduL	B-protein_type
.	O
Conserved	B-protein_state
residues	O
in	O
the	O
active	B-site
site	I-site
that	O
may	O
contribute	O
to	O
substrate	O
binding	O
and	O
/	O
or	O
transition	O
state	O
stabilization	O
include	O
Ser127	B-residue_name_number
,	O
Arg103	B-residue_name_number
,	O
Arg194	B-residue_name_number
,	O
Gln107	B-residue_name_number
,	O
Gln74	B-residue_name_number
,	O
and	O
Gln	B-residue_name_number
/	O
Glu77	B-residue_name_number
.	O

In	O
the	O
phosphate	B-protein_state
-	I-protein_state
bound	I-protein_state
crystal	B-evidence
structure	I-evidence
,	O
Ser127	B-residue_name_number
and	O
Arg103	B-residue_name_number
appear	O
to	O
position	O
the	O
phosphate	B-chemical
(	O
Fig	O
4b	O
).	O

Alternatively	O
,	O
Arg103	B-residue_name_number
might	O
act	O
as	O
a	O
base	O
to	O
render	O
the	O
phosphate	B-chemical
more	O
nucleophilic	O
.	O

The	O
functional	O
groups	O
of	O
Gln74	B-residue_name_number
,	O
Gln	B-residue_name_number
/	O
Glu77	B-residue_name_number
,	O
and	O
Arg194	B-residue_name_number
are	O
directed	O
away	O
from	O
the	O
active	B-site
site	I-site
in	O
both	O
CoA	B-protein_state
and	O
phosphate	B-protein_state
-	I-protein_state
bound	I-protein_state
crystal	B-evidence
structures	I-evidence
and	O
do	O
not	O
appear	O
to	O
be	O
involved	O
in	O
hydrogen	O
bonding	O
with	O
these	O
substrates	O
,	O
although	O
they	O
could	O
be	O
important	O
for	O
positioning	O
an	O
acyl	B-chemical
-	I-chemical
phosphate	I-chemical
.	O

The	O
free	O
CoA	B-protein_state
-	I-protein_state
bound	I-protein_state
form	O
is	O
presumably	O
poised	O
for	O
attack	O
upon	O
an	O
acyl	B-chemical
-	I-chemical
phosphate	I-chemical
,	O
indicating	O
that	O
the	O
enzyme	O
initially	O
binds	O
CoA	B-chemical
as	O
opposed	O
to	O
acyl	B-chemical
-	I-chemical
phosphate	I-chemical
.	O

This	O
hypothesis	O
is	O
strengthened	O
by	O
the	O
fact	O
that	O
the	O
CoA	B-protein_state
-	I-protein_state
bound	I-protein_state
crystals	B-evidence
were	O
obtained	O
without	O
added	O
CoA	B-chemical
,	O
indicating	O
that	O
the	O
protein	O
bound	B-protein_state
CoA	B-chemical
from	O
the	O
E	B-species
.	I-species
coli	I-species
expression	O
strain	O
and	O
retained	O
it	O
throughout	O
purification	O
and	O
crystallization	O
.	O

The	O
phosphate	B-protein_state
-	I-protein_state
bound	I-protein_state
structure	B-evidence
indicates	O
that	O
in	O
the	O
opposite	O
reaction	O
direction	O
phosphate	B-chemical
is	O
bound	O
first	O
,	O
and	O
then	O
an	O
acyl	B-chemical
-	I-chemical
CoA	I-chemical
enters	O
.	O

The	O
two	O
high	O
-	O
resolution	O
crystal	B-evidence
structures	I-evidence
presented	O
here	O
will	O
serve	O
as	O
the	O
foundation	O
for	O
mechanistic	O
studies	O
on	O
this	O
noncanonical	O
PTAC	B-protein_type
enzyme	O
to	O
determine	O
how	O
the	O
dimetal	B-site
active	I-site
site	I-site
functions	O
to	O
catalyze	O
both	O
forward	O
and	O
reverse	O
reactions	O
.	O

Functional	O
,	O
but	O
Not	O
Structural	O
,	O
Convergence	O
of	O
PduL	B-protein_type
and	O
Pta	B-protein_type

PduL	B-protein_type
and	O
Pta	B-protein_type
are	O
mechanistically	O
and	O
structurally	O
distinct	O
enzymes	O
that	O
catalyze	O
the	O
same	O
reaction	O
,	O
a	O
prime	O
example	O
of	O
evolutionary	O
convergence	O
upon	O
a	O
function	O
.	O

There	O
are	O
several	O
examples	O
of	O
such	O
functional	O
convergence	O
of	O
enzymes	O
,	O
although	O
typically	O
the	O
enzymes	O
have	O
independently	O
evolved	O
similar	O
,	O
or	O
even	O
identical	O
active	B-site
sites	I-site
;	O
for	O
example	O
,	O
the	O
carbonic	B-protein_type
anhydrase	I-protein_type
family	O
.	O

However	O
,	O
apparently	O
less	O
frequent	O
is	O
functional	O
convergence	O
that	O
is	O
supported	O
by	O
distinctly	O
different	O
active	B-site
sites	I-site
and	O
accordingly	O
catalytic	O
mechanism	O
,	O
as	O
revealed	O
by	O
comparison	O
of	O
the	O
structures	O
of	O
Pta	B-protein_type
and	O
PduL	B-protein_type
.	O
One	O
well	O
-	O
studied	O
example	O
of	O
this	O
is	O
the	O
β	B-protein_type
-	I-protein_type
lactamase	I-protein_type
family	O
of	O
enzymes	O
,	O
in	O
which	O
the	O
active	B-site
site	I-site
of	O
Class	O
A	O
and	O
Class	O
C	O
enzymes	O
involve	O
serine	O
-	O
based	O
catalysis	O
,	O
but	O
Class	O
B	O
enzymes	O
are	O
metalloproteins	B-protein_type
.	O

This	O
is	O
not	O
surprising	O
,	O
as	O
β	B-protein_type
-	I-protein_type
lactamases	I-protein_type
are	O
not	O
so	O
widespread	O
among	O
bacteria	B-taxonomy_domain
and	O
therefore	O
would	O
be	O
expected	O
to	O
have	O
evolved	O
independently	O
several	O
times	O
as	O
a	O
defense	O
mechanism	O
against	O
β	O
-	O
lactam	O
antibiotics	O
.	O

However	O
,	O
nearly	O
all	O
bacteria	B-taxonomy_domain
encode	O
Pta	B-protein_type
,	O
and	O
it	O
is	O
not	O
immediately	O
clear	O
why	O
the	O
Pta	B-protein_type
/	O
PduL	B-protein_type
functional	O
convergence	O
should	O
have	O
evolved	O
:	O
it	O
would	O
seem	O
to	O
be	O
evolutionarily	O
more	O
resourceful	O
for	O
the	O
Pta	B-gene
-	I-gene
encoding	I-gene
gene	I-gene
to	O
be	O
duplicated	O
and	O
repurposed	O
for	O
BMCs	B-complex_assembly
,	O
as	O
is	O
apparently	O
the	O
case	O
in	O
one	O
type	O
of	O
BMC	B-complex_assembly
—	I-complex_assembly
EUT1	I-complex_assembly
(	O
Table	O
1	O
).	O

There	O
could	O
be	O
some	O
intrinsic	O
biochemical	O
difference	O
between	O
the	O
two	O
enzymes	O
that	O
renders	O
PduL	B-protein_type
a	O
more	O
attractive	O
candidate	O
for	O
encapsulation	O
in	O
a	O
BMC	B-complex_assembly
—	O
for	O
example	O
,	O
PduL	B-protein_type
might	O
be	O
more	O
amenable	O
to	O
tight	O
packaging	O
,	O
or	O
is	O
better	O
suited	O
for	O
the	O
chemical	O
microenvironment	O
formed	O
within	O
the	O
lumen	O
of	O
the	O
BMC	B-complex_assembly
,	O
which	O
can	O
be	O
quite	O
different	O
from	O
the	O
cytosol	O
.	O

Further	O
biochemical	O
comparison	O
between	O
the	O
two	O
PTACs	B-protein_type
will	O
likely	O
yield	O
exciting	O
results	O
that	O
could	O
answer	O
this	O
evolutionary	O
question	O
.	O

BMCs	B-complex_assembly
are	O
now	O
known	O
to	O
be	O
widespread	O
among	O
the	O
bacteria	B-taxonomy_domain
and	O
are	O
involved	O
in	O
critical	O
segments	O
of	O
both	O
autotrophic	O
and	O
heterotrophic	O
biochemical	O
pathways	O
that	O
confer	O
to	O
the	O
host	O
organism	O
a	O
competitive	O
(	O
metabolic	O
)	O
advantage	O
in	O
select	O
niches	O
.	O

As	O
one	O
of	O
the	O
three	O
common	O
metabolosome	B-complex_assembly
core	O
enzymes	O
,	O
the	O
structure	B-evidence
of	O
PduL	B-protein_type
provides	O
a	O
key	O
missing	O
piece	O
to	O
our	O
structural	O
picture	O
of	O
the	O
shared	O
core	O
biochemistry	O
(	O
Fig	O
1	O
)	O
of	O
functionally	O
diverse	O
catabolic	B-protein_state
BMCs	B-complex_assembly
.	O

We	O
have	O
observed	O
the	O
oligomeric	O
state	O
differences	O
of	O
PduL	B-protein_type
to	O
correlate	O
with	O
the	O
presence	O
of	O
an	O
EP	B-structure_element
,	O
providing	O
new	O
insight	O
into	O
the	O
function	O
of	O
this	O
sequence	O
extension	O
in	O
BMC	B-complex_assembly
assembly	O
.	O

Moreover	O
,	O
our	O
results	O
suggest	O
a	O
means	O
for	O
Coenzyme	B-chemical
A	I-chemical
incorporation	O
during	O
metabolosome	B-complex_assembly
biogenesis	O
.	O

A	O
detailed	O
understanding	O
of	O
the	O
underlying	O
principles	O
governing	O
the	O
assembly	O
and	O
internal	O
structural	O
organization	O
of	O
BMCs	B-complex_assembly
is	O
a	O
requisite	O
for	O
synthetic	O
biologists	O
to	O
design	O
custom	O
nanoreactors	O
that	O
use	O
BMC	B-complex_assembly
architectures	O
as	O
a	O
template	O
.	O

Furthermore	O
,	O
given	O
the	O
growing	O
number	O
of	O
metabolosomes	B-complex_assembly
implicated	O
in	O
pathogenesis	O
,	O
the	O
PduL	B-protein_type
structure	B-evidence
will	O
be	O
useful	O
in	O
the	O
development	O
of	O
therapeutics	O
.	O

The	O
fact	O
that	O
PduL	B-protein_type
is	O
confined	O
almost	O
exclusively	O
to	O
metabolosomes	B-complex_assembly
can	O
be	O
used	O
to	O
develop	O
an	O
inhibitor	O
that	O
blocks	O
only	O
PduL	B-protein_type
and	O
not	O
Pta	B-protein_type
as	O
a	O
way	O
to	O
selectively	O
disrupt	O
BMC	B-complex_assembly
-	O
based	O
metabolism	O
,	O
while	O
not	O
affecting	O
most	O
commensal	O
organisms	O
that	O
require	O
PTAC	B-protein_type
activity	O
.	O

A	O
unified	O
mechanism	O
for	O
proteolysis	O
and	O
autocatalytic	B-ptm
activation	I-ptm
in	O
the	O
20S	B-complex_assembly
proteasome	I-complex_assembly

Biogenesis	O
of	O
the	O
20S	B-complex_assembly
proteasome	I-complex_assembly
is	O
tightly	O
regulated	O
.	O

The	O
N	O
-	O
terminal	O
propeptides	B-structure_element
protecting	O
the	O
active	B-site
-	I-site
site	I-site
threonines	B-residue_name
are	O
autocatalytically	B-ptm
released	O
only	O
on	O
completion	O
of	O
assembly	O
.	O

However	O
,	O
the	O
trigger	O
for	O
the	O
self	O
-	O
activation	O
and	O
the	O
reason	O
for	O
the	O
strict	B-protein_state
conservation	I-protein_state
of	O
threonine	B-residue_name
as	O
the	O
active	O
site	O
nucleophile	O
remain	O
enigmatic	O
.	O

Here	O
we	O
use	O
mutagenesis	B-experimental_method
,	O
X	B-experimental_method
-	I-experimental_method
ray	I-experimental_method
crystallography	I-experimental_method
and	O
biochemical	B-experimental_method
assays	I-experimental_method
to	O
suggest	O
that	O
Lys33	B-residue_name_number
initiates	O
nucleophilic	O
attack	O
of	O
the	O
propeptide	B-structure_element
by	O
deprotonating	O
the	O
Thr1	B-residue_name_number
hydroxyl	O
group	O
and	O
that	O
both	O
residues	O
together	O
with	O
Asp17	B-residue_name_number
are	O
part	O
of	O
a	O
catalytic	B-site
triad	I-site
.	O

Substitution	B-experimental_method
of	O
Thr1	B-residue_name_number
by	O
Cys	B-residue_name
disrupts	O
the	O
interaction	O
with	O
Lys33	B-residue_name_number
and	O
inactivates	B-protein_state
the	O
proteasome	B-complex_assembly
.	O

Although	O
a	O
Thr1Ser	B-mutant
mutant	B-protein_state
is	O
active	B-protein_state
,	O
it	O
is	O
less	O
efficient	O
compared	O
with	O
wild	B-protein_state
type	I-protein_state
because	O
of	O
the	O
unfavourable	O
orientation	O
of	O
Ser1	B-residue_name_number
towards	O
incoming	O
substrates	O
.	O

This	O
work	O
provides	O
insights	O
into	O
the	O
basic	O
mechanism	O
of	O
proteolysis	O
and	O
propeptide	B-ptm
autolysis	I-ptm
,	O
as	O
well	O
as	O
the	O
evolutionary	O
pressures	O
that	O
drove	O
the	O
proteasome	B-complex_assembly
to	O
become	O
a	O
threonine	B-protein_type
protease	I-protein_type
.	O

The	O
proteasome	B-complex_assembly
,	O
an	O
essential	O
molecular	O
machine	O
,	O
is	O
a	O
threonine	B-protein_type
protease	I-protein_type
,	O
but	O
the	O
evolution	O
and	O
the	O
components	O
of	O
its	O
proteolytic	O
centre	O
are	O
unclear	O
.	O

Here	O
,	O
the	O
authors	O
use	O
structural	O
biology	O
and	O
biochemistry	O
to	O
investigate	O
the	O
role	O
of	O
proteasome	B-complex_assembly
active	B-site
site	I-site
residues	O
on	O
maturation	O
and	O
activity	O
.	O

The	O
20S	B-complex_assembly
proteasome	I-complex_assembly
core	I-complex_assembly
particle	I-complex_assembly
(	O
CP	B-complex_assembly
)	O
is	O
the	O
key	O
non	B-protein_type
-	I-protein_type
lysosomal	I-protein_type
protease	I-protein_type
of	O
eukaryotic	B-taxonomy_domain
cells	O
.	O

Its	O
seven	O
different	O
α	B-protein
and	O
seven	O
different	O
β	B-protein
subunits	I-protein
assemble	O
into	O
four	O
heptameric	B-oligomeric_state
rings	B-structure_element
that	O
are	O
stacked	O
on	O
each	O
other	O
to	O
form	O
a	O
hollow	B-structure_element
cylinder	I-structure_element
.	O

While	O
the	O
inactive	B-protein_state
α	B-protein
subunits	I-protein
build	O
the	O
two	O
outer	O
rings	B-structure_element
,	O
the	O
β	B-protein
subunits	I-protein
form	O
the	O
inner	O
rings	B-structure_element
.	O

Only	O
three	O
out	O
of	O
the	O
seven	O
different	O
β	B-protein
subunits	I-protein
,	O
namely	O
β1	B-protein
,	O
β2	B-protein
and	O
β5	B-protein
,	O
bear	O
N	O
-	O
terminal	O
proteolytic	B-site
active	I-site
centres	I-site
,	O
and	O
before	O
CP	B-complex_assembly
maturation	O
these	O
are	O
protected	O
by	O
propeptides	B-structure_element
.	O

In	O
the	O
last	O
stage	O
of	O
CP	B-complex_assembly
biogenesis	O
,	O
the	O
prosegments	B-structure_element
are	O
autocatalytically	B-ptm
removed	I-ptm
through	O
nucleophilic	O
attack	O
by	O
the	O
active	B-site
site	I-site
residue	I-site
Thr1	B-residue_name_number
on	O
the	O
preceding	O
peptide	O
bond	O
involving	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
).	I-residue_name_number

Release	O
of	O
the	O
propeptides	B-structure_element
creates	O
a	O
functionally	O
active	B-protein_state
CP	B-complex_assembly
that	O
cleaves	O
proteins	O
into	O
short	O
peptides	O
.	O

Although	O
the	O
chemical	O
nature	O
of	O
the	O
substrate	B-site
-	I-site
binding	I-site
channel	I-site
and	O
hence	O
substrate	O
preferences	O
are	O
unique	O
to	O
each	O
of	O
the	O
distinct	O
active	B-protein_state
β	B-protein
subunits	I-protein
,	O
all	O
active	B-site
sites	I-site
employ	O
an	O
identical	O
reaction	O
mechanism	O
to	O
hydrolyse	O
peptide	O
bonds	O
.	O

Nucleophilic	O
attack	O
of	O
Thr1Oγ	B-residue_name_number
on	O
the	O
carbonyl	O
carbon	O
atom	O
of	O
the	O
scissile	O
peptide	O
bond	O
creates	O
a	O
first	O
cleavage	O
product	O
and	O
a	O
covalent	O
acyl	O
-	O
enzyme	O
intermediate	O
.	O

Hydrolysis	O
of	O
this	O
complex	B-complex_assembly
by	O
the	O
addition	O
of	O
a	O
nucleophilic	O
water	B-chemical
molecule	O
regenerates	O
the	O
enzyme	B-complex_assembly
and	O
releases	O
the	O
second	O
peptide	B-chemical
fragment	O
.	O

The	O
proteasome	B-complex_assembly
belongs	O
to	O
the	O
family	O
of	O
N	B-protein_type
-	I-protein_type
terminal	I-protein_type
nucleophilic	I-protein_type
(	I-protein_type
Ntn	I-protein_type
)	I-protein_type
hydrolases	I-protein_type
,	O
and	O
the	O
free	B-protein_state
N	O
-	O
terminal	O
amine	O
group	O
of	O
Thr1	B-residue_name_number
was	O
proposed	O
to	O
deprotonate	O
the	O
Thr1	B-residue_name_number
hydroxyl	O
group	O
to	O
generate	O
a	O
nucleophilic	O
Thr1Oγ	B-residue_name_number
for	O
peptide	O
-	O
bond	O
cleavage	O
.	O

This	O
mechanism	O
,	O
however	O
,	O
cannot	O
explain	O
autocatalytic	B-ptm
precursor	I-ptm
processing	I-ptm
because	O
in	O
the	O
immature	B-protein_state
active	B-site
sites	I-site
,	O
Thr1N	B-residue_name_number
is	O
part	O
of	O
the	O
peptide	O
bond	O
with	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
),	I-residue_name_number
the	O
bond	O
that	O
needs	O
to	O
be	O
hydrolysed	O
.	O

An	O
alternative	O
candidate	O
for	O
deprotonating	O
the	O
Thr1	B-residue_name_number
hydroxyl	O
group	O
is	O
the	O
side	O
chain	O
of	O
Lys33	B-residue_name_number
as	O
it	O
is	O
within	O
hydrogen	O
-	O
bonding	O
distance	O
to	O
Thr1OH	B-residue_name_number
(	O
2	O
.	O
7	O
Å	O
).	O

In	O
principle	O
it	O
could	O
function	O
as	O
the	O
general	O
base	O
during	O
both	O
autocatalytic	B-ptm
removal	I-ptm
of	O
the	O
propeptide	B-structure_element
and	O
protein	O
substrate	O
cleavage	O
.	O

Here	O
we	O
provide	O
experimental	O
evidences	O
for	O
this	O
distinct	O
view	O
of	O
the	O
proteasome	B-complex_assembly
active	B-site
-	I-site
site	I-site
mechanism	O
.	O

Data	O
from	O
biochemical	B-experimental_method
and	I-experimental_method
structural	I-experimental_method
analyses	I-experimental_method
of	O
proteasome	O
variants	O
with	O
mutations	O
in	O
the	O
β5	B-protein
propeptide	B-structure_element
and	O
the	O
active	B-site
site	I-site
strongly	O
support	O
the	O
model	O
and	O
deliver	O
novel	O
insights	O
into	O
the	O
structural	O
constraints	O
required	O
for	O
the	O
autocatalytic	B-ptm
activation	I-ptm
of	O
the	O
proteasome	B-complex_assembly
.	O

Furthermore	O
,	O
we	O
determine	O
the	O
advantages	O
of	O
Thr	B-residue_name
over	O
Cys	B-residue_name
or	O
Ser	B-residue_name
as	O
the	O
active	O
-	O
site	O
nucleophile	O
using	O
X	B-experimental_method
-	I-experimental_method
ray	I-experimental_method
crystallography	I-experimental_method
together	O
with	O
activity	B-experimental_method
and	I-experimental_method
inhibition	I-experimental_method
assays	I-experimental_method
.	O

Inactivation	O
of	O
proteasome	B-complex_assembly
subunits	B-protein
by	O
T1A	B-mutant
mutations	B-experimental_method

Proteasome	B-complex_assembly
-	O
mediated	O
degradation	O
of	O
cell	O
-	O
cycle	O
regulators	O
and	O
potentially	O
toxic	O
misfolded	O
proteins	O
is	O
required	O
for	O
the	O
viability	O
of	O
eukaryotic	B-taxonomy_domain
cells	O
.	O

Inactivation	O
of	O
the	O
active	B-site
site	I-site
Thr1	B-residue_name_number
by	O
mutation	B-experimental_method
to	I-experimental_method
Ala	B-residue_name
has	O
been	O
used	O
to	O
study	O
substrate	O
specificity	O
and	O
the	O
hierarchy	O
of	O
the	O
proteasome	B-complex_assembly
active	B-site
sites	I-site
.	O

Yeast	B-taxonomy_domain
strains	O
carrying	O
the	O
single	O
mutations	O
β1	B-mutant
-	I-mutant
T1A	I-mutant
or	O
β2	B-mutant
-	I-mutant
T1A	I-mutant
,	O
or	O
both	O
,	O
are	O
viable	O
,	O
even	O
though	O
one	O
or	O
two	O
of	O
the	O
three	O
distinct	O
catalytic	B-protein_state
β	B-protein
subunits	I-protein
are	O
disabled	B-protein_state
and	O
carry	B-protein_state
remnants	I-protein_state
of	I-protein_state
their	O
N	O
-	O
terminal	O
propeptides	B-structure_element
(	O
Table	O
1	O
).	O

These	O
results	O
indicate	O
that	O
the	O
β1	B-protein
and	O
β2	B-protein
proteolytic	O
activities	O
are	O
not	O
essential	O
for	O
cell	O
survival	O
.	O

By	O
contrast	O
,	O
the	O
T1A	B-mutant
mutation	O
in	O
subunit	O
β5	B-protein
has	O
been	O
reported	O
to	O
be	O
lethal	O
or	O
nearly	O
so	O
.	O

Viability	O
is	O
restored	O
if	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
subunit	O
has	O
its	O
propeptide	B-structure_element
(	O
pp	B-chemical
)	O
deleted	B-experimental_method
but	I-experimental_method
expressed	I-experimental_method
separately	I-experimental_method
in	O
trans	B-protein_state
(	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
pp	B-chemical
trans	B-protein_state
),	O
although	O
substantial	O
phenotypic	O
impairment	O
remains	O
(	O
Table	O
1	O
).	O

Our	O
present	O
crystallographic	B-experimental_method
analysis	I-experimental_method
of	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
pp	B-chemical
trans	B-protein_state
mutant	B-protein_state
demonstrates	O
that	O
the	O
mutation	B-experimental_method
per	O
se	O
does	O
not	O
structurally	O
alter	O
the	O
catalytic	B-site
active	I-site
site	I-site
and	O
that	O
the	O
trans	B-experimental_method
-	I-experimental_method
expressed	I-experimental_method
β5	B-protein
propeptide	B-structure_element
is	O
not	B-protein_state
bound	I-protein_state
in	O
the	O
β5	B-protein
substrate	B-site
-	I-site
binding	I-site
channel	I-site
(	O
Supplementary	O
Fig	O
.	O
1a	O
).	O

The	O
extremely	O
weak	O
growth	O
of	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
mutant	B-protein_state
pp	B-chemical
cis	B-protein_state
described	O
by	O
Chen	O
and	O
Hochstrasser	O
compared	O
with	O
the	O
inviability	O
reported	O
by	O
Heinemeyer	O
et	O
al	O
.	O
prompted	O
us	O
to	O
analyse	O
this	O
discrepancy	O
.	O

Sequencing	B-experimental_method
of	I-experimental_method
the	I-experimental_method
plasmids	I-experimental_method
,	O
testing	O
them	O
in	O
both	O
published	O
yeast	B-taxonomy_domain
strain	O
backgrounds	O
and	O
site	B-experimental_method
-	I-experimental_method
directed	I-experimental_method
mutagenesis	I-experimental_method
revealed	O
that	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
mutant	B-protein_state
pp	B-chemical
cis	B-protein_state
is	O
viable	O
,	O
but	O
suffers	O
from	O
a	O
marked	O
growth	O
defect	O
that	O
requires	O
extended	O
incubation	O
of	O
4	O
–	O
5	O
days	O
for	O
initial	O
colony	O
formation	O
(	O
Table	O
1	O
and	O
Supplementary	O
Methods	O
).	O

We	O
also	O
identified	O
an	O
additional	O
point	O
mutation	O
K81R	B-mutant
in	O
subunit	O
β5	B-protein
that	O
was	O
present	O
in	O
the	O
allele	O
used	O
in	O
ref	O
..	O
This	B-experimental_method
single	I-experimental_method
amino	I-experimental_method
-	I-experimental_method
acid	I-experimental_method
exchange	I-experimental_method
is	O
located	O
at	O
the	O
interface	B-site
of	O
the	O
subunits	O
α4	B-protein
,	O
β4	B-protein
and	O
β5	B-protein
(	O
Supplementary	O
Fig	O
.	O
1b	O
)	O
and	O
might	O
weakly	O
promote	O
CP	B-complex_assembly
assembly	O
by	O
enhancing	O
inter	O
-	O
subunit	O
contacts	O
.	O

The	O
slightly	O
better	O
growth	O
of	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
K81R	I-mutant
mutant	B-protein_state
allowed	O
us	O
to	O
solve	O
the	O
crystal	B-evidence
structure	I-evidence
of	O
a	O
yeast	B-taxonomy_domain
proteasome	B-complex_assembly
(	O
yCP	B-complex_assembly
)	O
with	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
mutation	O
,	O
which	O
is	O
discussed	O
in	O
the	O
following	O
section	O
(	O
for	O
details	O
see	O
Supplementary	O
Note	O
1	O
).	O

Propeptide	B-structure_element
conformation	O
and	O
triggering	O
of	O
autolysis	B-ptm

In	O
the	O
final	O
steps	O
of	O
proteasome	B-complex_assembly
biogenesis	O
,	O
the	O
propeptides	B-structure_element
are	O
autocatalytically	B-ptm
cleaved	I-ptm
from	O
the	O
mature	B-protein_state
β	B-protein
-	I-protein
subunit	I-protein
domains	I-protein
.	O

For	O
subunit	O
β1	B-protein
,	O
this	O
process	O
was	O
previously	O
inferred	O
to	O
require	O
that	O
the	O
propeptide	B-structure_element
residue	O
at	O
position	O
(-	B-residue_number
2	I-residue_number
)	I-residue_number
of	O
the	O
subunit	O
precursor	O
occupies	O
the	O
S1	B-site
specificity	I-site
pocket	I-site
of	O
the	O
substrate	B-site
-	I-site
binding	I-site
channel	I-site
formed	O
by	O
amino	O
acid	O
45	B-residue_number
(	O
for	O
details	O
see	O
Supplementary	O
Note	O
2	O
).	O

Furthermore	O
,	O
it	O
was	O
observed	O
that	O
the	O
prosegment	B-structure_element
forms	O
an	O
antiparallel	B-structure_element
β	I-structure_element
-	I-structure_element
sheet	I-structure_element
in	O
the	O
active	B-site
site	I-site
,	O
and	O
that	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
adopts	O
a	O
γ	B-structure_element
-	I-structure_element
turn	I-structure_element
conformation	I-structure_element
,	O
which	O
by	O
definition	O
is	O
characterized	O
by	O
a	O
hydrogen	O
bond	O
between	O
Leu	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
O	O
and	O
Thr1NH	B-residue_name_number
(	O
ref	O
.).	O

Here	O
we	O
again	O
analysed	O
the	O
β1	B-mutant
-	I-mutant
T1A	I-mutant
mutant	B-protein_state
crystallographically	B-experimental_method
but	O
in	O
addition	O
determined	O
the	O
structures	B-evidence
of	O
the	O
β2	B-mutant
-	I-mutant
T1A	I-mutant
single	O
and	O
β1	B-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
β2	I-mutant
-	I-mutant
T1A	I-mutant
double	O
mutants	O
(	O
Protein	O
Data	O
Bank	O
(	O
PDB	O
)	O
entry	O
codes	O
are	O
provided	O
in	O
Supplementary	O
Table	O
1	O
).	O

In	O
subunit	O
β1	B-protein
,	O
we	O
found	O
that	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
indeed	O
forms	O
a	O
sharp	B-structure_element
turn	I-structure_element
,	O
which	O
relaxes	O
on	O
prosegment	B-ptm
cleavage	I-ptm
(	O
Fig	O
.	O
1a	O
and	O
Supplementary	O
Fig	O
.	O
2a	O
).	O

However	O
,	O
the	O
γ	B-structure_element
-	I-structure_element
turn	I-structure_element
conformation	I-structure_element
and	O
the	O
associated	O
hydrogen	O
bond	O
initially	O
proposed	O
is	O
for	O
geometric	O
and	O
chemical	O
reasons	O
inappropriate	O
and	O
would	O
not	O
perfectly	O
position	O
the	O
carbonyl	O
carbon	O
atom	O
of	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
for	O
nucleophilic	O
attack	O
by	O
Thr1	B-residue_name_number
.	O

Regarding	O
the	O
β2	B-protein
propeptide	B-structure_element
,	O
Thr	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
occupies	O
the	O
S1	B-site
pocket	I-site
but	O
is	O
less	O
deeply	O
anchored	O
compared	O
with	O
Leu	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
in	O
β1	B-protein
,	O
which	O
might	O
be	O
due	O
to	O
the	O
rather	O
large	O
β2	B-protein
-	O
S1	B-site
pocket	I-site
created	O
by	O
Gly45	B-residue_name_number
.	O

Thr	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
positions	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
O	O
via	O
hydrogen	O
bonding	O
(∼	O
2	O
.	O
8	O
Å	O
)	O
in	O
a	O
perfect	O
trajectory	O
for	O
the	O
nucleophilic	O
attack	O
by	O
Thr1Oγ	B-residue_name_number
(	O
Fig	O
.	O
1b	O
and	O
Supplementary	O
Fig	O
.	O
2b	O
).	O

Next	O
,	O
we	O
examined	O
the	O
position	O
of	O
the	O
β5	B-protein
propeptide	B-structure_element
in	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
K81R	I-mutant
mutant	B-protein_state
.	O

Surprisingly	O
,	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
is	O
completely	O
extended	O
and	O
forces	O
the	O
histidine	B-residue_name
side	O
chain	O
at	O
position	O
(-	B-residue_number
2	I-residue_number
)	I-residue_number
to	O
occupy	O
the	O
S2	B-site
instead	O
of	O
the	O
S1	B-site
pocket	I-site
,	O
thereby	O
disrupting	O
the	O
antiparallel	B-structure_element
β	I-structure_element
-	I-structure_element
sheet	I-structure_element
.	O

Nonetheless	O
,	O
the	O
carbonyl	O
carbon	O
of	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
would	O
be	O
ideally	O
placed	O
for	O
nucleophilic	O
attack	O
by	O
Thr1Oγ	B-residue_name_number
(	O
Fig	O
.	O
1c	O
and	O
Supplementary	O
Fig	O
.	O
2c	O
,	O
d	O
).	O

As	O
the	O
K81R	B-mutant
mutation	O
is	O
located	O
far	O
from	O
the	O
active	B-site
site	I-site
(	O
Thr1Cα	B-residue_name_number
–	O
Arg81Cα	B-residue_name_number
:	O
24	O
Å	O
),	O
any	O
influence	O
on	O
propeptide	B-structure_element
conformation	O
can	O
be	O
excluded	O
.	O

Instead	O
,	O
the	O
plasticity	O
of	O
the	O
β5	B-protein
S1	B-site
pocket	I-site
caused	O
by	O
the	O
rotational	O
flexibility	O
of	O
Met45	B-residue_name_number
might	O
prevent	O
stable	O
accommodation	O
of	O
His	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
in	O
the	O
S1	B-site
site	I-site
and	O
thus	O
also	O
promote	O
its	O
immediate	O
release	O
after	O
autolysis	B-ptm
.	O

Processing	O
of	O
β	O
-	O
subunit	O
precursors	O
requires	O
deprotonation	O
of	O
Thr1OH	B-residue_name_number
;	O
however	O
,	O
the	O
general	O
base	O
initiating	O
autolysis	B-ptm
is	O
unknown	O
.	O

Remarkably	O
,	O
eukaryotic	B-taxonomy_domain
proteasomal	O
β5	B-protein
subunits	O
bear	O
a	O
His	B-residue_name
residue	O
in	O
position	O
(-	B-residue_number
2	I-residue_number
)	I-residue_number
of	O
the	O
propeptide	B-structure_element
(	O
Supplementary	O
Fig	O
.	O
3a	O
).	O

As	O
histidine	B-residue_name
commonly	O
functions	O
as	O
a	O
proton	O
shuttle	O
in	O
the	O
catalytic	B-site
triads	I-site
of	O
serine	B-protein_type
proteases	I-protein_type
,	O
we	O
investigated	O
the	O
role	O
of	O
His	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
in	O
processing	O
of	O
the	O
β5	B-protein
propeptide	B-structure_element
by	O
exchanging	B-experimental_method
it	I-experimental_method
for	I-experimental_method
Asn	B-residue_name
,	O
Lys	B-residue_name
,	O
Phe	B-residue_name
and	O
Ala	B-residue_name
.	O
All	O
yeast	B-taxonomy_domain
mutants	O
were	O
viable	O
at	O
30	O
°	O
C	O
,	O
but	O
suffered	O
from	O
growth	O
defects	O
at	O
37	O
°	O
C	O
with	O
the	O
H	B-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
N	I-mutant
and	O
H	B-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
F	I-mutant
mutants	O
being	O
most	O
affected	O
(	O
Supplementary	O
Fig	O
.	O
3b	O
and	O
Table	O
1	O
).	O

In	O
agreement	O
,	O
the	O
chymotrypsin	O
-	O
like	O
(	O
ChT	O
-	O
L	O
)	O
activity	O
of	O
H	B-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
N	I-mutant
and	O
H	B-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
F	I-mutant
mutant	B-protein_state
yCPs	B-complex_assembly
was	O
impaired	O
in	O
situ	O
and	O
in	O
vitro	O
(	O
Supplementary	O
Fig	O
.	O
3c	O
).	O

Structural	B-experimental_method
analyses	I-experimental_method
revealed	O
that	O
the	O
propeptides	B-structure_element
of	O
all	O
mutant	B-protein_state
yCPs	B-complex_assembly
shared	O
residual	O
2FO	B-evidence
–	I-evidence
FC	I-evidence
electron	I-evidence
densities	I-evidence
.	O

Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
and	O
Phe	B-residue_name
/	O
Lys	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
were	O
visualized	O
at	O
low	O
occupancy	O
,	O
while	O
Ala	B-residue_name
/	O
Asn	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
could	O
not	O
be	O
assigned	O
.	O

This	O
observation	O
indicates	O
a	O
mixture	O
of	O
processed	B-protein_state
and	O
unprocessed	B-protein_state
β5	B-protein
subunits	O
and	O
partially	O
impaired	O
autolysis	B-ptm
,	O
thereby	O
excluding	O
any	O
essential	O
role	O
of	O
residue	O
(-	B-residue_number
2	I-residue_number
)	I-residue_number
as	O
the	O
general	O
base	O
.	O

Next	O
,	O
we	O
examined	O
the	O
effect	O
of	O
residue	O
(-	B-residue_number
2	I-residue_number
)	I-residue_number
on	O
the	O
orientation	O
of	O
the	O
propeptide	B-structure_element
by	O
creating	B-experimental_method
mutants	I-experimental_method
that	I-experimental_method
combine	I-experimental_method
the	O
T1A	B-mutant
(	O
K81R	B-mutant
)	O
mutation	B-experimental_method
(	I-experimental_method
s	I-experimental_method
)	I-experimental_method
with	O
H	B-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
L	I-mutant
,	O
H	B-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
T	I-mutant
or	O
H	B-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
A	I-mutant
substitutions	B-experimental_method
.	O

Leu	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
is	O
encoded	O
in	O
the	O
yeast	B-taxonomy_domain
β1	B-protein
subunit	O
precursor	O
(	O
Supplementary	O
Fig	O
.	O
3a	O
);	O
Thr	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
is	O
generally	O
part	O
of	O
β2	B-protein
-	O
propeptides	B-structure_element
(	O
Supplementary	O
Fig	O
.	O
3a	O
);	O
and	O
Ala	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
was	O
expected	O
to	O
fit	O
the	O
β5	B-protein
-	O
S1	B-site
pocket	I-site
without	O
inducing	O
conformational	O
changes	O
of	O
Met45	B-residue_name_number
,	O
allowing	O
it	O
to	O
accommodate	O
‘	O
β1	O
-	O
like	O
'	O
propeptide	O
positioning	O
.	O

As	O
expected	O
from	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
mutants	O
,	O
the	O
yeasts	B-taxonomy_domain
show	O
severe	O
growth	O
phenotypes	O
,	O
with	O
minor	O
variations	O
(	O
Supplementary	O
Fig	O
.	O
4a	O
and	O
Table	O
1	O
).	O

We	O
determined	O
crystal	B-evidence
structures	I-evidence
of	O
the	O
β5	B-mutant
-	I-mutant
H	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
L	I-mutant
-	I-mutant
T1A	I-mutant
,	O
β5	B-mutant
-	I-mutant
H	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
T	I-mutant
-	I-mutant
T1A	I-mutant
and	O
the	O
β5	B-mutant
-	I-mutant
H	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
A	I-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
K81R	I-mutant
mutants	O
(	O
Supplementary	O
Table	O
1	O
).	O

For	O
the	O
β5	B-mutant
-	I-mutant
H	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
A	I-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
K81R	I-mutant
variant	O
,	O
only	O
the	O
residues	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
and	O
Ala	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
could	O
be	O
visualized	O
,	O
indicating	O
that	O
Ala	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
leads	O
to	O
insufficient	O
stabilization	O
of	O
the	O
propeptide	B-structure_element
in	O
the	O
substrate	B-site
-	I-site
binding	I-site
channel	I-site
(	O
Supplementary	O
Fig	O
.	O
4d	O
).	O

By	O
contrast	O
,	O
the	O
prosegments	B-structure_element
of	O
the	O
β5	B-mutant
-	I-mutant
H	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
L	I-mutant
-	I-mutant
T1A	I-mutant
and	O
the	O
β5	B-mutant
-	I-mutant
H	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
T	I-mutant
-	I-mutant
T1A	I-mutant
mutants	O
were	O
significantly	O
better	O
resolved	O
in	O
the	O
2FO	B-evidence
–	I-evidence
FC	I-evidence
electron	I-evidence
-	I-evidence
density	I-evidence
maps	I-evidence
yet	O
not	O
at	O
full	O
occupancy	O
(	O
Supplementary	O
Fig	O
.	O
4b	O
,	O
c	O
and	O
Supplementary	O
Table	O
1	O
),	O
suggesting	O
that	O
the	O
natural	O
propeptide	B-structure_element
bearing	O
His	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
is	O
most	O
favourable	O
.	O

Nevertheless	O
,	O
both	O
Leu	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
and	O
Thr	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
were	O
found	O
to	O
occupy	O
the	O
S1	B-site
specificity	I-site
pocket	I-site
formed	O
by	O
Met45	B-residue_name_number
(	O
Fig	O
.	O
2a	O
,	O
b	O
and	O
Supplementary	O
Fig	O
.	O
4f	O
–	O
h	O
).	O

This	O
result	O
proves	O
that	O
the	O
naturally	O
occurring	O
His	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
of	O
the	O
β5	B-protein
propeptide	B-structure_element
does	O
not	O
stably	O
fit	O
into	O
the	O
S1	B-site
site	I-site
.	O

Since	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
adopts	O
the	O
same	O
position	O
in	O
both	O
wild	B-protein_state
-	I-protein_state
type	I-protein_state
(	O
WT	B-protein_state
)	O
and	O
mutant	B-protein_state
β5	B-protein
propeptides	B-structure_element
,	O
and	O
since	O
in	O
all	O
cases	O
its	O
carbonyl	O
carbon	O
is	O
perfectly	O
placed	O
for	O
nucleophilic	O
attack	O
by	O
Thr1Oγ	B-residue_name_number
(	O
Fig	O
.	O
2b	O
),	O
we	O
propose	O
that	O
neither	O
binding	O
of	O
residue	O
(-	B-residue_number
2	I-residue_number
)	I-residue_number
to	O
the	O
S1	B-site
pocket	I-site
nor	O
formation	O
of	O
the	O
antiparallel	B-structure_element
β	I-structure_element
-	I-structure_element
sheet	I-structure_element
is	O
essential	O
for	O
autolysis	B-ptm
of	O
the	O
propeptide	B-structure_element
.	O

Next	O
,	O
we	O
determined	O
the	O
crystal	B-evidence
structure	I-evidence
of	O
a	O
chimeric	B-protein_state
yCP	B-complex_assembly
having	O
the	O
yeast	B-taxonomy_domain
β1	B-protein
-	O
propeptide	B-structure_element
replaced	B-experimental_method
by	I-experimental_method
its	O
β5	B-protein
counterpart	B-structure_element
.	O

Although	O
we	O
observed	O
fragments	O
of	O
2FO	B-evidence
–	I-evidence
FC	I-evidence
electron	I-evidence
density	I-evidence
in	O
the	O
β1	B-protein
active	B-site
site	I-site
,	O
the	O
data	O
were	O
not	O
interpretable	O
.	O

Bearing	O
in	O
mind	O
that	O
in	O
contrast	O
to	O
Thr	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
in	O
β2	B-protein
,	O
Leu	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
in	O
subunit	O
β1	B-protein
is	O
not	B-protein_state
conserved	I-protein_state
among	O
species	O
(	O
Supplementary	O
Fig	O
.	O
3a	O
),	O
we	O
created	B-experimental_method
a	O
β2	B-mutant
-	I-mutant
T	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
V	I-mutant
proteasome	B-complex_assembly
mutant	B-protein_state
.	O

As	O
proven	O
by	O
the	O
β2	B-mutant
-	I-mutant
T1A	I-mutant
crystal	B-evidence
structures	I-evidence
,	O
Thr	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
hydrogen	O
bonds	O
to	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
O	O
.	O
Although	O
this	O
interaction	O
was	O
not	O
observed	O
for	O
the	O
β5	B-mutant
-	I-mutant
H	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
T	I-mutant
-	I-mutant
T1A	I-mutant
mutant	B-protein_state
(	O
Fig	O
.	O
2c	O
and	O
Supplementary	O
Fig	O
.	O
4c	O
,	O
i	O
),	O
exchange	B-experimental_method
of	O
Thr	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
by	O
Val	B-residue_name
in	O
β2	B-protein
,	O
a	O
conservative	O
mutation	O
regarding	O
size	O
but	O
drastic	O
with	O
respect	O
to	O
polarity	O
,	O
was	O
found	O
to	O
inhibit	O
maturation	O
of	O
this	O
subunit	O
(	O
Fig	O
.	O
2d	O
and	O
Supplementary	O
Fig	O
.	O
4e	O
,	O
j	O
).	O

Notably	O
,	O
the	O
2FO	B-evidence
–	I-evidence
FC	I-evidence
electron	I-evidence
-	I-evidence
density	I-evidence
map	I-evidence
displays	O
a	O
different	O
orientation	O
for	O
the	O
β2	B-protein
propeptide	B-structure_element
than	O
has	O
been	O
observed	O
for	O
the	O
β2	B-mutant
-	I-mutant
T1A	I-mutant
proteasome	B-complex_assembly
.	O

In	O
particular	O
,	O
Val	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
is	O
displaced	O
from	O
the	O
S1	B-site
site	I-site
and	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
is	O
severely	O
shifted	O
(	O
movement	O
of	O
the	O
carbonyl	O
oxygen	O
atom	O
of	O
3	O
.	O
8	O
Å	O
),	O
thereby	O
preventing	O
nucleophilic	O
attack	O
of	O
Thr1	B-residue_name_number
(	O
Fig	O
.	O
2d	O
and	O
Supplementary	O
Fig	O
.	O
4j	O
,	O
k	O
).	O

These	O
results	O
further	O
confirm	O
that	O
correct	O
positioning	O
of	O
the	O
active	B-site
-	I-site
site	I-site
residues	I-site
and	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
is	O
decisive	O
for	O
the	O
maturation	O
of	O
the	O
proteasome	B-complex_assembly
.	O

The	O
active	B-site
site	I-site
of	O
the	O
proteasome	B-complex_assembly

Proton	O
shuttling	O
from	O
the	O
proteasomal	O
active	B-site
site	I-site
Thr1OH	B-residue_name_number
to	O
Thr1NH2	B-residue_name_number
via	O
a	O
nucleophilic	O
water	B-chemical
molecule	O
was	O
suggested	O
to	O
initiate	O
peptide	O
-	O
bond	O
hydrolysis	O
.	O

However	O
,	O
in	O
the	O
immature	B-protein_state
particle	B-complex_assembly
Thr1NH2	B-residue_name_number
is	O
blocked	O
by	O
the	O
propeptide	B-structure_element
and	O
cannot	O
activate	O
Thr1Oγ	B-residue_name_number
.	O

Instead	O
,	O
Lys33NH2	B-residue_name_number
,	O
which	O
is	O
in	O
hydrogen	O
-	O
bonding	O
distance	O
to	O
Thr1Oγ	B-residue_name_number
(	O
2	O
.	O
7	O
Å	O
)	O
in	O
all	O
catalytically	B-protein_state
active	I-protein_state
β	B-protein
subunits	I-protein
(	O
Fig	O
.	O
3a	O
,	O
b	O
),	O
was	O
proposed	O
to	O
serve	O
as	O
the	O
proton	O
acceptor	O
.	O

A	O
proposed	O
catalytic	B-site
tetrad	I-site
model	O
involving	O
Thr1OH	B-residue_name_number
,	O
Thr1NH2	B-residue_name_number
,	O
Lys33NH2	B-residue_name_number
and	O
Asp17Oδ	B-residue_name_number
,	O
as	O
well	O
as	O
a	O
nucleophilic	O
water	B-chemical
molecule	O
as	O
the	O
proton	O
shuttle	O
appeared	O
to	O
accommodate	O
all	O
possible	O
views	O
of	O
the	O
proteasomal	O
active	B-site
site	I-site
.	O

Twenty	O
years	O
later	O
,	O
with	O
a	O
plethora	O
of	O
yCP	B-complex_assembly
X	B-evidence
-	I-evidence
ray	I-evidence
structures	I-evidence
in	O
hand	O
,	O
we	O
decided	O
to	O
re	O
-	O
analyse	O
the	O
active	B-site
site	I-site
of	O
the	O
proteasome	B-complex_assembly
and	O
to	O
resolve	O
the	O
uncertainty	O
regarding	O
the	O
nature	O
of	O
the	O
general	O
base	O
.	O

Mutation	B-experimental_method
of	O
β5	B-protein
-	O
Lys33	B-residue_name_number
to	O
Ala	B-residue_name
causes	O
a	O
strongly	O
deleterious	O
phenotype	O
,	O
and	O
previous	O
structural	B-experimental_method
and	I-experimental_method
biochemical	I-experimental_method
analyses	I-experimental_method
confirmed	O
that	O
this	O
is	O
caused	O
by	O
failure	O
of	O
propeptide	B-ptm
cleavage	I-ptm
,	O
and	O
consequently	O
,	O
lack	O
of	O
ChT	O
-	O
L	O
activity	O
(	O
Fig	O
.	O
4a	O
,	O
Supplementary	O
Fig	O
.	O
3b	O
and	O
Table	O
1	O
;	O
for	O
details	O
see	O
Supplementary	O
Note	O
1	O
).	O

The	O
phenotype	O
of	O
the	O
β5	B-mutant
-	I-mutant
K33A	I-mutant
mutant	B-protein_state
was	O
however	O
less	O
pronounced	O
than	O
for	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
K81R	I-mutant
yeast	B-taxonomy_domain
(	O
Fig	O
.	O
4a	O
).	O

This	O
discrepancy	O
in	O
growth	O
was	O
traced	O
to	O
an	O
additional	O
point	O
mutation	O
L	B-mutant
(-	I-mutant
49	I-mutant
)	I-mutant
S	I-mutant
in	O
the	O
β5	B-protein
-	O
propeptide	B-structure_element
of	O
the	O
β5	B-mutant
-	I-mutant
K33A	I-mutant
mutant	B-protein_state
(	O
see	O
also	O
Supplementary	O
Note	O
1	O
).	O

Structural	B-experimental_method
comparison	I-experimental_method
of	O
the	O
β5	B-mutant
-	I-mutant
L	I-mutant
(-	I-mutant
49	I-mutant
)	I-mutant
S	I-mutant
-	I-mutant
K33A	I-mutant
and	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
K81R	I-mutant
active	B-site
sites	I-site
revealed	O
that	O
mutation	B-experimental_method
of	O
Lys33	B-residue_name_number
to	O
Ala	B-residue_name
creates	O
a	O
cavity	O
that	O
is	O
filled	O
with	O
Thr1	B-residue_name_number
and	O
the	O
remnant	O
propeptide	B-structure_element
.	O

This	O
structural	O
alteration	O
destroys	O
active	B-site
-	I-site
site	I-site
integrity	O
and	O
abolishes	O
catalytic	O
activity	O
of	O
the	O
β5	B-protein
active	B-site
site	I-site
(	O
Supplementary	O
Fig	O
.	O
5a	O
).	O

Additional	O
proof	O
for	O
the	O
key	O
function	O
of	O
Lys33	B-residue_name_number
was	O
obtained	O
from	O
the	O
β5	B-mutant
-	I-mutant
K33A	I-mutant
mutant	B-protein_state
,	O
with	O
the	O
propeptide	B-structure_element
expressed	B-experimental_method
separately	I-experimental_method
from	O
the	O
main	O
subunit	O
(	O
pp	B-chemical
trans	B-protein_state
).	O

The	O
Thr1	B-residue_name_number
N	O
terminus	O
of	O
this	O
mutant	B-protein_state
is	O
not	O
blocked	O
by	O
the	O
propeptide	B-structure_element
,	O
yet	O
its	O
catalytic	O
activity	O
is	O
reduced	O
by	O
∼	O
83	O
%	O
(	O
Supplementary	O
Fig	O
.	O
6b	O
).	O

Consistent	O
with	O
this	O
,	O
the	O
crystal	B-evidence
structure	I-evidence
of	O
the	O
β5	B-mutant
-	I-mutant
K33A	I-mutant
pp	B-chemical
trans	B-protein_state
mutant	B-protein_state
in	B-protein_state
complex	I-protein_state
with	I-protein_state
carfilzomib	B-chemical
only	O
showed	O
partial	O
occupancy	O
of	O
the	O
ligand	O
at	O
the	O
β5	B-protein
active	B-site
sites	I-site
(	O
Supplementary	O
Fig	O
.	O
5b	O
and	O
Supplementary	O
Table	O
1	O
).	O

Since	O
no	O
acetylation	B-ptm
of	O
the	O
Thr1	B-residue_name_number
N	O
terminus	O
was	O
observed	O
for	O
the	O
β5	B-mutant
-	I-mutant
K33A	I-mutant
pp	B-chemical
trans	B-protein_state
apo	B-protein_state
crystal	B-evidence
structure	I-evidence
,	O
the	O
reduced	O
reactivity	O
towards	O
substrates	O
and	O
inhibitors	O
indicates	O
that	O
Lys33NH2	B-residue_name_number
,	O
rather	O
than	O
Thr1NH2	B-residue_name_number
,	O
deprotonates	O
and	O
activates	O
Thr1OH	B-residue_name_number
.	O

Furthermore	O
,	O
the	O
crystal	B-evidence
structure	I-evidence
of	O
the	O
β5	B-mutant
-	I-mutant
K33A	I-mutant
pp	B-chemical
trans	B-protein_state
mutant	B-protein_state
without	B-protein_state
inhibitor	I-protein_state
revealed	O
that	O
Thr1Oγ	B-residue_name_number
strongly	O
coordinates	O
a	O
well	O
-	O
defined	O
water	B-chemical
molecule	O
(∼	O
2	O
Å	O
;	O
Fig	O
.	O
3c	O
and	O
Supplementary	O
Fig	O
.	O
5c	O
,	O
d	O
).	O

This	O
water	B-chemical
hydrogen	O
bonds	O
also	O
to	O
Arg19O	B-residue_name_number
(∼	O
3	O
.	O
0	O
Å	O
)	O
and	O
Asp17Oδ	B-residue_name_number
(∼	O
3	O
.	O
0	O
Å	O
),	O
and	O
thereby	O
presumably	O
enables	O
residual	O
activity	O
of	O
the	O
mutant	B-protein_state
.	O

Remarkably	O
,	O
the	O
solvent	O
molecule	O
occupies	O
the	O
position	O
normally	O
taken	O
by	O
Lys33NH2	B-residue_name_number
in	O
the	O
WT	B-protein_state
proteasome	B-complex_assembly
structure	B-evidence
(	O
Fig	O
.	O
3c	O
),	O
further	O
corroborating	O
the	O
essential	O
role	O
of	O
Lys33	B-residue_name_number
as	O
the	O
general	O
base	O
for	O
autolysis	B-ptm
and	O
proteolysis	O
.	O

Conservative	B-experimental_method
substitution	I-experimental_method
of	O
Lys33	B-residue_name_number
by	O
Arg	B-residue_name
delays	O
autolysis	B-ptm
of	O
the	O
β5	B-protein
precursor	O
and	O
impairs	O
yeast	B-taxonomy_domain
growth	O
(	O
for	O
details	O
see	O
Supplementary	O
Note	O
1	O
).	O

While	O
Thr1	B-residue_name_number
occupies	O
the	O
same	O
position	O
as	O
in	O
WT	B-protein_state
yCPs	B-complex_assembly
,	O
Arg33	B-residue_name_number
is	O
unable	O
to	O
hydrogen	O
bond	O
to	O
Asp17	B-residue_name_number
,	O
thereby	O
inactivating	O
the	O
β5	B-protein
active	B-site
site	I-site
(	O
Supplementary	O
Fig	O
.	O
5e	O
).	O

The	O
conservative	B-experimental_method
mutation	I-experimental_method
of	O
Asp17	B-residue_name_number
to	O
Asn	B-residue_name
in	O
subunit	O
β5	B-protein
of	O
the	O
yCP	B-complex_assembly
also	O
provokes	O
a	O
severe	O
growth	O
defect	O
(	O
Supplementary	O
Note	O
1	O
,	O
Supplementary	O
Fig	O
.	O
6a	O
and	O
Table	O
1	O
).	O

Notably	O
,	O
only	O
with	O
the	O
additional	O
point	O
mutation	O
L	B-mutant
(-	I-mutant
49	I-mutant
)	I-mutant
S	I-mutant
present	O
in	O
the	O
β5	B-protein
propeptide	B-structure_element
could	O
we	O
purify	O
a	O
small	O
amount	O
of	O
the	O
β5	B-mutant
-	I-mutant
D17N	I-mutant
mutant	B-protein_state
yCP	B-complex_assembly
.	O

As	O
determined	O
by	O
crystallographic	B-experimental_method
analysis	I-experimental_method
,	O
this	O
mutant	B-protein_state
β5	B-protein
subunit	O
was	O
partially	B-protein_state
processed	I-protein_state
(	O
Table	O
1	O
)	O
but	O
displayed	O
impaired	O
reactivity	O
towards	O
the	O
proteasome	B-complex_assembly
inhibitor	O
carfilzomib	B-chemical
compared	O
with	O
the	O
subunits	O
β1	B-protein
and	O
β2	B-protein
,	O
and	O
with	O
WT	B-protein_state
β5	B-protein
(	O
Supplementary	O
Fig	O
.	O
7a	O
).	O

In	O
contrast	O
to	O
the	O
cis	B-protein_state
-	O
construct	O
,	O
expression	B-experimental_method
of	O
the	O
β5	B-protein
propeptide	B-structure_element
in	O
trans	B-protein_state
allowed	O
straightforward	O
isolation	B-experimental_method
and	O
crystallization	B-experimental_method
of	O
the	O
D17N	B-mutant
mutant	B-protein_state
proteasome	B-complex_assembly
.	O

The	O
ChT	O
-	O
L	O
activity	O
of	O
the	O
β5	B-mutant
-	I-mutant
D17N	I-mutant
pp	B-chemical
in	O
trans	B-protein_state
CP	B-complex_assembly
towards	O
the	O
canonical	O
β5	B-protein
model	O
substrates	O
N	B-chemical
-	I-chemical
succinyl	I-chemical
-	I-chemical
Leu	I-chemical
-	I-chemical
Leu	I-chemical
-	I-chemical
Val	I-chemical
-	I-chemical
Tyr	I-chemical
-	I-chemical
7	I-chemical
-	I-chemical
amino	I-chemical
-	I-chemical
4	I-chemical
-	I-chemical
methylcoumarin	I-chemical
(	O
Suc	B-chemical
-	I-chemical
LLVY	I-chemical
-	I-chemical
AMC	I-chemical
)	O
and	O
carboxybenzyl	B-chemical
-	I-chemical
Gly	I-chemical
-	I-chemical
Gly	I-chemical
-	I-chemical
Leu	I-chemical
-	I-chemical
para	I-chemical
-	I-chemical
nitroanilide	I-chemical
(	O
Z	B-chemical
-	I-chemical
GGL	I-chemical
-	I-chemical
pNA	I-chemical
)	O
was	O
severely	O
reduced	O
(	O
Supplementary	O
Fig	O
.	O
6b	O
),	O
confirming	O
that	O
Asp17	B-residue_name_number
is	O
of	O
fundamental	O
importance	O
for	O
the	O
catalytic	O
activity	O
of	O
the	O
mature	B-protein_state
proteasome	B-complex_assembly
.	O

Even	O
though	O
the	O
β5	B-mutant
-	I-mutant
D17N	I-mutant
pp	B-chemical
trans	B-protein_state
yCP	B-complex_assembly
crystal	B-evidence
structure	I-evidence
appeared	O
identical	O
to	O
the	O
WT	B-protein_state
yCP	B-complex_assembly
(	O
Supplementary	O
Fig	O
.	O
7b	O
),	O
the	O
co	B-evidence
-	I-evidence
crystal	I-evidence
structure	I-evidence
with	O
the	O
α	B-chemical
′,	I-chemical
β	I-chemical
′	I-chemical
epoxyketone	I-chemical
inhibitor	O
carfilzomib	B-chemical
visualized	O
only	O
partial	O
occupancy	O
of	O
the	O
ligand	O
in	O
the	O
β5	B-protein
active	B-site
site	I-site
(	O
Supplementary	O
Fig	O
.	O
7a	O
).	O

This	O
observation	O
is	O
consistent	O
with	O
a	O
strongly	O
reduced	O
reactivity	O
of	O
β5	B-protein
-	O
Thr1	B-residue_name_number
and	O
the	O
crystal	B-evidence
structure	I-evidence
of	O
the	O
β5	B-mutant
-	I-mutant
D17N	I-mutant
pp	B-chemical
cis	B-protein_state
mutant	B-protein_state
in	B-protein_state
complex	I-protein_state
with	I-protein_state
carfilzomib	B-chemical
.	O

Autolysis	B-ptm
and	O
residual	O
catalytic	O
activity	O
of	O
the	O
β5	B-mutant
-	I-mutant
D17N	I-mutant
mutants	O
may	O
originate	O
from	O
the	O
carbonyl	O
group	O
of	O
Asn17	B-residue_name_number
,	O
which	O
albeit	O
to	O
a	O
lower	O
degree	O
still	O
can	O
polarize	O
Lys33	B-residue_name_number
for	O
the	O
activation	O
of	O
Thr1	B-residue_name_number
.	O

In	O
agreement	O
,	O
an	O
E17A	B-mutant
mutant	B-protein_state
in	O
the	O
proteasomal	O
β	B-protein
-	I-protein
subunit	I-protein
of	O
the	O
archaeon	B-taxonomy_domain
Thermoplasma	B-species
acidophilum	I-species
prevents	O
autolysis	B-ptm
and	O
catalysis	O
.	O

Strikingly	O
,	O
although	O
the	O
X	B-evidence
-	I-evidence
ray	I-evidence
data	I-evidence
on	O
the	O
β5	B-mutant
-	I-mutant
D17N	I-mutant
mutant	B-protein_state
with	O
the	O
propeptide	B-structure_element
expressed	B-experimental_method
in	O
cis	B-protein_state
and	O
in	O
trans	B-protein_state
looked	O
similar	O
,	O
there	O
was	O
a	O
pronounced	O
difference	O
in	O
their	O
growth	O
phenotypes	O
observed	O
(	O
Supplementary	O
Fig	O
.	O
6a	O
and	O
Supplementary	O
Fig	O
.	O
7b	O
).	O

On	O
the	O
basis	O
of	O
these	O
results	O
,	O
we	O
propose	O
that	O
CPs	B-complex_assembly
from	O
all	O
domains	O
of	O
life	O
use	O
a	O
catalytic	B-site
triad	I-site
consisting	O
of	O
Thr1	B-residue_name_number
,	O
Lys33	B-residue_name_number
and	O
Asp	B-residue_name
/	O
Glu17	B-residue_name_number
for	O
both	O
autocatalytic	B-ptm
precursor	I-ptm
processing	I-ptm
and	O
proteolysis	O
(	O
Fig	O
.	O
3d	O
).	O

This	O
model	O
is	O
also	O
consistent	O
with	O
the	O
fact	O
that	O
no	O
defined	O
water	B-chemical
molecule	O
is	O
observed	O
in	O
the	O
mature	B-protein_state
WT	B-protein_state
proteasomal	O
active	B-site
site	I-site
that	O
could	O
shuttle	O
the	O
proton	O
from	O
Thr1Oγ	B-residue_name_number
to	O
Thr1NH2	B-residue_name_number
.	O

To	O
explore	O
this	O
active	B-site
-	I-site
site	I-site
model	O
further	O
,	O
we	O
exchanged	B-experimental_method
the	I-experimental_method
conserved	I-experimental_method
Asp166	B-residue_name_number
residue	O
for	O
Asn	B-residue_name
in	O
the	O
yeast	B-taxonomy_domain
β5	B-protein
subunit	O
.	O

Asp166Oδ	B-residue_name_number
is	O
hydrogen	O
-	O
bonded	O
to	O
Thr1NH2	B-residue_name_number
via	O
Ser129OH	B-residue_name_number
and	O
Ser169OH	B-residue_name_number
,	O
and	O
therefore	O
was	O
proposed	O
to	O
be	O
involved	O
in	O
catalysis	O
.	O

The	O
β5	B-mutant
-	I-mutant
D166N	I-mutant
pp	B-chemical
cis	B-protein_state
yeast	B-taxonomy_domain
mutant	B-protein_state
is	O
significantly	O
impaired	O
in	O
growth	O
and	O
its	O
ChT	O
-	O
L	O
activity	O
is	O
drastically	O
reduced	O
(	O
Supplementary	O
Fig	O
.	O
6a	O
,	O
b	O
and	O
Table	O
1	O
).	O

X	B-evidence
-	I-evidence
ray	I-evidence
data	I-evidence
on	O
the	O
β5	B-mutant
-	I-mutant
D166N	I-mutant
mutant	B-protein_state
indicate	O
that	O
the	O
β5	B-protein
propeptide	B-structure_element
is	O
hydrolysed	O
,	O
but	O
due	O
to	O
reorientation	O
of	O
Ser129OH	B-residue_name_number
,	O
the	O
interaction	O
with	O
Asn166Oδ	B-residue_name_number
is	O
disrupted	O
(	O
Supplementary	O
Fig	O
.	O
8a	O
).	O

Instead	O
,	O
a	O
water	B-chemical
molecule	O
is	O
bound	B-protein_state
to	I-protein_state
Ser129OH	B-residue_name_number
and	O
Thr1NH2	B-residue_name_number
(	O
Supplementary	O
Fig	O
.	O
8b	O
),	O
which	O
may	O
enable	O
precursor	B-ptm
processing	I-ptm
.	O

The	O
hydrogen	O
bonds	O
involving	O
Ser169OH	B-residue_name_number
are	O
intact	O
and	O
may	O
account	O
for	O
residual	O
substrate	O
turnover	O
.	O

Soaking	B-experimental_method
the	O
β5	B-mutant
-	I-mutant
D166N	I-mutant
crystals	B-experimental_method
with	O
carfilzomib	B-chemical
and	O
MG132	B-chemical
resulted	O
in	O
covalent	O
modification	O
of	O
Thr1	B-residue_name_number
at	O
high	O
occupancy	O
(	O
Supplementary	O
Fig	O
.	O
8c	O
).	O

In	O
the	O
carfilzomib	B-complex_assembly
complex	I-complex_assembly
structure	B-evidence
,	O
Thr1Oγ	B-residue_name_number
and	O
Thr1N	B-residue_name_number
incorporate	O
into	O
a	O
morpholine	O
ring	O
structure	O
and	O
Ser129	B-residue_name_number
adopts	O
its	O
WT	B-protein_state
-	O
like	O
orientation	O
.	O

In	O
the	O
MG132	B-protein_state
-	I-protein_state
bound	I-protein_state
state	I-protein_state
,	O
Thr1N	B-residue_name_number
is	O
unmodified	B-protein_state
,	O
and	O
we	O
again	O
observe	O
that	O
Ser129	B-residue_name_number
is	O
hydrogen	O
-	O
bonded	O
to	O
a	O
water	B-chemical
molecule	O
instead	O
of	O
Asn166	B-residue_name_number
.	O

Whereas	O
Asn	B-residue_name
can	O
to	O
some	O
degree	O
replace	O
Asp166	B-residue_name_number
due	O
to	O
its	O
carbonyl	O
group	O
in	O
the	O
side	O
chain	O
,	O
Ala	B-residue_name
at	O
this	O
position	O
was	O
found	O
to	O
prevent	O
both	O
autolysis	B-ptm
and	O
catalysis	O
.	O

These	O
results	O
suggest	O
that	O
Asp166	B-residue_name_number
and	O
Ser129	B-residue_name_number
function	O
as	O
a	O
proton	O
shuttle	O
and	O
affect	O
the	O
protonation	O
state	O
of	O
Thr1N	B-residue_name_number
during	O
autolysis	B-ptm
and	O
catalysis	O
.	O

Substitution	B-experimental_method
of	O
the	O
active	B-site
-	I-site
site	I-site
Thr1	B-residue_name_number
by	O
Cys	B-residue_name

Mutation	B-experimental_method
of	O
Thr1	B-residue_name_number
to	O
Cys	B-residue_name
inactivates	O
the	O
20S	B-complex_assembly
proteasome	I-complex_assembly
from	O
the	O
archaeon	B-taxonomy_domain
T	B-species
.	I-species
acidophilum	I-species
.	O

In	O
yeast	B-taxonomy_domain
,	O
this	O
mutation	B-experimental_method
causes	O
a	O
strong	O
growth	O
defect	O
(	O
Fig	O
.	O
4a	O
and	O
Table	O
1	O
),	O
although	O
the	O
propeptide	B-structure_element
is	O
hydrolysed	O
,	O
as	O
shown	O
here	O
by	O
its	O
X	B-evidence
-	I-evidence
ray	I-evidence
structure	I-evidence
.	O

In	O
one	O
of	O
the	O
two	O
β5	B-protein
subunits	O
,	O
however	O
,	O
we	O
found	O
the	O
cleaved	B-protein_state
propeptide	B-structure_element
still	B-protein_state
bound	I-protein_state
in	O
the	O
substrate	B-site
-	I-site
binding	I-site
channel	I-site
(	O
Fig	O
.	O
4c	O
).	O

His	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
occupies	O
the	O
S2	B-site
pocket	I-site
like	O
observed	O
for	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
K81R	I-mutant
mutant	B-protein_state
,	O
but	O
in	O
contrast	O
to	O
the	O
latter	O
,	O
the	O
propeptide	B-structure_element
in	O
the	O
T1C	B-mutant
mutant	B-protein_state
adopts	O
an	O
antiparallel	B-structure_element
β	I-structure_element
-	I-structure_element
sheet	I-structure_element
conformation	O
as	O
known	O
from	O
inhibitors	O
like	O
MG132	B-chemical
(	O
Fig	O
.	O
4c	O
–	O
e	O
and	O
Supplementary	O
Fig	O
.	O
9b	O
).	O

On	O
the	O
basis	O
of	O
the	O
phenotype	O
of	O
the	O
T1C	B-mutant
mutant	B-protein_state
and	O
the	O
propeptide	B-structure_element
remnant	O
identified	O
in	O
its	O
active	B-site
site	I-site
,	O
we	O
suppose	O
that	O
autolysis	B-ptm
is	O
retarded	O
and	O
may	O
not	O
have	O
been	O
completed	O
before	O
crystallization	B-experimental_method
.	O

Owing	O
to	O
the	O
unequal	O
positions	O
of	O
the	O
two	O
β5	B-protein
subunits	O
within	O
the	O
CP	B-complex_assembly
in	O
the	O
crystal	O
lattice	O
,	O
maturation	O
and	O
propeptide	B-structure_element
displacement	O
may	O
occur	O
at	O
different	O
timescales	O
in	O
the	O
two	O
subunits	O
.	O

Despite	O
propeptide	B-ptm
hydrolysis	I-ptm
,	O
the	O
β5	B-mutant
-	I-mutant
T1C	I-mutant
active	B-site
site	I-site
is	O
catalytically	B-protein_state
inactive	I-protein_state
(	O
Fig	O
.	O
4b	O
and	O
Supplementary	O
Fig	O
.	O
9a	O
).	O

In	O
agreement	O
,	O
soaking	B-experimental_method
crystals	I-experimental_method
with	O
the	O
CP	B-complex_assembly
inhibitors	O
bortezomib	B-chemical
or	O
carfilzomib	B-chemical
modifies	O
only	O
the	O
β1	B-protein
and	O
β2	B-protein
active	B-site
sites	I-site
,	O
while	O
leaving	O
the	O
β5	B-mutant
-	I-mutant
T1C	I-mutant
proteolytic	B-site
centres	I-site
unmodified	B-protein_state
even	O
though	O
they	O
are	O
only	O
partially	O
occupied	O
by	O
the	O
cleaved	B-protein_state
propeptide	B-structure_element
remnant	O
.	O

Moreover	O
,	O
the	O
structural	B-evidence
data	I-evidence
reveal	O
that	O
the	O
thiol	O
group	O
of	O
Cys1	B-residue_name_number
is	O
rotated	O
by	O
74	O
°	O
with	O
respect	O
to	O
the	O
hydroxyl	O
side	O
chain	O
of	O
Thr1	B-residue_name_number
(	O
Fig	O
.	O
4f	O
and	O
Supplementary	O
Fig	O
.	O
9b	O
).	O

Consequently	O
,	O
the	O
hydrogen	O
bond	O
bridging	O
the	O
active	O
-	O
site	O
nucleophile	O
and	O
Lys33	B-residue_name_number
in	O
WT	B-protein_state
CPs	B-complex_assembly
is	O
broken	O
with	O
Cys1	B-residue_name_number
.	O

Notably	O
,	O
the	O
2FO	B-evidence
–	I-evidence
FC	I-evidence
electron	I-evidence
-	I-evidence
density	I-evidence
map	I-evidence
of	O
the	O
T1C	B-mutant
mutant	B-protein_state
also	O
indicates	O
that	O
Lys33NH2	B-residue_name_number
is	O
disordered	B-protein_state
.	O

Together	O
,	O
these	O
observations	O
suggest	O
that	O
efficient	O
peptide	O
-	O
bond	O
hydrolysis	O
requires	O
that	O
Lys33NH2	B-residue_name_number
hydrogen	O
bonds	O
to	O
the	O
active	O
site	O
nucleophile	O
.	O

The	O
benefit	O
of	O
Thr	B-residue_name
over	O
Ser	B-residue_name
as	O
the	O
active	O
-	O
site	O
nucleophile	O

All	O
proteasomes	B-complex_assembly
strictly	B-protein_state
employ	I-protein_state
threonine	B-residue_name
as	O
the	O
active	B-site
-	I-site
site	I-site
residue	I-site
instead	O
of	O
serine	B-residue_name
.	O

To	O
investigate	O
the	O
reason	O
for	O
this	O
singularity	O
,	O
we	O
analysed	O
a	O
β5	B-mutant
-	I-mutant
T1S	I-mutant
mutant	B-protein_state
,	O
which	O
is	O
viable	O
but	O
suffers	O
from	O
growth	O
defects	O
(	O
Fig	O
.	O
4a	O
and	O
Table	O
1	O
).	O

Activity	B-experimental_method
assays	I-experimental_method
with	O
the	O
β5	B-protein
-	O
specific	O
substrate	O
Suc	B-chemical
-	I-chemical
LLVY	I-chemical
-	I-chemical
AMC	I-chemical
demonstrated	O
that	O
the	O
ChT	O
-	O
L	O
activity	O
of	O
the	O
T1S	B-mutant
mutant	B-protein_state
is	O
reduced	O
by	O
40	O
–	O
45	O
%	O
compared	O
with	O
WT	B-protein_state
proteasomes	B-complex_assembly
depending	O
on	O
the	O
incubation	O
temperature	O
(	O
Fig	O
.	O
4b	O
and	O
Supplementary	O
Fig	O
.	O
9c	O
).	O

By	O
contrast	O
,	O
turnover	O
of	O
the	O
substrate	O
Z	B-chemical
-	I-chemical
GGL	I-chemical
-	I-chemical
pNA	I-chemical
,	O
used	O
to	O
monitor	O
ChT	O
-	O
L	O
activity	O
in	O
situ	O
but	O
in	O
a	O
less	O
quantitative	O
fashion	O
,	O
is	O
not	O
detectably	O
impaired	O
(	O
Supplementary	O
Fig	O
.	O
9a	O
).	O

Crystal	B-evidence
structure	I-evidence
analysis	O
of	O
the	O
β5	B-mutant
-	I-mutant
T1S	I-mutant
mutant	B-protein_state
confirmed	O
precursor	B-ptm
processing	I-ptm
(	O
Fig	O
.	O
4g	O
),	O
and	O
ligand	B-complex_assembly
-	I-complex_assembly
complex	I-complex_assembly
structures	B-evidence
with	O
bortezomib	B-chemical
and	O
carfilzomib	B-chemical
unambiguously	O
corroborated	O
the	O
reactivity	O
of	O
Ser1	B-residue_name_number
(	O
Fig	O
.	O
5	O
).	O

However	O
,	O
the	O
apo	B-protein_state
crystal	B-evidence
structure	I-evidence
revealed	O
that	O
Ser1Oγ	B-residue_name_number
is	O
turned	O
away	O
from	O
the	O
substrate	B-site
-	I-site
binding	I-site
channel	I-site
(	O
Fig	O
.	O
4g	O
).	O

Compared	O
with	O
Thr1Oγ	B-residue_name_number
in	O
WT	B-protein_state
CP	B-complex_assembly
structures	B-evidence
,	O
Ser1Oγ	B-residue_name_number
is	O
rotated	O
by	O
60	O
°.	O

Because	O
both	O
conformations	O
of	O
Ser1Oγ	B-residue_name_number
are	O
hydrogen	O
-	O
bonded	O
to	O
Lys33NH2	B-residue_name_number
(	O
Fig	O
.	O
4h	O
),	O
the	O
relay	O
system	O
is	O
capable	O
of	O
hydrolysing	O
peptide	O
substrates	O
,	O
albeit	O
at	O
lower	O
rates	O
compared	O
with	O
Thr1	B-residue_name_number
.	O

The	O
active	B-site
-	I-site
site	I-site
residue	I-site
Thr1	B-residue_name_number
is	O
fixed	O
in	O
its	O
position	O
,	O
as	O
its	O
methyl	O
group	O
is	O
engaged	O
in	O
hydrophobic	O
interactions	O
with	O
Thr3	B-residue_name_number
and	O
Ala46	B-residue_name_number
(	O
Fig	O
.	O
4h	O
).	O

Consequently	O
,	O
the	O
hydroxyl	O
group	O
of	O
Thr1	B-residue_name_number
requires	O
no	O
reorientation	O
before	O
substrate	O
cleavage	O
and	O
is	O
thus	O
more	O
catalytically	O
efficient	O
than	O
Ser1	B-residue_name_number
.	O

In	O
agreement	O
,	O
at	O
an	O
elevated	O
growing	O
temperature	O
of	O
37	O
°	O
C	O
the	O
T1S	B-mutant
mutant	B-protein_state
is	O
unable	O
to	O
grow	O
(	O
Fig	O
.	O
4a	O
).	O

In	O
vitro	O
,	O
the	O
mutant	B-protein_state
proteasome	B-complex_assembly
is	O
less	O
susceptible	O
to	O
proteasome	B-complex_assembly
inhibition	O
by	O
bortezomib	B-chemical
(	O
3	O
.	O
7	O
-	O
fold	O
)	O
and	O
carfilzomib	B-chemical
(	O
1	O
.	O
8	O
-	O
fold	O
;	O
Fig	O
.	O
5	O
).	O

Nevertheless	O
,	O
inhibitor	B-complex_assembly
complex	I-complex_assembly
structures	B-evidence
indicate	O
identical	O
binding	O
modes	O
compared	O
with	O
the	O
WT	B-protein_state
yCP	B-complex_assembly
structures	B-evidence
,	O
with	B-protein_state
the	I-protein_state
same	I-protein_state
inhibitors	I-protein_state
.	O

Notably	O
,	O
the	O
affinity	B-evidence
of	O
the	O
tetrapeptide	O
carfilzomib	B-chemical
is	O
less	O
impaired	O
,	O
as	O
it	O
is	O
better	O
stabilized	O
in	O
the	O
substrate	B-site
-	I-site
binding	I-site
channel	I-site
than	O
the	O
dipeptide	O
bortezomib	B-chemical
,	O
which	O
lacks	O
a	O
defined	O
P3	O
site	O
and	O
has	O
only	O
a	O
few	O
interactions	O
with	O
the	O
surrounding	O
protein	O
.	O

Hence	O
,	O
the	O
mean	B-evidence
residence	I-evidence
time	I-evidence
of	O
carfilzomib	B-chemical
at	O
the	O
active	B-site
site	I-site
is	O
prolonged	O
and	O
the	O
probability	O
to	O
covalently	O
react	O
with	O
Ser1	B-residue_name_number
is	O
increased	O
.	O

Considered	O
together	O
,	O
these	O
results	O
provide	O
a	O
plausible	O
explanation	O
for	O
the	O
invariance	O
of	O
threonine	B-residue_name
as	O
the	O
active	O
-	O
site	O
nucleophile	O
in	O
proteasomes	B-complex_assembly
in	O
all	O
three	O
domains	O
of	O
life	O
,	O
as	O
well	O
as	O
in	O
proteasome	B-protein_type
-	I-protein_type
like	I-protein_type
proteases	I-protein_type
such	O
as	O
HslV	B-protein
(	O
ref	O
.).	O

The	O
20S	B-complex_assembly
proteasome	I-complex_assembly
CP	B-complex_assembly
is	O
the	O
major	O
non	B-protein_type
-	I-protein_type
lysosomal	I-protein_type
protease	I-protein_type
in	O
eukaryotic	B-taxonomy_domain
cells	O
,	O
and	O
its	O
assembly	O
is	O
highly	O
organized	O
.	O

The	O
β	B-protein
-	I-protein
subunit	I-protein
propeptides	B-structure_element
,	O
particularly	O
that	O
of	O
β5	B-protein
,	O
are	O
key	O
factors	O
that	O
help	O
drive	O
proper	O
assembly	O
of	O
the	O
CP	B-complex_assembly
complex	O
.	O

In	O
addition	O
,	O
they	O
prevent	O
irreversible	O
inactivation	O
of	O
the	O
Thr1	B-residue_name_number
N	O
terminus	O
by	O
N	B-ptm
-	I-ptm
acetylation	I-ptm
.	O

By	O
contrast	O
,	O
the	O
prosegments	B-structure_element
of	O
β	B-protein
subunits	I-protein
are	O
dispensable	O
for	O
archaeal	B-taxonomy_domain
proteasome	B-complex_assembly
assembly	O
,	O
at	O
least	O
when	O
heterologously	B-experimental_method
expressed	I-experimental_method
in	O
Escherichia	B-species
coli	I-species
.	O

In	O
eukaryotes	B-taxonomy_domain
,	O
deletion	O
of	O
or	O
failure	O
to	O
cleave	O
the	O
β1	B-protein
and	O
β2	B-protein
propeptides	B-structure_element
is	O
well	O
tolerated	O
.	O

However	O
,	O
removal	B-experimental_method
of	I-experimental_method
the	O
β5	B-protein
prosegment	B-structure_element
or	O
any	O
interference	O
with	O
its	O
cleavage	O
causes	O
severe	O
phenotypic	O
defects	O
.	O

These	O
observations	O
highlight	O
the	O
unique	O
function	O
and	O
importance	O
of	O
the	O
β5	B-protein
propeptide	B-structure_element
as	O
well	O
as	O
the	O
β5	B-protein
active	B-site
site	I-site
for	O
maturation	O
and	O
function	O
of	O
the	O
eukaryotic	B-taxonomy_domain
CP	B-complex_assembly
.	O

Here	O
we	O
have	O
described	O
the	O
atomic	B-evidence
structures	I-evidence
of	O
various	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
mutants	O
,	O
which	O
allowed	O
for	O
the	O
first	O
time	O
visualization	O
of	O
the	O
residual	O
β5	B-protein
propeptide	B-structure_element
.	O

Depending	O
on	O
the	O
(-	B-residue_number
2	I-residue_number
)	I-residue_number
residue	O
we	O
observed	O
various	O
propeptide	B-structure_element
conformations	O
,	O
but	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
is	O
in	O
all	O
structures	B-evidence
perfectly	O
located	O
for	O
the	O
nucleophilic	O
attack	O
by	O
Thr1Oγ	B-residue_name_number
,	O
although	O
it	O
does	O
not	O
adopt	O
the	O
tight	B-structure_element
turn	I-structure_element
observed	O
for	O
the	O
prosegment	B-structure_element
of	O
subunit	O
β1	B-protein
.	O

From	O
these	O
data	O
we	O
conclude	O
that	O
only	O
the	O
positioning	O
of	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
and	O
Thr1	B-residue_name_number
as	O
well	O
as	O
the	O
integrity	O
of	O
the	O
proteasomal	O
active	B-site
site	I-site
are	O
required	O
for	O
autolysis	B-ptm
.	O

In	O
this	O
regard	O
,	O
inappropriate	O
N	B-ptm
-	I-ptm
acetylation	I-ptm
of	O
the	O
Thr1	B-residue_name_number
N	O
terminus	O
cannot	O
be	O
removed	O
by	O
Thr1Oγ	B-residue_name_number
due	O
to	O
the	O
rotational	O
freedom	O
and	O
flexibility	O
of	O
the	O
acetyl	O
group	O
.	O

The	O
propeptide	B-structure_element
needs	O
some	O
anchoring	O
in	O
the	O
substrate	B-site
-	I-site
binding	I-site
channel	I-site
to	O
properly	O
position	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
),	I-residue_name_number
but	O
this	O
seems	O
to	O
be	O
independent	O
of	O
the	O
orientation	O
of	O
residue	O
(-	B-residue_number
2	I-residue_number
).	I-residue_number

Autolytic	O
activation	O
of	O
the	O
CP	B-complex_assembly
constitutes	O
one	O
of	O
the	O
final	O
steps	O
of	O
proteasome	O
biogenesis	O
,	O
but	O
the	O
trigger	O
for	O
propeptide	B-ptm
cleavage	I-ptm
had	O
remained	O
enigmatic	O
.	O

On	O
the	O
basis	O
of	O
the	O
numerous	O
CP	B-complex_assembly
:	I-complex_assembly
ligand	I-complex_assembly
complexes	O
solved	O
during	O
the	O
past	O
18	O
years	O
and	O
in	O
the	O
current	O
study	O
,	O
we	O
provide	O
a	O
revised	O
interpretation	O
of	O
proteasome	B-complex_assembly
active	B-site
-	I-site
site	I-site
architecture	I-site
.	O

We	O
propose	O
a	O
catalytic	B-site
triad	I-site
for	O
the	O
active	B-site
site	I-site
of	O
the	O
CP	B-complex_assembly
consisting	O
of	O
residues	O
Thr1	B-residue_name_number
,	O
Lys33	B-residue_name_number
and	O
Asp	B-residue_name
/	O
Glu17	B-residue_name_number
,	O
which	O
are	O
conserved	O
among	O
all	O
proteolytically	O
active	O
eukaryotic	B-taxonomy_domain
,	O
bacterial	B-taxonomy_domain
and	O
archaeal	B-taxonomy_domain
proteasome	B-complex_assembly
subunits	O
.	O

Lys33NH2	B-residue_name_number
is	O
expected	O
to	O
act	O
as	O
the	O
proton	O
acceptor	O
during	O
autocatalytic	B-ptm
removal	I-ptm
of	O
the	O
propeptides	B-structure_element
,	O
as	O
well	O
as	O
during	O
substrate	O
proteolysis	O
,	O
while	O
Asp17Oδ	B-residue_name_number
orients	O
Lys33NH2	B-residue_name_number
and	O
makes	O
it	O
more	O
prone	O
to	O
protonation	O
by	O
raising	O
its	O
pKa	O
(	O
hydrogen	O
bond	O
distance	O
:	O
Lys33NH3	B-residue_name_number
+–	O
Asp17Oδ	B-residue_name_number
:	O
2	O
.	O
9	O
Å	O
).	O

Analogously	O
to	O
the	O
proteasome	B-complex_assembly
,	O
a	O
Thr	B-site
–	I-site
Lys	I-site
–	I-site
Asp	I-site
triad	I-site
is	O
also	O
found	O
in	O
L	B-protein_type
-	I-protein_type
asparaginase	I-protein_type
.	O

Thus	O
,	O
specific	O
protein	O
surroundings	O
can	O
significantly	O
alter	O
the	O
chemical	O
properties	O
of	O
amino	O
acids	O
such	O
as	O
Lys	B-residue_name
to	O
function	O
as	O
an	O
acid	O
–	O
base	O
catalyst	O
.	O

In	O
this	O
new	O
view	O
of	O
the	O
proteasomal	O
active	B-site
site	I-site
,	O
the	O
positively	O
charged	O
Thr1NH3	B-residue_name_number
+-	O
terminus	O
hydrogen	O
bonds	O
to	O
the	O
amide	O
nitrogen	O
of	O
incoming	O
peptide	O
substrates	O
and	O
stabilizes	O
as	O
well	O
as	O
activates	O
them	O
for	O
the	O
endoproteolytic	B-ptm
cleavage	I-ptm
by	O
Thr1Oγ	B-residue_name_number
(	O
Fig	O
.	O
3d	O
).	O

Consistent	O
with	O
this	O
model	O
,	O
the	O
positively	O
charged	O
Thr1	B-residue_name_number
N	O
terminus	O
is	O
engaged	O
in	O
hydrogen	O
bonds	O
with	O
inhibitory	O
compounds	O
like	O
fellutamide	B-chemical
B	I-chemical
(	O
ref	O
.),	O
α	B-chemical
-	I-chemical
ketoamides	I-chemical
,	O
homobelactosin	B-chemical
C	I-chemical
(	O
ref	O
.)	O
and	O
salinosporamide	B-chemical
A	I-chemical
(	O
ref	O
.).	O

Furthermore	O
,	O
opening	O
of	O
the	O
β	O
-	O
lactone	O
compound	O
omuralide	B-chemical
by	O
Thr1	B-residue_name_number
creates	O
a	O
C3	O
-	O
hydroxyl	O
group	O
,	O
whose	O
proton	O
originates	O
from	O
Thr1NH3	B-residue_name_number
+.	O

The	O
resulting	O
uncharged	O
Thr1NH2	B-residue_name_number
is	O
hydrogen	O
-	O
bridged	O
to	O
the	O
C3	O
-	O
OH	O
group	O
.	O

In	O
agreement	O
,	O
acetylation	B-ptm
of	O
the	O
Thr1	B-residue_name_number
N	O
terminus	O
irreversibly	O
blocks	O
hydrolytic	O
activity	O
,	O
and	O
binding	O
of	O
substrates	O
is	O
prevented	O
for	O
steric	O
reasons	O
.	O

By	O
acting	O
as	O
a	O
proton	O
donor	O
during	O
catalysis	O
,	O
the	O
Thr1	B-residue_name_number
N	O
terminus	O
may	O
also	O
favour	O
cleavage	O
of	O
substrate	O
peptide	O
bonds	O
(	O
Fig	O
.	O
3d	O
).	O

Cleavage	O
of	O
the	O
scissile	O
peptide	O
bond	O
requires	O
protonation	O
of	O
the	O
emerging	O
free	O
amine	O
,	O
and	O
in	O
the	O
proteasome	B-complex_assembly
,	O
the	O
Thr1	B-residue_name_number
amine	O
group	O
is	O
likely	O
to	O
assume	O
this	O
function	O
.	O

Analogously	O
,	O
Thr1NH3	B-residue_name_number
+	O
might	O
promote	O
the	O
bivalent	O
reaction	O
mode	O
of	O
epoxyketone	O
inhibitors	O
by	O
protonating	O
the	O
epoxide	O
moiety	O
to	O
create	O
a	O
positively	O
charged	O
trivalent	O
oxygen	O
atom	O
that	O
is	O
subsequently	O
nucleophilically	O
attacked	O
by	O
Thr1NH2	B-residue_name_number
.	O

During	O
autolysis	B-ptm
the	O
Thr1	B-residue_name_number
N	O
terminus	O
is	O
engaged	O
in	O
a	O
hydroxyoxazolidine	O
ring	O
intermediate	O
(	O
Fig	O
.	O
3d	O
),	O
which	O
is	O
unstable	O
and	O
short	O
-	O
lived	O
.	O

Breakdown	O
of	O
this	O
tetrahedral	O
transition	O
state	O
releases	O
the	O
Thr1	B-residue_name_number
N	O
terminus	O
that	O
is	O
protonated	O
by	O
aspartic	B-residue_name_number
acid	I-residue_name_number
166	I-residue_name_number
via	O
Ser129OH	B-residue_name_number
to	O
yield	O
Thr1NH3	B-residue_name_number
+.	O

The	O
residues	O
Ser129	B-residue_name_number
and	O
Asp166	B-residue_name_number
are	O
expected	O
to	O
increase	O
the	O
pKa	O
value	O
of	O
Thr1N	B-residue_name_number
,	O
thereby	O
favouring	O
its	O
charged	O
state	O
.	O

Consistent	O
with	O
playing	O
an	O
essential	O
role	O
in	O
proton	O
shuttling	O
,	O
the	O
mutation	B-experimental_method
D166A	B-mutant
prevents	O
autolysis	B-ptm
of	O
the	O
archaeal	B-taxonomy_domain
CP	B-complex_assembly
and	O
the	O
exchange	B-experimental_method
D166N	B-mutant
impairs	O
catalytic	O
activity	O
of	O
the	O
yeast	B-taxonomy_domain
CP	B-complex_assembly
about	O
60	O
%.	O

The	O
mutation	B-experimental_method
D166N	B-mutant
lowers	O
the	O
pKa	O
of	O
Thr1N	B-residue_name_number
,	O
which	O
is	O
thus	O
more	O
likely	O
to	O
exist	O
in	O
the	O
uncharged	O
deprotonated	O
state	O
(	O
Thr1NH2	B-residue_name_number
).	O

This	O
interpretation	O
agrees	O
with	O
the	O
strongly	O
reduced	O
catalytic	O
activity	O
of	O
the	O
β5	B-mutant
-	I-mutant
D166N	I-mutant
mutant	B-protein_state
on	O
the	O
one	O
hand	O
,	O
and	O
the	O
ability	O
to	O
react	O
readily	O
with	O
carfilzomib	B-chemical
on	O
the	O
other	O
.	O

Hence	O
,	O
the	O
proteasome	B-complex_assembly
can	O
be	O
viewed	O
as	O
having	O
a	O
second	B-site
triad	I-site
that	O
is	O
essential	O
for	O
efficient	O
proteolysis	O
.	O

While	O
Lys33NH2	B-residue_name_number
and	O
Asp17Oδ	B-residue_name_number
are	O
required	O
to	O
deprotonate	O
the	O
Thr1	B-residue_name_number
hydroxyl	O
side	O
chain	O
,	O
Ser129OH	B-residue_name_number
and	O
Asp166OH	B-residue_name_number
serve	O
to	O
protonate	O
the	O
N	O
-	O
terminal	O
amine	O
group	O
of	O
Thr1	B-residue_name_number
.	O

In	O
accord	O
with	O
the	O
proposed	O
Thr1	B-residue_name_number
–	O
Lys33	B-residue_name_number
–	O
Asp17	B-residue_name_number
catalytic	B-site
triad	I-site
,	O
crystallographic	B-evidence
data	I-evidence
on	O
the	O
proteolytically	B-protein_state
inactive	I-protein_state
β5	B-mutant
-	I-mutant
T1C	I-mutant
mutant	B-protein_state
demonstrate	O
that	O
the	O
interaction	O
of	O
Lys33NH2	B-residue_name_number
and	O
Cys1	B-residue_name_number
is	O
broken	O
.	O

However	O
,	O
owing	O
to	O
Cys	B-residue_name
being	O
a	O
strong	O
nucleophile	O
,	O
the	O
propeptide	B-structure_element
can	O
still	O
be	O
cleaved	B-protein_state
off	O
over	O
time	O
.	O

While	O
only	O
one	O
single	O
turnover	O
is	O
necessary	O
for	O
autolysis	B-ptm
,	O
continuous	O
enzymatic	O
activity	O
is	O
required	O
for	O
significant	O
and	O
detectable	O
substrate	O
hydrolysis	O
.	O

Notably	O
,	O
in	O
the	O
Ntn	B-protein_type
hydrolase	I-protein_type
penicillin	B-protein_type
acylase	I-protein_type
,	O
substitution	B-experimental_method
of	O
the	O
catalytic	B-protein_state
N	O
-	O
terminal	O
Ser	B-residue_name
residue	O
by	O
Cys	B-residue_name
also	O
inactivates	B-protein_state
the	O
enzyme	B-protein_type
but	O
still	O
enables	O
precursor	B-ptm
processing	I-ptm
.	O

To	O
investigate	O
why	O
the	O
CP	B-complex_assembly
specifically	O
employs	O
threonine	B-residue_name
as	O
its	O
active	B-site
-	I-site
site	I-site
residue	I-site
,	O
we	O
used	O
a	O
β5	B-mutant
-	I-mutant
T1S	I-mutant
mutant	B-protein_state
of	O
the	O
yCP	B-complex_assembly
and	O
characterized	O
it	O
biochemically	B-experimental_method
and	I-experimental_method
structurally	I-experimental_method
.	O

Activity	B-experimental_method
assays	I-experimental_method
with	O
the	O
β5	B-mutant
-	I-mutant
T1S	I-mutant
mutant	B-protein_state
revealed	O
reduced	O
turnover	O
of	O
Suc	B-chemical
-	I-chemical
LLVY	I-chemical
-	I-chemical
AMC	I-chemical
.	O

We	O
also	O
observed	O
slightly	O
lower	O
affinity	O
of	O
the	O
β5	B-mutant
-	I-mutant
T1S	I-mutant
mutant	B-protein_state
yCP	B-complex_assembly
for	O
the	O
Food	O
and	O
Drug	O
Administration	O
-	O
approved	O
proteasome	B-complex_assembly
inhibitors	O
bortezomib	B-chemical
and	O
carfilzomib	B-chemical
.	O

Structural	B-evidence
analyses	I-evidence
support	O
these	O
findings	O
with	O
the	O
T1S	B-mutant
mutant	B-protein_state
and	O
provide	O
an	O
explanation	O
for	O
the	O
strict	B-protein_state
use	I-protein_state
of	I-protein_state
Thr	B-residue_name
residues	O
in	O
proteasomes	B-complex_assembly
.	O

Thr1	B-residue_name_number
is	O
well	O
anchored	O
in	O
the	O
active	B-site
site	I-site
by	O
hydrophobic	O
interactions	O
of	O
its	O
Cγ	O
methyl	O
group	O
with	O
Ala46	B-residue_name_number
(	O
Cβ	O
),	O
Lys33	B-residue_name_number
(	O
carbon	O
side	O
chain	O
)	O
and	O
Thr3	B-residue_name_number
(	O
Cγ	O
).	O

Notably	O
,	O
proteolytically	B-protein_state
active	I-protein_state
proteasome	B-complex_assembly
subunits	O
from	O
archaea	B-taxonomy_domain
,	O
yeast	B-taxonomy_domain
and	O
mammals	B-taxonomy_domain
,	O
including	O
constitutive	O
,	O
immuno	O
-	O
and	O
thymoproteasome	O
subunits	O
,	O
either	O
encode	O
Thr	B-residue_name
or	O
Ile	B-residue_name
at	O
position	O
3	B-residue_number
,	O
indicating	O
the	O
importance	O
of	O
the	O
Cγ	O
for	O
fixing	O
the	O
position	O
of	O
the	O
nucleophilic	O
Thr1	B-residue_name_number
.	O

In	O
contrast	O
to	O
Thr1	B-residue_name_number
,	O
the	O
hydroxyl	O
group	O
of	O
Ser1	B-residue_name_number
occupies	O
the	O
position	O
of	O
the	O
Thr1	B-residue_name_number
methyl	O
side	O
chain	O
in	O
the	O
WT	B-protein_state
enzyme	B-complex_assembly
,	O
which	O
requires	O
its	O
reorientation	O
relative	O
to	O
the	O
substrate	O
to	O
allow	O
cleavage	O
(	O
Fig	O
.	O
4g	O
,	O
h	O
).	O

Notably	O
,	O
in	O
the	O
threonine	B-protein_type
aspartase	I-protein_type
Taspase1	B-protein
,	O
mutation	B-experimental_method
of	O
the	O
active	B-site
-	I-site
site	I-site
Thr234	B-residue_name_number
to	O
Ser	B-residue_name
also	O
places	O
the	O
side	O
chain	O
in	O
the	O
position	O
of	O
the	O
methyl	O
group	O
of	O
Thr234	B-residue_name_number
in	O
the	O
WT	B-protein_state
,	O
thereby	O
reducing	O
catalytic	O
activity	O
.	O

Similarly	O
,	O
although	O
the	O
serine	B-residue_name
mutant	B-protein_state
is	O
active	B-protein_state
,	O
threonine	B-residue_name
is	O
more	O
efficient	O
in	O
the	O
context	O
of	O
the	O
proteasome	B-complex_assembly
active	B-site
site	I-site
.	O

The	O
greater	O
suitability	O
of	O
threonine	B-residue_name
for	O
the	O
proteasome	B-complex_assembly
active	B-site
site	I-site
,	O
which	O
has	O
been	O
noted	O
in	O
biochemical	O
as	O
well	O
as	O
in	O
kinetic	O
studies	O
,	O
constitutes	O
a	O
likely	O
reason	O
for	O
the	O
conservation	B-protein_state
of	O
the	O
Thr1	B-residue_name_number
residue	O
in	O
all	O
proteasomes	B-complex_assembly
from	O
bacteria	B-taxonomy_domain
to	O
eukaryotes	B-taxonomy_domain
.	O

Conformation	O
of	O
proteasomal	O
propeptides	B-structure_element
.	O

(	O
a	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
β1	B-mutant
-	I-mutant
T1A	I-mutant
propeptide	B-structure_element
and	O
the	O
matured	B-protein_state
WT	B-protein_state
β1	B-protein
active	B-site
-	I-site
site	I-site
Thr1	B-residue_name_number
.	O

Only	O
the	O
residues	O
(-	B-residue_range
5	I-residue_range
)	I-residue_range
to	I-residue_range
(-	I-residue_range
1	I-residue_range
)	I-residue_range
of	O
the	O
β1	B-mutant
-	I-mutant
T1A	I-mutant
propeptide	B-structure_element
are	O
displayed	O
.	O

The	O
major	O
determinant	O
of	O
the	O
S1	B-site
specificity	I-site
pocket	I-site
,	O
residue	O
45	B-residue_number
,	O
is	O
depicted	O
.	O

Note	O
the	O
tight	O
conformation	O
of	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
and	O
Ala1	B-residue_name_number
before	O
propeptide	B-structure_element
removal	O
(	O
G	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
turn	O
;	O
cyan	O
double	O
arrow	O
)	O
compared	O
with	O
the	O
relaxed	O
,	O
processed	B-protein_state
WT	B-protein_state
active	B-site
-	I-site
site	I-site
Thr1	B-residue_name_number
(	O
red	O
double	O
arrow	O
).	O

The	O
black	O
arrow	O
indicates	O
the	O
attack	O
of	O
Thr1Oγ	B-residue_name_number
onto	O
the	O
carbonyl	O
carbon	O
atom	O
of	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
).	I-residue_name_number

(	O
b	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
β1	B-mutant
-	I-mutant
T1A	I-mutant
propeptide	B-structure_element
and	O
the	O
β2	B-mutant
-	I-mutant
T1A	I-mutant
propeptide	B-structure_element
highlights	O
subtle	O
differences	O
in	O
their	O
conformations	O
,	O
but	O
illustrates	O
that	O
Ala1	B-residue_name_number
and	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
match	O
well	O
.	O

Thr	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
OH	O
is	O
hydrogen	O
-	O
bonded	O
to	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
O	O
(∼	O
2	O
.	O
8	O
Å	O
;	O
black	O
dashed	O
line	O
).	O

(	O
c	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
β1	B-mutant
-	I-mutant
T1A	I-mutant
,	O
the	O
β2	B-mutant
-	I-mutant
T1A	I-mutant
and	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
K81R	I-mutant
propeptide	B-structure_element
remnants	O
depict	O
their	O
differences	O
in	O
conformation	O
.	O

While	O
residue	O
(-	B-residue_number
2	I-residue_number
)	I-residue_number
of	O
the	O
β1	B-protein
and	O
β2	B-protein
prosegments	B-structure_element
fit	O
the	O
S1	B-site
pocket	I-site
,	O
His	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
of	O
the	O
β5	B-protein
propeptide	B-structure_element
occupies	O
the	O
S2	B-site
pocket	I-site
.	O

Nonetheless	O
,	O
in	O
all	O
mutants	O
the	O
carbonyl	O
carbon	O
atom	O
of	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
is	O
ideally	O
placed	O
for	O
the	O
nucleophilic	O
attack	O
by	O
Thr1Oγ	B-residue_name_number
.	O

The	O
hydrogen	O
bond	O
between	O
Thr	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
OH	O
and	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
O	O
(∼	O
2	O
.	O
8	O
Å	O
)	O
is	O
indicated	O
by	O
a	O
black	O
dashed	O
line	O
.	O

Mutations	B-experimental_method
of	O
residue	O
(-	B-residue_number
2	I-residue_number
)	I-residue_number
and	O
their	O
influence	O
on	O
propeptide	B-structure_element
conformation	O
and	O
autolysis	B-ptm
.	O

(	O
a	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
β1	B-mutant
-	I-mutant
T1A	I-mutant
propeptide	B-structure_element
and	O
the	O
β5	B-mutant
-	I-mutant
H	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
L	I-mutant
-	I-mutant
T1A	I-mutant
mutant	B-protein_state
propeptide	B-structure_element
.	O

The	O
(-	B-residue_number
2	I-residue_number
)	I-residue_number
residues	O
of	O
both	O
prosegments	B-structure_element
point	O
into	O
the	O
S1	B-site
pocket	I-site
.	O

(	O
b	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
β5	B-protein
propeptides	B-structure_element
in	O
the	O
β5	B-mutant
-	I-mutant
H	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
L	I-mutant
-	I-mutant
T1A	I-mutant
,	O
β5	B-mutant
-	I-mutant
H	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
T	I-mutant
-	I-mutant
T1A	I-mutant
,	O
β5	B-mutant
-(	I-mutant
H	I-mutant
-	I-mutant
2	I-mutant
)	I-mutant
A	I-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
K81R	I-mutant
and	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
K81R	I-mutant
mutant	B-protein_state
proteasomes	B-complex_assembly
.	O

While	O
the	O
residues	O
(-	B-residue_range
2	I-residue_range
)	I-residue_range
to	I-residue_range
(-	I-residue_range
4	I-residue_range
)	I-residue_range
vary	O
in	O
their	O
conformation	O
,	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
and	O
Ala1	B-residue_name_number
are	O
located	O
in	O
all	O
structures	B-evidence
at	O
the	O
same	O
positions	O
.	O

(	O
c	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
β2	B-mutant
-	I-mutant
T1A	I-mutant
propeptide	B-structure_element
and	O
the	O
β5	B-mutant
-	I-mutant
H	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
T	I-mutant
-	I-mutant
T1A	I-mutant
mutant	B-protein_state
propeptide	B-structure_element
.	O

The	O
(-	B-residue_number
2	I-residue_number
)	I-residue_number
residues	O
of	O
both	O
prosegments	B-structure_element
point	O
into	O
the	O
S1	B-site
pocket	I-site
,	O
but	O
only	O
Thr	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
OH	O
of	O
β2	B-protein
forms	O
a	O
hydrogen	O
bridge	O
to	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
O	O
(	O
black	O
dashed	O
line	O
).	O

(	O
d	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
matured	B-protein_state
β2	B-protein
active	B-site
site	I-site
,	O
the	O
WT	B-protein_state
β2	B-mutant
-	I-mutant
T1A	I-mutant
propeptide	B-structure_element
and	O
the	O
β2	B-mutant
-	I-mutant
T	I-mutant
(-	I-mutant
2	I-mutant
)	I-mutant
V	I-mutant
mutant	B-protein_state
propeptide	B-structure_element
.	O

Notably	O
,	O
Val	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
of	O
the	O
latter	O
does	O
not	O
occupy	O
the	O
S1	B-site
pocket	I-site
,	O
thereby	O
changing	O
the	O
orientation	O
of	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
)	I-residue_name_number
and	O
preventing	O
nucleophilic	O
attack	O
of	O
Thr1Oγ	B-residue_name_number
on	O
the	O
carbonyl	O
carbon	O
atom	O
of	O
Gly	B-residue_name_number
(-	I-residue_name_number
1	I-residue_name_number
).	I-residue_name_number

Architecture	O
and	O
proposed	O
reaction	O
mechanism	O
of	O
the	O
proteasomal	O
active	B-site
site	I-site
.	O

(	O
a	O
)	O
Hydrogen	B-site
-	I-site
bonding	I-site
network	I-site
at	O
the	O
mature	B-protein_state
WT	B-protein_state
β5	B-protein
proteasomal	O
active	B-site
site	I-site
(	O
dotted	O
lines	O
).	O

Thr1OH	B-residue_name_number
is	O
hydrogen	O
-	O
bonded	O
to	O
Lys33NH2	B-residue_name_number
(	O
2	O
.	O
7	O
Å	O
),	O
which	O
in	O
turn	O
interacts	O
with	O
Asp17Oδ	B-residue_name_number
.	O

The	O
Thr1	B-residue_name_number
N	O
terminus	O
is	O
engaged	O
in	O
hydrogen	O
bonds	O
with	O
Ser129Oγ	B-residue_name_number
,	O
the	O
carbonyl	O
oxygen	O
of	O
residue	O
168	B-residue_number
,	O
Ser169Oγ	B-residue_name_number
and	O
Asp166Oδ	B-residue_name_number
.	O

(	O
b	O
)	O
The	O
orientations	O
of	O
the	O
active	B-site
-	I-site
site	I-site
residues	I-site
involved	O
in	O
hydrogen	O
bonding	O
are	O
strictly	B-protein_state
conserved	I-protein_state
in	O
each	O
proteolytic	B-site
centre	I-site
,	O
as	O
shown	O
by	O
superposition	B-experimental_method
of	O
the	O
β	B-protein
subunits	I-protein
.	O

(	O
c	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
WT	B-protein_state
β5	B-protein
and	O
the	O
β5	B-mutant
-	I-mutant
K33A	I-mutant
pp	B-chemical
trans	B-protein_state
mutant	B-protein_state
active	B-site
site	I-site
.	O

In	O
the	O
latter	O
,	O
a	O
water	B-chemical
molecule	O
(	O
red	O
sphere	O
)	O
is	O
found	O
at	O
the	O
position	O
where	O
in	O
the	O
WT	B-protein_state
structure	O
the	O
side	O
chain	O
amine	O
group	O
of	O
Lys33	B-residue_name_number
is	O
located	O
.	O

Similarly	O
to	O
Lys33	B-residue_name_number
,	O
the	O
water	B-chemical
molecule	O
hydrogen	O
bonds	O
to	O
Arg19O	B-residue_name_number
,	O
Asp17Oδ	B-residue_name_number
and	O
Thr1OH	B-residue_name_number
.	O

Note	O
,	O
the	O
strong	O
interaction	O
with	O
the	O
water	B-chemical
molecule	O
causes	O
a	O
minor	O
shift	O
of	O
Thr1	B-residue_name_number
,	O
while	O
all	O
other	O
active	B-site
-	I-site
site	I-site
residues	I-site
remain	O
in	O
place	O
.	O

(	O
d	O
)	O
Proposed	O
chemical	O
reaction	O
mechanism	O
for	O
autocatalytic	B-ptm
precursor	I-ptm
processing	I-ptm
and	O
proteolysis	O
in	O
the	O
proteasome	B-complex_assembly
.	O

The	O
active	B-site
-	I-site
site	I-site
Thr1	B-residue_name_number
is	O
depicted	O
in	O
blue	O
,	O
the	O
propeptide	B-structure_element
segment	O
and	O
the	O
peptide	O
substrate	O
are	O
coloured	O
in	O
green	O
,	O
whereas	O
the	O
scissile	O
peptide	O
bond	O
is	O
highlighted	O
in	O
red	O
.	O

Autolysis	B-ptm
(	O
left	O
set	O
of	O
structures	O
)	O
is	O
initiated	O
by	O
deprotonation	O
of	O
Thr1OH	B-residue_name_number
via	O
Lys33NH2	B-residue_name_number
and	O
the	O
formation	O
of	O
a	O
tetrahedral	O
transition	O
state	O
.	O

The	O
strictly	B-protein_state
conserved	I-protein_state
oxyanion	O
hole	O
Gly47NH	B-residue_name_number
stabilizing	O
the	O
negatively	O
charged	O
intermediate	O
is	O
illustrated	O
as	O
a	O
semicircle	O
.	O

Collapse	O
of	O
the	O
transition	O
state	O
frees	O
the	O
Thr1	B-residue_name_number
N	O
terminus	O
(	O
by	O
completing	O
an	O
N	O
-	O
to	O
-	O
O	O
acyl	O
shift	O
of	O
the	O
propeptide	B-structure_element
),	O
which	O
is	O
subsequently	O
protonated	O
by	O
Asp166OH	B-residue_name_number
via	O
Ser129OH	B-residue_name_number
.	O

Next	O
,	O
Thr1NH2	B-residue_name_number
polarizes	O
a	O
water	B-chemical
molecule	O
for	O
the	O
nucleophilic	O
attack	O
of	O
the	O
acyl	O
-	O
enzyme	O
intermediate	O
.	O

On	O
hydrolysis	O
of	O
the	O
latter	O
,	O
the	O
active	B-site
-	I-site
site	I-site
Thr1	B-residue_name_number
is	O
ready	O
for	O
catalysis	O
(	O
right	O
set	O
of	O
structures	O
).	O

The	O
charged	O
Thr1	B-residue_name_number
N	O
terminus	O
may	O
engage	O
in	O
the	O
orientation	O
of	O
the	O
amide	O
moiety	O
and	O
donate	O
a	O
proton	O
to	O
the	O
emerging	O
N	O
terminus	O
of	O
the	O
C	O
-	O
terminal	O
cleavage	O
product	O
.	O

The	O
resulting	O
deprotonated	O
Thr1NH2	B-residue_name_number
finally	O
activates	O
a	O
water	B-chemical
molecule	O
for	O
hydrolysis	O
of	O
the	O
acyl	O
-	O
enzyme	O
.	O

The	O
proteasome	B-complex_assembly
favours	O
threonine	B-residue_name
as	O
the	O
active	O
-	O
site	O
nucleophile	O
.	O

(	O
a	O
)	O
Growth	B-experimental_method
tests	I-experimental_method
by	I-experimental_method
serial	I-experimental_method
dilution	I-experimental_method
of	O
WT	B-protein_state
and	O
pre2	O
(	O
β5	B-protein
)	O
mutant	B-protein_state
yeast	B-taxonomy_domain
cultures	O
reveal	O
growth	O
defects	O
of	O
the	O
active	B-site
-	I-site
site	I-site
mutants	B-experimental_method
under	O
the	O
indicated	O
conditions	O
after	O
2	O
days	O
(	O
2	O
d	O
)	O
of	O
incubation	O
.	O

(	O
b	O
)	O
Purified	O
WT	B-protein_state
and	O
mutant	B-protein_state
proteasomes	B-complex_assembly
were	O
tested	O
for	O
their	O
chymotrypsin	O
-	O
like	O
activity	O
(	O
β5	B-protein
)	O
using	O
the	O
substrate	O
Suc	B-chemical
-	I-chemical
LLVY	I-chemical
-	I-chemical
AMC	I-chemical
.	O

(	O
c	O
)	O
Illustration	O
of	O
the	O
2FO	B-evidence
–	I-evidence
FC	I-evidence
electron	I-evidence
-	I-evidence
density	I-evidence
map	I-evidence
(	O
blue	O
mesh	O
contoured	O
at	O
1σ	O
)	O
for	O
the	O
β5	B-mutant
-	I-mutant
T1C	I-mutant
propeptide	B-structure_element
fragment	O
.	O

The	O
prosegment	B-structure_element
is	O
cleaved	B-protein_state
but	O
still	B-protein_state
bound	I-protein_state
in	O
the	O
substrate	B-site
-	I-site
binding	I-site
channel	I-site
.	O

Notably	O
,	O
His	B-residue_name_number
(-	I-residue_name_number
2	I-residue_name_number
)	I-residue_name_number
does	O
not	O
occupy	O
the	O
S1	B-site
pocket	I-site
formed	O
by	O
Met45	B-residue_name_number
,	O
similar	O
to	O
what	O
was	O
observed	O
for	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
K81R	I-mutant
mutant	B-protein_state
.	O

(	O
d	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
β5	B-mutant
-	I-mutant
T1A	I-mutant
-	I-mutant
K81R	I-mutant
and	O
the	O
β5	B-mutant
-	I-mutant
T1C	I-mutant
mutant	B-protein_state
subunits	O
onto	O
the	O
WT	B-protein_state
β5	B-protein
subunit	O
.	O

(	O
e	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
β5	B-mutant
-	I-mutant
T1C	I-mutant
propeptide	B-structure_element
onto	O
the	O
β1	B-mutant
-	I-mutant
T1A	I-mutant
active	B-site
site	I-site
(	O
blue	O
)	O
and	O
the	O
WT	B-protein_state
β5	B-protein
active	B-site
site	I-site
in	B-protein_state
complex	I-protein_state
with	I-protein_state
the	O
proteasome	B-complex_assembly
inhibitor	O
MG132	B-chemical
(	O
ref	O
.).	O

The	O
inhibitor	B-chemical
as	O
well	O
as	O
the	O
propeptides	B-structure_element
adopt	O
similar	O
conformations	O
in	O
the	O
substrate	B-site
-	I-site
binding	I-site
channel	I-site
.	O

(	O
f	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
WT	B-protein_state
β5	B-protein
and	O
β5	B-mutant
-	I-mutant
T1C	I-mutant
mutant	B-protein_state
active	B-site
sites	I-site
illustrates	O
the	O
different	O
orientations	O
of	O
the	O
hydroxyl	O
group	O
of	O
Thr1	B-residue_name_number
and	O
the	O
thiol	O
side	O
chain	O
of	O
Cys1	B-residue_name_number
.	O

(	O
g	O
)	O
Structural	B-experimental_method
superposition	I-experimental_method
of	O
the	O
WT	B-protein_state
β5	B-protein
and	O
β5	B-mutant
-	I-mutant
T1S	I-mutant
mutant	B-protein_state
active	B-site
sites	I-site
reveals	O
different	O
orientations	O
of	O
the	O
hydroxyl	O
groups	O
of	O
Thr1	B-residue_name_number
and	O
Ser1	B-residue_name_number
,	O
respectively	O
.	O

The	O
2FO	B-evidence
–	I-evidence
FC	I-evidence
electron	I-evidence
-	I-evidence
density	I-evidence
map	I-evidence
for	O
Ser1	B-residue_name_number
(	O
blue	O
mesh	O
contoured	O
at	O
1σ	O
)	O
is	O
illustrated	O
.	O

(	O
h	O
)	O
The	O
methyl	O
group	O
of	O
Thr1	B-residue_name_number
is	O
anchored	O
by	O
hydrophobic	O
interactions	O
with	O
Ala46Cβ	B-residue_name_number
and	O
Thr3Cγ	B-residue_name_number
.	O

Ser1	O
lacks	B-protein_state
this	O
stabilization	O
and	O
is	O
therefore	O
rotated	O
by	O
60	O
°.	O

Inhibition	O
of	O
WT	B-protein_state
and	O
mutant	B-protein_state
β5	B-mutant
-	I-mutant
T1S	I-mutant
proteasomes	B-complex_assembly
by	O
bortezomib	B-chemical
and	O
carfilzomib	B-chemical
.	O

Inhibition	B-experimental_method
assays	I-experimental_method
(	O
left	O
panel	O
).	O

Purified	O
yeast	B-taxonomy_domain
proteasomes	B-complex_assembly
were	O
tested	O
for	O
the	O
susceptibility	O
of	O
their	O
ChT	O
-	O
L	O
(	O
β5	B-protein
)	O
activity	O
to	O
inhibition	O
by	O
bortezomib	B-chemical
and	O
carfilzomib	B-chemical
using	O
the	O
substrate	O
Suc	B-chemical
-	I-chemical
LLVY	I-chemical
-	I-chemical
AMC	I-chemical
.	O

IC50	B-evidence
values	I-evidence
were	O
determined	O
in	O
triplicate	O
;	O
s	O
.	O
d	O
.'	O
s	O
are	O
indicated	O
by	O
error	O
bars	O
.	O

Note	O
that	O
IC50	B-evidence
values	I-evidence
depend	O
on	O
time	O
and	O
enzyme	O
concentration	O
.	O

Proteasomes	B-complex_assembly
(	O
final	O
concentration	O
:	O
66	O
nM	O
)	O
were	O
incubated	O
with	O
inhibitor	O
for	O
45	O
min	O
before	O
substrate	O
addition	O
(	O
final	O
concentration	O
:	O
200	O
μM	O
).	O

Structures	B-evidence
of	O
the	O
β5	B-mutant
-	I-mutant
T1S	I-mutant
mutant	B-protein_state
in	O
complex	B-complex_assembly
with	I-complex_assembly
both	I-complex_assembly
ligands	I-complex_assembly
(	O
green	O
)	O
prove	O
the	O
reactivity	O
of	O
Ser1	B-residue_name_number
(	O
right	O
panel	O
).	O

The	O
2FO	B-evidence
–	I-evidence
FC	I-evidence
electron	I-evidence
-	I-evidence
density	I-evidence
maps	I-evidence
(	O
blue	O
mesh	O
)	O
for	O
Ser1	B-residue_name_number
(	O
brown	O
)	O
and	O
the	O
covalently	O
bound	O
ligands	O
(	O
green	O
;	O
only	O
the	O
P1	B-site
site	I-site
(	O
Leu1	B-residue_name_number
)	O
is	O
shown	O
)	O
are	O
contoured	O
at	O
1σ	O
.	O

The	O
WT	B-protein_state
proteasome	B-complex_assembly
:	I-complex_assembly
inhibitor	I-complex_assembly
complex	I-complex_assembly
structures	B-evidence
(	O
inhibitor	O
in	O
grey	O
;	O
Thr1	B-residue_name_number
in	O
black	O
)	O
are	O
superimposed	B-experimental_method
and	O
demonstrate	O
that	O
mutation	B-experimental_method
of	O
Thr1	B-residue_name_number
to	O
Ser	B-residue_name
does	O
not	O
affect	O
the	O
binding	O
mode	O
of	O
bortezomib	B-chemical
or	O
carfilzomib	B-chemical
.	O

An	O
extended	B-protein_state
U2AF65	B-structure_element
–	I-structure_element
RNA	I-structure_element
-	I-structure_element
binding	I-structure_element
domain	I-structure_element
recognizes	O
the	O
3	B-site
′	I-site
splice	I-site
site	I-site
signal	O

How	O
the	O
essential	O
pre	B-protein_type
-	I-protein_type
mRNA	I-protein_type
splicing	I-protein_type
factor	I-protein_type
U2AF65	B-protein
recognizes	O
the	O
polypyrimidine	B-chemical
(	O
Py	B-chemical
)	O
signals	O
of	O
the	O
major	O
class	O
of	O
3	B-site
′	I-site
splice	I-site
sites	I-site
in	O
human	B-species
gene	O
transcripts	O
remains	O
incompletely	O
understood	O
.	O

We	O
determined	B-experimental_method
four	I-experimental_method
structures	I-experimental_method
of	O
an	O
extended	B-protein_state
U2AF65	B-structure_element
–	I-structure_element
RNA	I-structure_element
-	I-structure_element
binding	I-structure_element
domain	I-structure_element
bound	B-protein_state
to	I-protein_state
Py	B-chemical
-	I-chemical
tract	I-chemical
oligonucleotides	I-chemical
at	O
resolutions	O
between	O
2	O
.	O
0	O
and	O
1	O
.	O
5	O
Å	O
.	O
These	O
structures	B-evidence
together	O
with	O
RNA	B-experimental_method
binding	I-experimental_method
and	I-experimental_method
splicing	I-experimental_method
assays	I-experimental_method
reveal	O
unforeseen	O
roles	O
for	O
U2AF65	B-protein
inter	B-site
-	I-site
domain	I-site
residues	I-site
in	O
recognizing	O
a	O
contiguous	B-structure_element
,	O
nine	O
-	O
nucleotide	B-chemical
Py	B-chemical
tract	I-chemical
.	O

The	O
U2AF65	B-protein
linker	B-structure_element
residues	O
between	O
the	O
dual	O
RNA	B-structure_element
recognition	I-structure_element
motifs	I-structure_element
(	O
RRMs	B-structure_element
)	O
recognize	O
the	O
central	O
nucleotide	B-chemical
,	O
whereas	O
the	O
N	O
-	O
and	O
C	O
-	O
terminal	O
RRM	B-structure_element
extensions	I-structure_element
recognize	O
the	O
3	B-site
′	I-site
terminus	I-site
and	O
third	B-residue_number
nucleotide	B-chemical
.	O

Single	B-experimental_method
-	I-experimental_method
molecule	I-experimental_method
FRET	I-experimental_method
experiments	O
suggest	O
that	O
conformational	O
selection	O
and	O
induced	O
fit	O
of	O
the	O
U2AF65	B-protein
RRMs	B-structure_element
are	O
complementary	O
mechanisms	O
for	O
Py	B-chemical
-	I-chemical
tract	I-chemical
association	O
.	O

Altogether	O
,	O
these	O
results	O
advance	O
the	O
mechanistic	O
understanding	O
of	O
molecular	O
recognition	O
for	O
a	O
major	O
class	O
of	O
splice	B-site
site	I-site
signals	O
.	O

The	O
pre	B-protein_type
-	I-protein_type
mRNA	I-protein_type
splicing	I-protein_type
factor	I-protein_type
U2AF65	B-protein
recognizes	O
3	B-site
′	I-site
splice	I-site
sites	I-site
in	O
human	B-species
gene	O
transcripts	O
,	O
but	O
the	O
details	O
are	O
not	O
fully	O
understood	O
.	O

Here	O
,	O
the	O
authors	O
report	O
U2AF65	B-protein
structures	B-evidence
and	O
single	B-experimental_method
molecule	I-experimental_method
FRET	I-experimental_method
that	O
reveal	O
mechanistic	O
insights	O
into	O
splice	B-site
site	I-site
recognition	O
.	O

The	O
differential	O
skipping	O
or	O
inclusion	O
of	O
alternatively	O
spliced	O
pre	B-structure_element
-	I-structure_element
mRNA	I-structure_element
regions	I-structure_element
is	O
a	O
major	O
source	O
of	O
diversity	O
for	O
nearly	O
all	O
human	B-species
gene	O
transcripts	O
.	O

The	O
splice	B-site
sites	I-site
are	O
marked	O
by	O
relatively	O
short	B-structure_element
consensus	I-structure_element
sequences	I-structure_element
and	O
are	O
regulated	O
by	O
additional	O
pre	B-structure_element
-	I-structure_element
mRNA	I-structure_element
motifs	I-structure_element
(	O
reviewed	O
in	O
ref	O
.).	O

At	O
the	O
3	B-site
′	I-site
splice	I-site
site	I-site
of	O
the	O
major	O
intron	O
class	O
,	O
these	O
include	O
a	O
polypyrimidine	B-chemical
(	I-chemical
Py	I-chemical
)	I-chemical
tract	I-chemical
comprising	O
primarily	O
Us	B-residue_name
or	O
Cs	B-residue_name
,	O
which	O
is	O
preceded	O
by	O
a	O
branch	B-site
point	I-site
sequence	I-site
(	O
BPS	B-site
)	O
that	O
ultimately	O
serves	O
as	O
the	O
nucleophile	O
in	O
the	O
splicing	O
reaction	O
and	O
an	O
AG	B-chemical
-	I-chemical
dinucleotide	I-chemical
at	O
the	O
3	B-site
′	I-site
splice	I-site
site	I-site
junction	O
.	O

Disease	O
-	O
causing	O
mutations	O
often	O
compromise	O
pre	B-chemical
-	I-chemical
mRNA	I-chemical
splicing	O
(	O
reviewed	O
in	O
refs	O
),	O
yet	O
a	O
priori	O
predictions	O
of	O
splice	B-site
sites	I-site
and	O
the	O
consequences	O
of	O
their	O
mutations	O
are	O
challenged	O
by	O
the	O
brevity	O
and	O
degeneracy	O
of	O
known	O
splice	B-site
site	I-site
sequences	O
.	O

High	O
-	O
resolution	O
structures	B-evidence
of	O
intact	B-protein_state
splicing	B-complex_assembly
factor	I-complex_assembly
–	I-complex_assembly
RNA	I-complex_assembly
complexes	O
would	O
offer	O
key	O
insights	O
regarding	O
the	O
juxtaposition	O
of	O
the	O
distinct	O
splice	B-site
site	I-site
consensus	O
sequences	O
and	O
their	O
relationship	O
to	O
disease	O
-	O
causing	O
point	O
mutations	O
.	O

The	O
early	O
-	O
stage	O
pre	B-protein_type
-	I-protein_type
mRNA	I-protein_type
splicing	I-protein_type
factor	I-protein_type
U2AF65	B-protein
is	O
essential	O
for	O
viability	O
in	O
vertebrates	B-taxonomy_domain
and	O
other	O
model	O
organisms	O
(	O
for	O
example	O
,	O
ref	O
.).	O

A	O
tightly	O
controlled	O
assembly	B-complex_assembly
among	O
U2AF65	B-protein
,	O
the	O
pre	B-chemical
-	I-chemical
mRNA	I-chemical
,	O
and	O
partner	O
proteins	O
sequentially	O
identifies	O
the	O
3	B-site
′	I-site
splice	I-site
site	I-site
and	O
promotes	O
association	O
of	O
the	O
spliceosome	B-complex_assembly
,	O
which	O
ultimately	O
accomplishes	O
the	O
task	O
of	O
splicing	O
.	O

Initially	O
U2AF65	B-protein
recognizes	O
the	O
Py	B-chemical
-	I-chemical
tract	I-chemical
splice	B-site
site	I-site
signal	O
.	O

In	O
turn	O
,	O
the	O
ternary	B-complex_assembly
complex	I-complex_assembly
of	O
U2AF65	B-protein
with	O
SF1	B-protein
and	O
U2AF35	B-protein
identifies	O
the	O
surrounding	O
BPS	B-site
and	O
3	B-site
′	I-site
splice	I-site
site	I-site
junctions	O
.	O

Subsequently	O
U2AF65	B-protein
recruits	O
the	O
U2	B-complex_assembly
small	I-complex_assembly
nuclear	I-complex_assembly
ribonucleoprotein	I-complex_assembly
particle	I-complex_assembly
(	O
snRNP	B-complex_assembly
)	O
and	O
ultimately	O
dissociates	O
from	O
the	O
active	B-protein_state
spliceosome	B-complex_assembly
.	O

Biochemical	B-experimental_method
characterizations	I-experimental_method
of	O
U2AF65	B-protein
demonstrated	O
that	O
tandem	O
RNA	B-structure_element
recognition	I-structure_element
motifs	I-structure_element
(	O
RRM1	B-structure_element
and	O
RRM2	B-structure_element
)	O
recognize	O
the	O
Py	B-chemical
tract	I-chemical
(	O
Fig	O
.	O
1a	O
).	O

Milestone	O
crystal	B-evidence
structures	I-evidence
of	O
the	O
core	B-protein_state
U2AF65	B-protein
RRM1	B-structure_element
and	O
RRM2	B-structure_element
connected	O
by	O
a	O
shortened	B-protein_state
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
(	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
)	O
detailed	O
a	O
subset	O
of	O
nucleotide	O
interactions	O
with	O
the	O
individual	O
U2AF65	B-protein
RRMs	B-structure_element
.	O

A	O
subsequent	O
NMR	B-experimental_method
structure	B-evidence
characterized	O
the	O
side	B-protein_state
-	I-protein_state
by	I-protein_state
-	I-protein_state
side	I-protein_state
arrangement	O
of	O
the	O
minimal	B-protein_state
U2AF65	B-protein
RRM1	B-structure_element
and	O
RRM2	B-structure_element
connected	O
by	O
a	O
linker	B-structure_element
of	O
natural	B-protein_state
length	I-protein_state
(	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
),	O
yet	O
depended	O
on	O
the	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
crystal	B-evidence
structures	I-evidence
for	O
RNA	B-chemical
interactions	O
and	O
an	O
ab	O
initio	O
model	O
for	O
the	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
conformation	O
.	O

As	O
such	O
,	O
the	O
molecular	O
mechanisms	O
for	O
Py	B-chemical
-	I-chemical
tract	I-chemical
recognition	O
by	O
the	O
intact	B-protein_state
U2AF65	B-structure_element
–	I-structure_element
RNA	I-structure_element
-	I-structure_element
binding	I-structure_element
domain	I-structure_element
remained	O
unknown	O
.	O

Here	O
,	O
we	O
use	O
X	B-experimental_method
-	I-experimental_method
ray	I-experimental_method
crystallography	I-experimental_method
and	O
biochemical	B-experimental_method
studies	I-experimental_method
to	O
reveal	O
new	O
roles	O
in	O
Py	B-chemical
-	I-chemical
tract	I-chemical
recognition	O
for	O
the	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
and	O
key	O
residues	O
surrounding	O
the	O
core	B-protein_state
U2AF65	B-protein
RRMs	B-structure_element
.	O

We	O
use	O
single	B-experimental_method
-	I-experimental_method
molecule	I-experimental_method
Förster	I-experimental_method
resonance	I-experimental_method
energy	I-experimental_method
transfer	I-experimental_method
(	O
smFRET	B-experimental_method
)	O
to	O
characterize	O
the	O
conformational	B-evidence
dynamics	I-evidence
of	O
this	O
extended	B-protein_state
U2AF65	B-structure_element
–	I-structure_element
RNA	I-structure_element
-	I-structure_element
binding	I-structure_element
domain	I-structure_element
during	O
Py	B-chemical
-	I-chemical
tract	I-chemical
recognition	O
.	O

Cognate	O
U2AF65	B-protein
–	O
Py	B-chemical
-	I-chemical
tract	I-chemical
recognition	O
requires	O
RRM	B-structure_element
extensions	I-structure_element

The	O
RNA	B-evidence
affinity	I-evidence
of	O
the	O
minimal	B-protein_state
U2AF651	B-mutant
,	I-mutant
2	I-mutant
domain	O
comprising	O
the	O
core	B-protein_state
RRM1	B-structure_element
–	O
RRM2	B-structure_element
folds	B-structure_element
(	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
,	O
residues	O
148	B-residue_range
–	I-residue_range
336	I-residue_range
)	O
is	O
relatively	O
weak	O
compared	O
with	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
U2AF65	B-protein
(	O
Fig	O
.	O
1a	O
,	O
b	O
;	O
Supplementary	O
Fig	O
.	O
1	O
).	O

Historically	O
,	O
this	O
difference	O
was	O
attributed	O
to	O
the	O
U2AF65	B-protein
arginine	B-structure_element
–	I-structure_element
serine	I-structure_element
rich	I-structure_element
domain	I-structure_element
,	O
which	O
contacts	O
pre	B-complex_assembly
-	I-complex_assembly
mRNA	I-complex_assembly
–	I-complex_assembly
U2	I-complex_assembly
snRNA	I-complex_assembly
duplexes	I-complex_assembly
outside	O
of	O
the	O
Py	B-chemical
tract	I-chemical
.	O

We	O
noticed	O
that	O
the	O
RNA	B-evidence
-	I-evidence
binding	I-evidence
affinity	I-evidence
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
domain	O
was	O
greatly	O
enhanced	O
by	O
the	O
addition	B-experimental_method
of	I-experimental_method
seven	I-experimental_method
and	I-experimental_method
six	I-experimental_method
residues	I-experimental_method
at	O
the	O
respective	O
N	O
and	O
C	O
termini	O
of	O
the	O
minimal	B-protein_state
RRM1	B-structure_element
and	O
RRM2	B-structure_element
(	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
,	O
residues	O
141	B-residue_range
–	I-residue_range
342	I-residue_range
;	O
Fig	O
.	O
1a	O
).	O

In	O
a	O
fluorescence	B-experimental_method
anisotropy	I-experimental_method
assay	I-experimental_method
for	O
binding	O
a	O
representative	O
Py	B-chemical
tract	I-chemical
derived	O
from	O
the	O
well	O
-	O
characterized	O
splice	B-site
site	I-site
of	O
the	O
adenovirus	B-gene
major	I-gene
late	I-gene
promoter	I-gene
(	O
AdML	B-gene
),	O
the	O
RNA	B-evidence
affinity	I-evidence
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
increased	O
by	O
100	O
-	O
fold	O
relative	O
to	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
to	O
comparable	O
levels	O
as	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
U2AF65	B-protein
(	O
Fig	O
.	O
1b	O
;	O
Supplementary	O
Fig	O
.	O
1a	O
–	O
d	O
).	O

Likewise	O
,	O
both	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
and	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
U2AF65	B-protein
showed	O
similar	O
sequence	B-evidence
specificity	I-evidence
for	O
U	B-structure_element
-	I-structure_element
rich	I-structure_element
stretches	I-structure_element
in	O
the	O
5	B-site
′-	I-site
region	I-site
of	O
the	O
Py	B-chemical
tract	I-chemical
and	O
promiscuity	O
for	O
C	B-structure_element
-	I-structure_element
rich	I-structure_element
regions	I-structure_element
in	O
the	O
3	B-site
′-	I-site
region	I-site
(	O
Fig	O
.	O
1c	O
,	O
Supplementary	O
Fig	O
.	O
1e	O
–	O
h	O
).	O

U2AF65	B-protein_state
-	I-protein_state
bound	I-protein_state
Py	B-chemical
tract	I-chemical
comprises	O
nine	O
contiguous	B-structure_element
nucleotides	B-chemical

To	O
investigate	O
the	O
structural	O
basis	O
for	O
cognate	O
U2AF65	B-protein
recognition	O
of	O
a	O
contiguous	B-structure_element
Py	B-chemical
tract	I-chemical
,	O
we	O
determined	B-experimental_method
four	O
crystal	B-evidence
structures	I-evidence
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
bound	B-protein_state
to	I-protein_state
Py	B-chemical
-	I-chemical
tract	I-chemical
oligonucleotides	I-chemical
(	O
Fig	O
.	O
2a	O
;	O
Table	O
1	O
).	O

By	O
sequential	B-experimental_method
boot	I-experimental_method
strapping	I-experimental_method
(	O
Methods	O
),	O
we	O
optimized	O
the	O
oligonucleotide	B-chemical
length	O
,	O
the	O
position	O
of	O
a	O
Br	B-chemical
-	I-chemical
dU	I-chemical
,	O
and	O
the	O
identity	O
of	O
the	O
terminal	O
nucleotide	B-chemical
(	O
rU	B-residue_name
,	O
dU	B-residue_name
and	O
rC	B-residue_name
)	O
to	O
achieve	O
full	O
views	O
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
bound	B-protein_state
to	I-protein_state
contiguous	B-structure_element
Py	B-chemical
tracts	I-chemical
at	O
up	O
to	O
1	O
.	O
5	O
Å	O
resolution	O
.	O

The	O
protein	O
and	O
oligonucleotide	B-chemical
conformations	O
are	O
nearly	O
identical	O
among	O
the	O
four	O
new	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
(	O
Supplementary	O
Fig	O
.	O
2a	O
).	O

The	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
RRM1	B-structure_element
and	O
RRM2	B-structure_element
associate	O
with	O
the	O
Py	B-chemical
tract	I-chemical
in	O
a	O
parallel	B-protein_state
,	O
side	B-protein_state
-	I-protein_state
by	I-protein_state
-	I-protein_state
side	I-protein_state
arrangement	O
(	O
shown	O
for	O
representative	O
structure	O
iv	O
in	O
Fig	O
.	O
2b	O
,	O
c	O
;	O
Supplementary	O
Movie	O
1	O
).	O

An	O
extended	B-protein_state
conformation	I-protein_state
of	O
the	O
U2AF65	B-protein
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
traverses	O
across	O
the	O
α	B-structure_element
-	I-structure_element
helical	I-structure_element
surface	I-structure_element
of	O
RRM1	B-structure_element
and	O
the	O
central	O
β	B-structure_element
-	I-structure_element
strands	I-structure_element
of	O
RRM2	B-structure_element
and	O
is	O
well	O
defined	O
in	O
the	O
electron	B-evidence
density	I-evidence
(	O
Fig	O
.	O
2b	O
).	O

The	O
extensions	B-structure_element
at	O
the	O
N	O
terminus	O
of	O
RRM1	B-structure_element
and	O
C	O
terminus	O
of	O
RRM2	B-structure_element
adopt	O
well	O
-	O
ordered	O
α	B-structure_element
-	I-structure_element
helices	I-structure_element
.	O

Both	O
RRM1	B-structure_element
/	O
RRM2	B-structure_element
extensions	B-structure_element
and	O
the	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
directly	O
recognize	O
the	O
bound	B-protein_state
oligonucleotide	B-chemical
.	O

We	O
compare	O
the	O
global	O
conformation	O
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
with	O
the	O
prior	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
crystal	B-evidence
structure	I-evidence
and	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
NMR	B-experimental_method
structure	B-evidence
in	O
the	O
Supplementary	O
Discussion	O
and	O
Supplementary	O
Fig	O
.	O
2	O
.	O

The	O
discovery	O
of	O
nine	O
U2AF65	B-site
-	I-site
binding	I-site
sites	I-site
for	O
contiguous	B-structure_element
Py	B-chemical
-	I-chemical
tract	I-chemical
nucleotides	I-chemical
was	O
unexpected	O
.	O

Based	O
on	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
structures	B-evidence
,	O
we	O
originally	O
hypothesized	O
that	O
the	O
U2AF65	B-protein
RRMs	B-structure_element
would	O
bind	O
the	O
minimal	B-protein_state
seven	O
nucleotides	B-chemical
observed	O
in	O
these	O
structures	B-evidence
.	O

Surprisingly	O
,	O
the	O
RRM2	B-structure_element
extension	I-structure_element
/	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
contribute	O
new	O
central	O
nucleotide	B-site
-	I-site
binding	I-site
sites	I-site
near	O
the	O
RRM1	B-site
/	I-site
RRM2	I-site
junction	I-site
and	O
the	O
RRM1	B-structure_element
extension	I-structure_element
recognizes	O
the	O
3	O
′-	O
terminal	O
nucleotide	B-chemical
(	O
Fig	O
.	O
2c	O
;	O
Supplementary	O
Movie	O
1	O
).	O

The	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
characterize	O
ribose	B-chemical
(	O
r	B-chemical
)	O
nucleotides	B-chemical
at	O
all	O
of	O
the	O
binding	B-site
sites	I-site
except	O
the	O
seventh	B-residue_number
and	O
eighth	B-residue_number
deoxy	B-chemical
-(	I-chemical
d	I-chemical
)	I-chemical
U	I-chemical
,	O
which	O
are	O
likely	O
to	O
lack	O
2	O
′-	O
hydroxyl	O
contacts	O
based	O
on	O
the	O
RNA	B-protein_state
-	I-protein_state
bound	I-protein_state
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
structure	B-evidence
.	O

Qualitatively	O
,	O
a	O
subset	O
of	O
the	O
U2AF651	B-site
,	I-site
2L	I-site
-	I-site
nucleotide	I-site
-	I-site
binding	I-site
sites	I-site
(	O
sites	B-site
1	I-site
–	I-site
3	I-site
and	O
7	B-site
–	I-site
9	I-site
)	O
share	O
similar	O
locations	O
to	O
those	O
of	O
the	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
structures	B-evidence
(	O
Supplementary	O
Figs	O
2c	O
,	O
d	O
and	O
3	O
).	O

Yet	O
,	O
only	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
interactions	O
at	O
sites	B-site
1	I-site
and	I-site
7	I-site
are	O
nearly	O
identical	O
to	O
those	O
of	O
the	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
structures	B-evidence
(	O
Supplementary	O
Fig	O
.	O
3a	O
,	O
f	O
).	O

In	O
striking	O
departures	O
from	O
prior	O
partial	O
views	O
,	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
reveal	O
three	O
unanticipated	O
nucleotide	B-site
-	I-site
binding	I-site
sites	I-site
at	O
the	O
centre	O
of	O
the	O
Py	B-chemical
tract	I-chemical
,	O
as	O
well	O
as	O
numerous	O
new	O
interactions	O
that	O
underlie	O
cognate	O
recognition	O
of	O
the	O
Py	B-chemical
tract	I-chemical
(	O
Fig	O
.	O
3a	O
–	O
h	O
).	O

U2AF65	B-protein
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
interacts	O
with	O
the	O
Py	B-chemical
tract	I-chemical

The	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
RRM2	B-structure_element
,	O
the	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
and	O
RRM1	B-structure_element
concomitantly	O
recognize	O
the	O
three	O
central	O
nucleotides	B-chemical
of	O
the	O
Py	B-chemical
tract	I-chemical
,	O
which	O
are	O
likely	O
to	O
coordinate	O
the	O
conformational	O
arrangement	O
of	O
these	O
disparate	O
portions	O
of	O
the	O
protein	O
.	O

Residues	O
in	O
the	O
C	B-structure_element
-	I-structure_element
terminal	I-structure_element
region	I-structure_element
of	O
the	O
U2AF65	B-protein
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
comprise	O
a	O
centrally	O
located	O
binding	B-site
site	I-site
for	O
the	O
fifth	B-residue_number
nucleotide	B-chemical
on	O
the	O
RRM2	B-site
surface	I-site
and	O
abutting	O
the	O
RRM1	B-site
/	I-site
RRM2	I-site
interface	I-site
(	O
Fig	O
.	O
3d	O
).	O

The	O
backbone	O
amide	O
of	O
the	O
linker	B-structure_element
V254	B-residue_name_number
and	O
the	O
carbonyl	O
of	O
T252	B-residue_name_number
engage	O
in	O
hydrogen	O
bonds	O
with	O
the	O
rU5	B-residue_name_number
-	O
O4	O
and	O
-	O
N3H	O
atoms	O
.	O

In	O
the	O
C	O
-	O
terminal	O
β	B-structure_element
-	I-structure_element
strand	I-structure_element
of	O
RRM1	B-structure_element
,	O
the	O
side	O
chains	O
of	O
K225	B-residue_name_number
and	O
R227	B-residue_name_number
donate	O
additional	O
hydrogen	O
bonds	O
to	O
the	O
rU5	B-residue_name_number
-	O
O2	O
lone	O
pair	O
electrons	O
.	O

The	O
C	B-structure_element
-	I-structure_element
terminal	I-structure_element
region	I-structure_element
of	O
the	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
also	O
participates	O
in	O
the	O
preceding	O
rU4	B-site
-	I-site
binding	I-site
site	I-site
,	O
where	O
the	O
V254	B-residue_name_number
backbone	O
carbonyl	O
and	O
D256	B-residue_name_number
carboxylate	O
position	O
the	O
K260	B-residue_name_number
side	O
chain	O
to	O
hydrogen	O
bond	O
with	O
the	O
rU4	B-residue_name_number
-	O
O4	O
(	O
Fig	O
.	O
3c	O
).	O

Otherwise	O
,	O
the	O
rU4	B-residue_name_number
nucleotide	B-chemical
packs	O
against	O
F304	B-residue_name_number
in	O
the	O
signature	O
ribonucleoprotein	B-structure_element
consensus	I-structure_element
motif	I-structure_element
(	I-structure_element
RNP	I-structure_element
)-	I-structure_element
2	I-structure_element
of	O
RRM2	B-structure_element
.	O

At	O
the	O
opposite	O
side	O
of	O
the	O
central	O
fifth	B-residue_number
nucleotide	B-chemical
,	O
the	O
sixth	B-residue_number
rU6	B-residue_name_number
nucleotide	B-chemical
is	O
located	O
at	O
the	O
inter	B-site
-	I-site
RRM1	I-site
/	I-site
RRM2	I-site
interface	I-site
(	O
Fig	O
.	O
3e	O
;	O
Supplementary	O
Movie	O
1	O
).	O

This	O
nucleotide	B-chemical
twists	O
to	O
face	O
away	O
from	O
the	O
U2AF65	B-protein
linker	B-structure_element
and	O
instead	O
inserts	O
the	O
rU6	B-residue_name_number
-	O
uracil	B-residue_name
into	O
a	O
sandwich	O
between	O
the	O
β2	B-structure_element
/	I-structure_element
β3	I-structure_element
loops	I-structure_element
of	O
RRM1	B-structure_element
and	O
RRM2	B-structure_element
.	O

The	O
rU6	B-residue_name_number
base	O
edge	O
is	O
relatively	O
solvent	B-protein_state
exposed	I-protein_state
;	O
accordingly	O
,	O
the	O
rU6	B-residue_name_number
hydrogen	O
bonds	O
with	O
U2AF65	B-protein
are	O
water	B-chemical
mediated	O
apart	O
from	O
a	O
single	O
direct	O
interaction	O
by	O
the	O
RRM1	B-structure_element
-	O
N196	B-residue_name_number
side	O
chain	O
.	O

We	O
tested	B-experimental_method
the	I-experimental_method
contribution	I-experimental_method
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
interactions	O
with	O
the	O
new	O
central	O
nucleotide	B-chemical
to	O
Py	B-evidence
-	I-evidence
tract	I-evidence
affinity	I-evidence
(	O
Fig	O
.	O
3i	O
;	O
Supplementary	O
Fig	O
.	O
4a	O
,	O
b	O
).	O

Mutagenesis	B-experimental_method
of	O
either	O
V254	B-residue_name_number
in	O
the	O
U2AF65	B-protein
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
to	O
proline	B-residue_name
or	O
RRM1	B-structure_element
–	O
R227	B-residue_name_number
to	O
alanine	B-residue_name
,	O
which	O
remove	O
the	O
hydrogen	O
bond	O
with	O
the	O
fifth	B-residue_number
uracil	B-residue_name
-	O
O4	O
or	O
-	O
O2	O
,	O
reduced	O
the	O
affinities	B-evidence
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
for	O
the	O
representative	O
AdML	B-gene
Py	B-chemical
tract	I-chemical
by	O
four	O
-	O
or	O
five	O
-	O
fold	O
,	O
respectively	O
.	O

The	O
energetic	O
penalties	O
due	O
to	O
these	O
mutations	O
(	O
ΔΔG	B-evidence
0	O
.	O
8	O
–	O
0	O
.	O
9	O
kcal	O
mol	O
−	O
1	O
)	O
are	O
consistent	O
with	O
the	O
loss	O
of	O
each	O
hydrogen	O
bond	O
with	O
the	O
rU5	B-residue_name_number
base	O
and	O
support	O
the	O
relevance	O
of	O
the	O
central	O
nucleotide	O
interactions	O
observed	O
in	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
.	O

U2AF65	B-protein
RRM	B-structure_element
extensions	I-structure_element
interact	O
with	O
the	O
Py	B-chemical
tract	I-chemical

The	O
N	B-structure_element
-	I-structure_element
and	I-structure_element
C	I-structure_element
-	I-structure_element
terminal	I-structure_element
extensions	I-structure_element
of	O
the	O
U2AF65	B-protein
RRM1	B-structure_element
and	O
RRM2	B-structure_element
directly	O
contact	O
the	O
bound	B-protein_state
Py	B-chemical
tract	I-chemical
.	O

Rather	O
than	O
interacting	O
with	O
a	O
new	O
5	O
′-	O
terminal	O
nucleotide	B-chemical
as	O
we	O
had	O
hypothesized	O
,	O
the	O
C	O
-	O
terminal	O
α	B-structure_element
-	I-structure_element
helix	I-structure_element
of	O
RRM2	B-structure_element
instead	O
folds	O
across	O
one	O
surface	O
of	O
rU3	B-residue_name_number
in	O
the	O
third	B-site
binding	I-site
site	I-site
(	O
Fig	O
.	O
3b	O
).	O

There	O
,	O
a	O
salt	O
bridge	O
between	O
the	O
K340	B-residue_name_number
side	O
chain	O
and	O
nucleotide	B-chemical
phosphate	O
,	O
as	O
well	O
as	O
G338	B-residue_name_number
-	O
base	O
stacking	O
and	O
a	O
hydrogen	O
bond	O
between	O
the	O
backbone	O
amide	O
of	O
G338	B-residue_name_number
and	O
the	O
rU3	B-residue_name_number
-	O
O4	O
,	O
secure	O
the	O
RRM2	B-structure_element
extension	I-structure_element
.	O

Indirectly	O
,	O
the	O
additional	O
contacts	O
with	O
the	O
third	B-residue_number
nucleotide	B-chemical
shift	O
the	O
rU2	B-residue_name_number
nucleotide	B-chemical
in	O
the	O
second	B-site
binding	I-site
site	I-site
closer	O
to	O
the	O
C	O
-	O
terminal	O
β	B-structure_element
-	I-structure_element
strand	I-structure_element
of	O
RRM2	B-structure_element
.	O

Consequently	O
,	O
the	O
U2AF651	B-protein_state
,	I-protein_state
2L	I-protein_state
-	I-protein_state
bound	I-protein_state
rU2	B-residue_name_number
-	O
O4	O
and	O
-	O
N3H	O
form	O
dual	O
hydrogen	O
bonds	O
with	O
the	O
K329	B-residue_name_number
backbone	O
atoms	O
(	O
Fig	O
.	O
3a	O
),	O
rather	O
than	O
a	O
single	O
hydrogen	O
bond	O
with	O
the	O
K329	B-residue_name_number
side	O
chain	O
as	O
in	O
the	O
prior	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
structure	B-evidence
(	O
Supplementary	O
Fig	O
.	O
3b	O
).	O

At	O
the	O
N	O
terminus	O
,	O
the	O
α	B-structure_element
-	I-structure_element
helical	I-structure_element
extension	I-structure_element
of	O
U2AF65	B-protein
RRM1	B-structure_element
positions	O
the	O
Q147	B-residue_name_number
side	O
chain	O
to	O
bridge	O
the	O
eighth	B-residue_number
and	O
ninth	B-residue_number
nucleotides	B-chemical
at	O
the	O
3	B-site
′	I-site
terminus	I-site
of	O
the	O
Py	B-chemical
tract	I-chemical
(	O
Fig	O
.	O
3f	O
–	O
h	O
).	O

The	O
Q147	B-residue_name_number
residue	O
participates	O
in	O
hydrogen	O
bonds	O
with	O
the	O
-	O
N3H	O
of	O
the	O
eighth	B-residue_number
uracil	B-residue_name
and	O
-	O
O2	O
of	O
the	O
ninth	B-residue_number
pyrimidine	B-chemical
.	O

The	O
adjacent	O
R146	B-residue_name_number
guanidinium	O
group	O
donates	O
hydrogen	O
bonds	O
to	O
the	O
3	O
′-	O
terminal	O
ribose	B-chemical
-	O
O2	O
′	O
and	O
O3	O
′	O
atoms	O
,	O
where	O
it	O
could	O
form	O
a	O
salt	O
bridge	O
with	O
a	O
phospho	O
-	O
diester	O
group	O
in	O
the	O
context	O
of	O
a	O
longer	O
pre	B-chemical
-	I-chemical
mRNA	I-chemical
.	O

Consistent	O
with	O
loss	O
of	O
a	O
hydrogen	O
bond	O
with	O
the	O
ninth	B-residue_number
pyrimidine	B-chemical
-	O
O2	O
(	O
ΔΔG	B-evidence
1	O
.	O
0	O
kcal	O
mol	O
−	O
1	O
),	O
mutation	B-experimental_method
of	O
the	O
Q147	B-residue_name_number
to	O
an	O
alanine	B-residue_name
reduced	O
U2AF651	B-evidence
,	I-evidence
2L	I-evidence
affinity	I-evidence
for	O
the	O
AdML	B-gene
Py	B-chemical
tract	I-chemical
by	O
five	O
-	O
fold	O
(	O
Fig	O
.	O
3i	O
;	O
Supplementary	O
Fig	O
.	O
4c	O
).	O

We	O
compare	B-experimental_method
U2AF65	B-protein
interactions	O
with	O
uracil	B-residue_name
relative	O
to	O
cytosine	B-residue_name
pyrimidines	B-chemical
at	O
the	O
ninth	B-site
binding	I-site
site	I-site
in	O
Fig	O
.	O
3g	O
,	O
h	O
and	O
the	O
Supplementary	O
Discussion	O
.	O

Versatile	O
primary	O
sequence	O
of	O
the	O
U2AF65	B-protein
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element

The	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
reveal	O
that	O
the	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
mediates	O
an	O
extensive	B-site
interface	I-site
with	O
the	O
second	O
α	B-structure_element
-	I-structure_element
helix	I-structure_element
of	O
RRM1	B-structure_element
,	O
the	O
β2	B-structure_element
/	I-structure_element
β3	I-structure_element
strands	I-structure_element
of	O
RRM2	B-structure_element
and	O
the	O
N	O
-	O
terminal	O
α	B-structure_element
-	I-structure_element
helical	I-structure_element
extension	I-structure_element
of	O
RRM1	B-structure_element
.	O

Altogether	O
,	O
the	O
U2AF65	B-protein
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
residues	O
(	O
R228	B-residue_range
–	I-residue_range
K260	I-residue_range
)	O
bury	O
2	O
,	O
800	O
Å2	O
of	O
surface	O
area	O
in	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
holo	B-protein_state
-	I-protein_state
protein	I-protein_state
,	O
suggestive	O
of	O
a	O
cognate	B-site
interface	I-site
compared	O
with	O
1	O
,	O
900	O
Å2	O
for	O
a	O
typical	O
protein	O
–	O
protein	O
complex	O
.	O

The	O
path	O
of	O
the	O
linker	B-structure_element
initiates	O
at	O
P229	B-residue_name_number
following	O
the	O
core	B-protein_state
RRM1	B-structure_element
β	B-structure_element
-	I-structure_element
strand	I-structure_element
,	O
in	O
a	O
kink	B-structure_element
that	O
is	O
positioned	O
by	O
intra	O
-	O
molecular	O
stacking	O
among	O
the	O
consecutive	O
R228	B-residue_name_number
,	O
Y232	B-residue_name_number
and	O
P234	B-residue_name_number
side	O
chains	O
(	O
Fig	O
.	O
4a	O
,	O
lower	O
right	O
).	O

A	O
second	B-structure_element
kink	I-structure_element
at	O
P236	B-residue_name_number
,	O
coupled	O
with	O
respective	O
packing	O
of	O
the	O
L235	B-residue_name_number
and	O
M238	B-residue_name_number
side	O
chains	O
on	O
the	O
N	O
-	O
terminal	O
α	B-structure_element
-	I-structure_element
helical	I-structure_element
RRM1	I-structure_element
extension	I-structure_element
and	O
the	O
core	B-protein_state
RRM1	B-structure_element
α2	B-structure_element
-	I-structure_element
helix	I-structure_element
,	O
reverses	O
the	O
direction	O
of	O
the	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
towards	O
the	O
RRM1	B-site
/	I-site
RRM2	I-site
interface	I-site
and	O
away	O
from	O
the	O
RNA	B-site
-	I-site
binding	I-site
site	I-site
.	O

In	O
the	O
neighbouring	O
apical	O
region	O
of	O
the	O
linker	B-structure_element
,	O
the	O
V244	B-residue_name_number
and	O
V246	B-residue_name_number
side	O
chains	O
pack	O
in	O
a	O
hydrophobic	B-site
pocket	I-site
between	O
two	O
α	B-structure_element
-	I-structure_element
helices	I-structure_element
of	O
the	O
core	B-protein_state
RRM1	B-structure_element
.	O

The	O
adjacent	O
V249	B-residue_name_number
and	O
V250	B-residue_name_number
are	O
notable	O
for	O
their	O
respective	O
interactions	O
that	O
connect	O
RRM1	B-structure_element
and	O
RRM2	B-structure_element
at	O
this	O
distal	O
interface	B-site
from	O
the	O
RNA	B-site
-	I-site
binding	I-site
site	I-site
(	O
Fig	O
.	O
4a	O
,	O
top	O
).	O

A	O
third	B-structure_element
kink	I-structure_element
stacks	O
P247	B-residue_name_number
and	O
G248	B-residue_name_number
with	O
Y245	B-residue_name_number
and	O
re	O
-	O
orients	O
the	O
C	B-structure_element
-	I-structure_element
terminal	I-structure_element
region	I-structure_element
of	O
the	O
linker	B-structure_element
towards	O
the	O
RRM2	B-structure_element
and	O
bound	B-protein_state
RNA	B-chemical
.	O

At	O
the	O
RNA	B-chemical
surface	O
,	O
the	O
key	O
V254	B-residue_name_number
that	O
recognizes	O
the	O
fifth	B-residue_number
uracil	B-residue_name
is	O
secured	O
via	O
hydrophobic	O
contacts	O
between	O
its	O
side	O
chain	O
and	O
the	O
β	B-structure_element
-	I-structure_element
sheet	I-structure_element
surface	I-structure_element
of	O
RRM2	B-structure_element
,	O
chiefly	O
the	O
consensus	O
RNP1	B-structure_element
-	O
F304	B-residue_name_number
residue	O
that	O
stacks	O
with	O
the	O
fourth	B-residue_number
uracil	B-residue_name
(	O
Fig	O
.	O
4a	O
,	O
lower	O
left	O
).	O

Few	O
direct	O
contacts	O
are	O
made	O
between	O
the	O
remaining	O
residues	O
of	O
the	O
linker	B-structure_element
and	O
the	O
U2AF65	B-protein
RRM2	B-structure_element
;	O
instead	O
,	O
the	O
C	O
-	O
terminal	O
conformation	O
of	O
the	O
linker	B-structure_element
appears	O
primarily	O
RNA	B-chemical
mediated	O
(	O
Fig	O
.	O
3c	O
,	O
d	O
).	O

We	O
investigated	O
whether	O
the	O
observed	O
contacts	O
between	O
the	O
RRMs	B-structure_element
and	O
linker	B-structure_element
were	O
critical	O
for	O
RNA	O
binding	O
by	O
structure	B-experimental_method
-	I-experimental_method
guided	I-experimental_method
mutagenesis	I-experimental_method
(	O
Fig	O
.	O
4b	O
).	O

We	O
titrated	B-experimental_method
these	O
mutant	B-protein_state
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
proteins	O
into	O
fluorescein	B-chemical
-	O
labelled	O
AdML	B-gene
Py	B-chemical
-	I-chemical
tract	I-chemical
RNA	I-chemical
and	O
fit	O
the	O
fluorescence	B-evidence
anisotropy	I-evidence
changes	I-evidence
to	O
obtain	O
the	O
apparent	O
equilibrium	B-evidence
affinities	I-evidence
(	O
Supplementary	O
Fig	O
.	O
4d	O
–	O
h	O
).	O

We	O
introduced	O
glycine	B-residue_name
substitutions	B-experimental_method
to	O
maximally	O
reduce	O
the	O
buried	O
surface	O
area	O
without	O
directly	O
interfering	O
with	O
its	O
hydrogen	O
bonds	O
between	O
backbone	O
atoms	O
and	O
the	O
base	O
.	O

First	O
,	O
we	O
replaced	B-experimental_method
V249	B-residue_name_number
and	O
V250	B-residue_name_number
at	O
the	O
RRM1	B-site
/	I-site
RRM2	I-site
interface	I-site
and	O
V254	B-residue_name_number
at	O
the	O
bound	B-protein_state
RNA	B-chemical
site	O
with	O
glycine	B-residue_name
(	O
3Gly	B-mutant
).	O

However	O
,	O
the	O
resulting	O
decrease	O
in	O
the	O
AdML	B-gene
RNA	B-evidence
affinity	I-evidence
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
-	I-mutant
3Gly	I-mutant
mutant	B-protein_state
relative	O
to	O
wild	B-protein_state
-	I-protein_state
type	I-protein_state
protein	B-protein
was	O
not	O
significant	O
(	O
Fig	O
.	O
4b	O
).	O

In	O
parallel	O
,	O
we	O
replaced	B-experimental_method
five	O
linker	B-structure_element
residues	I-structure_element
(	O
S251	B-residue_name_number
,	O
T252	B-residue_name_number
,	O
V253	B-residue_name_number
,	O
V254	B-residue_name_number
and	O
P255	B-residue_name_number
)	O
at	O
the	O
fifth	B-site
nucleotide	I-site
-	I-site
binding	I-site
site	I-site
with	O
glycines	B-residue_name
(	O
5Gly	B-mutant
)	O
and	O
also	O
found	O
that	O
the	O
RNA	B-evidence
affinity	I-evidence
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
-	I-mutant
5Gly	I-mutant
mutant	B-protein_state
likewise	O
decreased	O
only	O
slightly	O
relative	O
to	O
wild	B-protein_state
-	I-protein_state
type	I-protein_state
protein	B-protein
.	O

A	O
more	O
conservative	B-experimental_method
substitution	I-experimental_method
of	O
these	O
five	O
residues	O
(	O
251	B-residue_range
–	I-residue_range
255	I-residue_range
)	O
with	O
an	O
unrelated	O
sequence	O
capable	O
of	O
backbone	O
-	O
mediated	O
hydrogen	O
bonds	O
(	O
STVVP	B-mutant
>	I-mutant
NLALA	I-mutant
)	O
confirmed	O
the	O
subtle	O
impact	O
of	O
this	O
versatile	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
sequence	I-structure_element
on	O
affinity	B-evidence
for	O
the	O
AdML	B-gene
Py	B-chemical
tract	I-chemical
.	O

Finally	O
,	O
to	O
ensure	O
that	O
these	O
selective	O
mutations	O
were	O
sufficient	O
to	O
disrupt	O
the	O
linker	B-structure_element
/	O
RRM	B-structure_element
contacts	O
,	O
we	O
substituted	B-experimental_method
glycine	B-residue_name
for	O
the	O
majority	O
of	O
buried	O
hydrophobic	O
residues	O
in	O
the	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
(	O
including	O
M144	B-residue_name_number
,	O
L235	B-residue_name_number
,	O
M238	B-residue_name_number
,	O
V244	B-residue_name_number
,	O
V246	B-residue_name_number
,	O
V249	B-residue_name_number
,	O
V250	B-residue_name_number
,	O
S251	B-residue_name_number
,	O
T252	B-residue_name_number
,	O
V253	B-residue_name_number
,	O
V254	B-residue_name_number
,	O
P255	B-residue_name_number
;	O
called	O
12Gly	B-mutant
).	O

Despite	O
12	B-experimental_method
concurrent	I-experimental_method
mutations	I-experimental_method
,	O
the	O
AdML	B-gene
RNA	B-evidence
affinity	I-evidence
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
-	I-mutant
12Gly	I-mutant
variant	B-protein_state
was	O
reduced	O
by	O
only	O
three	O
-	O
fold	O
relative	O
to	O
the	O
unmodified	B-protein_state
protein	B-protein
(	O
Fig	O
.	O
4b	O
),	O
which	O
is	O
less	O
than	O
the	O
penalty	O
of	O
the	O
V254P	B-mutant
mutation	O
that	O
disrupts	O
the	O
rU5	B-residue_name_number
hydrogen	O
bond	O
(	O
Fig	O
.	O
3d	O
,	O
i	O
).	O

To	O
test	O
the	O
interplay	O
of	O
the	O
U2AF65	B-protein
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
with	O
its	O
N	O
-	O
and	O
C	O
-	O
terminal	O
RRM	B-structure_element
extensions	I-structure_element
,	O
we	O
constructed	B-experimental_method
an	O
internal	O
linker	B-experimental_method
deletion	I-experimental_method
of	O
20	B-residue_range
-	I-residue_range
residues	I-residue_range
within	O
the	O
extended	B-protein_state
RNA	B-structure_element
-	I-structure_element
binding	I-structure_element
domain	I-structure_element
(	O
dU2AF651	B-mutant
,	I-mutant
2L	I-mutant
).	O

We	O
found	O
that	O
the	O
affinity	B-evidence
of	O
dU2AF651	B-mutant
,	I-mutant
2L	I-mutant
for	O
the	O
AdML	B-gene
RNA	B-chemical
was	O
significantly	O
reduced	O
relative	O
to	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
(	O
four	O
-	O
fold	O
,	O
Figs	O
1b	O
and	O
4b	O
;	O
Supplementary	O
Fig	O
.	O
4i	O
).	O

Yet	O
,	O
it	O
is	O
well	O
known	O
that	O
the	O
linker	B-experimental_method
deletion	I-experimental_method
in	O
the	O
context	O
of	O
the	O
minimal	B-protein_state
RRM1	B-structure_element
–	O
RRM2	B-structure_element
boundaries	O
has	O
no	O
detectable	O
effect	O
on	O
the	O
RNA	B-evidence
affinities	I-evidence
of	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
compared	O
with	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
(	O
refs	O
;	O
Figs	O
1b	O
and	O
4b	O
;	O
Supplementary	O
Fig	O
.	O
4j	O
).	O

The	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
suggest	O
that	O
an	O
extended	B-protein_state
conformation	I-protein_state
of	O
the	O
truncated	B-protein_state
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
would	O
suffice	O
to	O
connect	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
RRM1	B-structure_element
C	O
terminus	O
to	O
the	O
N	O
terminus	O
of	O
RRM2	B-structure_element
(	O
24	O
Å	O
distance	O
between	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
R227	B-residue_name_number
-	O
Cα	O
–	O
H259	B-residue_name_number
-	O
Cα	O
atoms	O
),	O
which	O
agrees	O
with	O
the	O
greater	O
RNA	B-evidence
affinities	I-evidence
of	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
and	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
dual	B-protein_state
RRMs	B-structure_element
compared	O
with	O
the	O
individual	B-protein_state
U2AF65	B-protein
RRMs	B-structure_element
.	O

However	O
,	O
stretching	O
of	O
the	O
truncated	B-protein_state
dU2AF651	B-mutant
,	I-mutant
2L	I-mutant
linker	B-structure_element
to	O
connect	O
the	O
RRM	B-structure_element
termini	I-structure_element
is	O
expected	O
to	O
disrupt	O
its	O
nucleotide	O
interactions	O
.	O

Likewise	O
,	O
deletion	B-experimental_method
of	O
the	O
N	O
-	O
terminal	O
RRM1	B-structure_element
extension	I-structure_element
in	O
the	O
shortened	B-protein_state
constructs	O
would	O
remove	O
packing	O
interactions	O
that	O
position	O
the	O
linker	B-structure_element
in	O
a	O
kinked	B-structure_element
turn	I-structure_element
following	O
P229	B-residue_name_number
(	O
Fig	O
.	O
4a	O
),	O
consistent	O
with	O
the	O
lower	O
RNA	B-evidence
affinities	I-evidence
of	O
dU2AF651	B-mutant
,	I-mutant
2L	I-mutant
,	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
and	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
compared	O
with	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
.	O

To	O
further	O
test	O
cooperation	O
among	O
the	O
U2AF65	B-protein
RRM	B-structure_element
extensions	I-structure_element
and	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
for	O
RNA	O
recognition	O
,	O
we	O
tested	O
the	O
impact	O
of	O
a	O
triple	O
Q147A	B-mutant
/	O
V254P	B-mutant
/	O
R227A	B-mutant
mutation	B-experimental_method
(	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
-	I-mutant
3Mut	I-mutant
)	O
for	O
RNA	O
binding	O
(	O
Fig	O
.	O
4b	O
;	O
Supplementary	O
Fig	O
.	O
4d	O
).	O

Notably	O
,	O
the	O
Q147A	B-mutant
/	O
V254P	B-mutant
/	O
R227A	B-mutant
mutation	B-experimental_method
reduced	O
the	O
RNA	B-evidence
affinity	I-evidence
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
-	I-mutant
3Mut	I-mutant
protein	O
by	O
30	O
-	O
fold	O
more	O
than	O
would	O
be	O
expected	O
based	O
on	O
simple	O
addition	O
of	O
the	O
ΔΔG	B-evidence
'	O
s	O
for	O
the	O
single	O
mutations	O
.	O

This	O
difference	O
indicates	O
that	O
the	O
linearly	B-protein_state
distant	I-protein_state
regions	B-structure_element
of	O
the	O
U2AF65	B-protein
primary	O
sequence	O
,	O
including	O
Q147	B-residue_name_number
in	O
the	O
N	O
-	O
terminal	O
RRM1	B-structure_element
extension	I-structure_element
and	O
R227	B-residue_name_number
/	O
V254	B-residue_name_number
in	O
the	O
N	O
-/	O
C	O
-	O
terminal	O
linker	B-structure_element
regions	I-structure_element
at	O
the	O
fifth	B-site
nucleotide	I-site
site	I-site
,	O
cooperatively	O
recognize	O
the	O
Py	B-chemical
tract	I-chemical
.	O

Altogether	O
,	O
we	O
conclude	O
that	O
the	O
conformation	O
of	O
the	O
U2AF65	B-protein
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
is	O
key	O
for	O
recognizing	O
RNA	B-chemical
and	O
is	O
positioned	O
by	O
the	O
RRM	B-structure_element
extension	I-structure_element
but	O
otherwise	O
relatively	O
independent	O
of	O
the	O
side	O
chain	O
composition	O
.	O

The	O
non	O
-	O
additive	O
effects	O
of	O
the	O
Q147A	B-mutant
/	O
V254P	B-mutant
/	O
R227A	B-mutant
triple	B-experimental_method
mutation	I-experimental_method
,	O
coupled	O
with	O
the	O
context	O
-	O
dependent	O
penalties	O
of	O
an	O
internal	O
U2AF65	B-protein
linker	B-experimental_method
deletion	I-experimental_method
,	O
highlights	O
the	O
importance	O
of	O
the	O
structural	O
interplay	O
among	O
the	O
U2AF65	B-protein
linker	B-structure_element
and	O
the	O
N	B-structure_element
-	I-structure_element
and	I-structure_element
C	I-structure_element
-	I-structure_element
terminal	I-structure_element
extensions	I-structure_element
flanking	O
the	O
core	B-protein_state
RRMs	B-structure_element
.	O

Importance	O
of	O
U2AF65	B-complex_assembly
–	I-complex_assembly
RNA	I-complex_assembly
contacts	O
for	O
pre	B-chemical
-	I-chemical
mRNA	I-chemical
splicing	O

We	O
proceeded	O
to	O
test	O
the	O
importance	O
of	O
new	O
U2AF65	B-complex_assembly
–	I-complex_assembly
Py	I-complex_assembly
-	I-complex_assembly
tract	I-complex_assembly
interactions	O
for	O
splicing	O
of	O
a	O
model	O
pre	B-chemical
-	I-chemical
mRNA	I-chemical
substrate	O
in	O
a	O
human	B-species
cell	O
line	O
(	O
Fig	O
.	O
5	O
;	O
Supplementary	O
Fig	O
.	O
5	O
).	O

As	O
a	O
representative	O
splicing	O
substrate	O
,	O
we	O
utilized	O
a	O
well	O
-	O
characterized	O
minigene	B-chemical
splicing	I-chemical
reporter	I-chemical
(	O
called	O
pyPY	B-chemical
)	O
comprising	O
a	O
weak	O
(	O
that	O
is	O
,	O
degenerate	O
,	O
py	B-chemical
)	O
and	O
strong	O
(	O
that	O
is	O
,	O
U	B-structure_element
-	I-structure_element
rich	I-structure_element
,	O
PY	B-chemical
)	O
polypyrimidine	B-chemical
tracts	I-chemical
preceding	O
two	O
alternative	O
splice	B-site
sites	I-site
(	O
Fig	O
.	O
5a	O
).	O

When	O
transfected	B-experimental_method
into	O
HEK293T	O
cells	O
containing	O
only	O
endogenous	B-protein_state
U2AF65	B-protein
,	O
the	O
PY	B-site
splice	I-site
site	I-site
is	O
used	O
and	O
the	O
remaining	O
transcript	O
remains	O
unspliced	O
.	O

When	O
co	B-experimental_method
-	I-experimental_method
transfected	I-experimental_method
with	O
an	O
expression	B-experimental_method
plasmid	I-experimental_method
for	O
wild	B-protein_state
-	I-protein_state
type	I-protein_state
U2AF65	B-protein
,	O
use	O
of	O
the	O
py	B-site
splice	I-site
site	I-site
significantly	O
increases	O
(	O
by	O
more	O
than	O
five	O
-	O
fold	O
)	O
and	O
as	O
documented	O
converts	O
a	O
fraction	O
of	O
the	O
unspliced	O
to	O
spliced	O
transcript	O
.	O

The	O
strong	O
PY	B-site
splice	I-site
site	I-site
is	O
insensitive	O
to	O
added	O
U2AF65	B-protein
,	O
suggesting	O
that	O
endogenous	B-protein_state
U2AF65	B-protein
levels	O
are	O
sufficient	O
to	O
saturate	O
this	O
site	O
(	O
Supplementary	O
Fig	O
.	O
5b	O
).	O

We	O
introduced	O
the	O
triple	B-experimental_method
mutation	I-experimental_method
(	O
V254P	B-mutant
/	O
R227A	B-mutant
/	O
Q147A	B-mutant
)	O
that	O
significantly	O
reduced	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
association	O
with	O
the	O
Py	B-chemical
tract	I-chemical
(	O
Fig	O
.	O
4b	O
)	O
in	O
the	O
context	O
of	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
U2AF65	B-protein
(	O
U2AF65	B-mutant
-	I-mutant
3Mut	I-mutant
).	O

Co	B-experimental_method
-	I-experimental_method
transfection	I-experimental_method
of	O
the	O
U2AF65	B-mutant
-	I-mutant
3Mut	I-mutant
with	O
the	O
pyPY	B-chemical
splicing	O
substrate	O
significantly	O
reduced	O
splicing	O
of	O
the	O
weak	O
‘	B-site
py	I-site
'	I-site
splice	I-site
site	I-site
relative	O
to	O
wild	B-protein_state
-	I-protein_state
type	I-protein_state
U2AF65	B-protein
(	O
Fig	O
.	O
5b	O
,	O
c	O
).	O

We	O
conclude	O
that	O
the	O
Py	B-chemical
-	I-chemical
tract	I-chemical
interactions	O
with	O
these	O
residues	O
of	O
the	O
U2AF65	B-protein
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
and	O
RRM	B-structure_element
extensions	I-structure_element
are	O
important	O
for	O
splicing	O
as	O
well	O
as	O
for	O
binding	O
a	O
representative	O
of	O
the	O
major	B-structure_element
U2	I-structure_element
-	I-structure_element
class	I-structure_element
of	I-structure_element
splice	I-structure_element
sites	I-structure_element
.	O

Sparse	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
contacts	O
underlie	O
apo	B-protein_state
-	O
U2AF65	B-protein
dynamics	O

The	O
direct	O
interface	B-site
between	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
RRM1	B-structure_element
and	O
RRM2	B-structure_element
is	O
minor	O
,	O
burying	O
265	O
Å2	O
of	O
solvent	O
accessible	O
surface	O
area	O
compared	O
with	O
570	O
Å2	O
on	O
average	O
for	O
a	O
crystal	O
packing	O
interface	O
.	O

A	O
handful	O
of	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
hydrogen	O
bonds	O
are	O
apparent	O
between	O
the	O
side	O
chains	O
of	O
RRM1	B-structure_element
-	O
N155	B-residue_name_number
and	O
RRM2	B-structure_element
-	O
K292	B-residue_name_number
,	O
RRM1	B-structure_element
-	O
N155	B-residue_name_number
and	O
RRM2	B-structure_element
-	O
D272	B-residue_name_number
as	O
well	O
as	O
the	O
backbone	O
atoms	O
of	O
RRM1	B-structure_element
-	O
G221	B-residue_name_number
and	O
RRM2	B-structure_element
-	O
D273	B-residue_name_number
(	O
Fig	O
.	O
4c	O
).	O

This	O
minor	O
U2AF65	B-protein
RRM1	B-site
/	I-site
RRM2	I-site
interface	I-site
,	O
coupled	O
with	O
the	O
versatile	O
sequence	O
of	O
the	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
,	O
highlighted	O
the	O
potential	O
role	O
for	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
conformational	O
dynamics	O
in	O
U2AF65	B-protein
-	O
splice	O
site	O
recognition	O
.	O

Paramagnetic	B-experimental_method
resonance	I-experimental_method
enhancement	I-experimental_method
(	O
PRE	B-experimental_method
)	O
measurements	O
previously	O
had	O
suggested	O
a	O
predominant	O
back	B-protein_state
-	I-protein_state
to	I-protein_state
-	I-protein_state
back	I-protein_state
,	O
or	O
‘	O
closed	B-protein_state
'	O
conformation	O
of	O
the	O
apo	B-protein_state
-	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
RRM1	B-structure_element
and	O
RRM2	B-structure_element
in	O
equilibrium	O
with	O
a	O
minor	O
‘	O
open	B-protein_state
'	O
conformation	O
resembling	O
the	O
RNA	B-protein_state
-	I-protein_state
bound	I-protein_state
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
arrangement	O
.	O

Yet	O
,	O
small	B-experimental_method
-	I-experimental_method
angle	I-experimental_method
X	I-experimental_method
-	I-experimental_method
ray	I-experimental_method
scattering	I-experimental_method
(	O
SAXS	B-experimental_method
)	O
data	O
indicated	O
that	O
both	O
the	O
minimal	B-protein_state
U2AF651	B-mutant
,	I-mutant
2	I-mutant
and	O
longer	O
constructs	O
comprise	O
a	O
highly	B-protein_state
diverse	I-protein_state
continuum	I-protein_state
of	I-protein_state
conformations	I-protein_state
in	O
the	O
absence	B-protein_state
of	I-protein_state
RNA	B-chemical
that	O
includes	O
the	O
‘	O
closed	B-protein_state
'	O
and	O
‘	O
open	B-protein_state
'	O
conformations	O
.	O

To	O
complement	O
the	O
static	O
portraits	O
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structure	B-evidence
that	O
we	O
had	O
determined	O
by	O
X	B-experimental_method
-	I-experimental_method
ray	I-experimental_method
crystallography	I-experimental_method
,	O
we	O
used	O
smFRET	B-experimental_method
to	O
characterize	O
the	O
probability	B-evidence
distribution	I-evidence
functions	I-evidence
and	O
time	O
dependence	O
of	O
U2AF65	B-protein
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
conformational	O
dynamics	O
in	O
solution	O
.	O

The	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
dynamics	O
of	O
U2AF65	B-protein
were	O
followed	O
using	O
FRET	B-experimental_method
between	O
fluorophores	B-chemical
attached	O
to	O
RRM1	B-structure_element
and	O
RRM2	B-structure_element
(	O
Fig	O
.	O
6a	O
,	O
b	O
,	O
Methods	O
).	O

The	O
positions	O
of	O
single	O
cysteine	B-residue_name
mutations	B-experimental_method
for	O
fluorophore	B-chemical
attachment	O
(	O
A181C	B-mutant
in	O
RRM1	B-structure_element
and	O
Q324C	B-mutant
in	O
RRM2	B-structure_element
)	O
were	O
chosen	O
based	O
on	O
inspection	O
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
and	O
the	O
‘	O
closed	B-protein_state
'	O
model	O
of	O
apo	B-protein_state
-	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
.	O

Criteria	O
included	O
(	O
i	O
)	O
residue	O
locations	O
that	O
are	O
distant	O
from	O
and	O
hence	O
not	O
expected	O
to	O
interfere	O
with	O
the	O
RRM	B-complex_assembly
/	I-complex_assembly
RNA	I-complex_assembly
or	O
inter	B-site
-	I-site
RRM	I-site
interfaces	I-site
,	O
(	O
ii	O
)	O
inter	O
-	O
dye	O
distances	O
(	O
50	O
Å	O
for	O
U2AF651	B-complex_assembly
,	I-complex_assembly
2L	I-complex_assembly
–	I-complex_assembly
Py	I-complex_assembly
tract	I-complex_assembly
and	O
30	O
Å	O
for	O
the	O
closed	B-protein_state
apo	B-protein_state
-	O
model	O
)	O
that	O
are	O
expected	O
to	O
be	O
near	O
the	O
Förster	B-experimental_method
radius	I-experimental_method
(	I-experimental_method
Ro	I-experimental_method
)	I-experimental_method
for	O
the	O
Cy3	B-chemical
/	O
Cy5	B-chemical
pair	O
(	O
56	O
Å	O
),	O
where	O
changes	O
in	O
the	O
efficiency	O
of	O
energy	O
transfer	O
are	O
most	O
sensitive	O
to	O
distance	O
,	O
and	O
(	O
iii	O
)	O
FRET	B-evidence
efficiencies	I-evidence
that	O
are	O
calculated	O
to	O
be	O
significantly	O
greater	O
for	O
the	O
‘	O
closed	B-protein_state
'	O
apo	B-protein_state
-	O
model	O
as	O
opposed	O
to	O
the	O
‘	O
open	B-protein_state
'	O
RNA	B-protein_state
-	I-protein_state
bound	I-protein_state
structures	B-evidence
(	O
by	O
∼	O
30	O
%).	O

The	O
FRET	B-evidence
efficiencies	I-evidence
of	O
either	O
of	O
these	O
structurally	O
characterized	O
conformations	O
also	O
are	O
expected	O
to	O
be	O
significantly	O
greater	O
than	O
elongated	B-protein_state
U2AF65	B-protein
conformations	O
that	O
lack	B-protein_state
inter	O
-	O
RRM	B-structure_element
contacts	O
.	O

Double	O
-	O
cysteine	B-residue_name
variant	B-protein_state
of	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
was	O
modified	B-experimental_method
with	O
equimolar	O
amount	O
of	O
Cy3	B-chemical
and	O
Cy5	B-chemical
.	O

Only	O
traces	B-evidence
that	O
showed	O
single	O
photobleaching	O
events	O
for	O
both	O
donor	O
and	O
acceptor	O
dyes	O
and	O
anti	O
-	O
correlated	O
changes	O
in	O
acceptor	O
and	O
donor	O
fluorescence	O
were	O
included	O
in	O
smFRET	B-experimental_method
data	O
analysis	O
.	O

We	O
first	O
characterized	O
the	O
conformational	O
dynamics	O
spectrum	O
of	O
U2AF65	B-protein
in	O
the	O
absence	B-protein_state
of	I-protein_state
RNA	B-chemical
(	O
Fig	O
.	O
6c	O
,	O
d	O
;	O
Supplementary	O
Fig	O
.	O
7a	O
,	O
b	O
).	O

The	O
double	O
-	O
labelled	O
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
protein	O
was	O
tethered	B-protein_state
to	O
a	O
slide	O
via	O
biotin	B-chemical
-	I-chemical
NTA	I-chemical
/	I-chemical
Ni	I-chemical
+	I-chemical
2	I-chemical
resin	I-chemical
.	O

Virtually	O
no	O
fluorescent	O
molecules	O
were	O
detected	O
in	O
the	O
absence	B-protein_state
of	I-protein_state
biotin	B-chemical
-	I-chemical
NTA	I-chemical
/	I-chemical
Ni	I-chemical
+	I-chemical
2	I-chemical
,	O
which	O
demonstrates	O
the	O
absence	B-protein_state
of	I-protein_state
detectable	O
non	O
-	O
specific	O
binding	O
of	O
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
to	O
the	O
slide	O
.	O

The	O
FRET	B-evidence
distribution	I-evidence
histogram	I-evidence
built	O
from	O
more	O
than	O
a	O
thousand	O
traces	B-evidence
of	O
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
in	O
the	O
absence	B-protein_state
of	I-protein_state
ligand	B-chemical
showed	O
an	O
extremely	O
broad	O
distribution	O
centred	O
at	O
a	O
FRET	B-evidence
efficiency	I-evidence
of	O
∼	O
0	O
.	O
4	O
(	O
Fig	O
.	O
6d	O
).	O

Approximately	O
40	O
%	O
of	O
the	O
smFRET	B-experimental_method
traces	B-evidence
showed	O
apparent	O
transitions	O
between	O
multiple	O
FRET	B-evidence
values	I-evidence
(	O
for	O
example	O
,	O
Fig	O
.	O
6c	O
).	O

Despite	O
the	O
large	O
width	O
of	O
the	O
FRET	B-evidence
-	I-evidence
distribution	I-evidence
histogram	I-evidence
,	O
the	O
majority	O
(	O
80	O
%)	O
of	O
traces	B-evidence
that	O
showed	O
fluctuations	O
sampled	O
only	O
two	O
distinct	O
FRET	B-evidence
states	I-evidence
(	O
for	O
example	O
,	O
Supplementary	O
Fig	O
.	O
7a	O
).	O

Approximately	O
70	O
%	O
of	O
observed	O
fluctuations	O
were	O
interchanges	O
between	O
the	O
∼	O
0	O
.	O
65	O
and	O
∼	O
0	O
.	O
45	O
FRET	B-evidence
values	I-evidence
(	O
Supplementary	O
Fig	O
.	O
7b	O
).	O

We	O
cannot	O
exclude	O
a	O
possibility	O
that	O
tethering	O
of	O
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
to	O
the	O
microscope	O
slide	O
introduces	O
structural	O
heterogeneity	O
into	O
the	O
protein	O
and	O
,	O
thus	O
,	O
contributes	O
to	O
the	O
breadth	O
of	O
the	O
FRET	B-evidence
distribution	I-evidence
histogram	I-evidence
.	O

However	O
,	O
the	O
presence	O
of	O
repetitive	O
fluctuations	O
between	O
particular	O
FRET	B-evidence
values	I-evidence
supports	O
the	O
hypothesis	O
that	O
RNA	B-protein_state
-	I-protein_state
free	I-protein_state
U2AF65	B-protein
samples	O
several	O
distinct	O
conformations	O
.	O

This	O
result	O
is	O
consistent	O
with	O
the	O
broad	O
ensembles	O
of	O
extended	B-protein_state
solution	O
conformations	O
that	O
best	O
fit	O
the	O
SAXS	B-experimental_method
data	O
collected	O
for	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
as	O
well	O
as	O
for	O
a	O
longer	O
construct	O
(	O
residues	O
136	B-residue_range
–	I-residue_range
347	I-residue_range
).	O

We	O
conclude	O
that	O
weak	O
contacts	O
between	O
the	O
U2AF65	B-protein
RRM1	B-structure_element
and	O
RRM2	B-structure_element
permit	O
dissociation	O
of	O
these	O
RRMs	B-structure_element
in	O
the	O
absence	B-protein_state
of	I-protein_state
RNA	B-chemical
.	O

U2AF65	B-protein
conformational	O
selection	O
and	O
induced	O
fit	O
by	O
bound	B-protein_state
RNA	B-chemical

We	O
next	O
used	O
smFRET	B-experimental_method
to	O
probe	O
the	O
conformational	O
selection	O
of	O
distinct	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
arrangements	O
following	O
association	O
of	O
U2AF65	B-protein
with	O
the	O
AdML	B-gene
Py	B-chemical
-	I-chemical
tract	I-chemical
prototype	O
.	O

Addition	O
of	O
the	O
AdML	B-gene
RNA	B-chemical
to	O
tethered	B-protein_state
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
selectively	O
increases	O
a	O
fraction	O
of	O
molecules	O
showing	O
an	O
∼	O
0	O
.	O
45	O
apparent	O
FRET	B-evidence
efficiency	I-evidence
,	O
suggesting	O
that	O
RNA	O
binding	O
stabilizes	O
a	O
single	O
conformation	O
,	O
which	O
corresponds	O
to	O
the	O
0	O
.	O
45	O
FRET	B-evidence
state	I-evidence
(	O
Fig	O
.	O
6e	O
,	O
f	O
).	O

To	O
assess	O
the	O
possible	O
contributions	O
of	O
RNA	B-protein_state
-	I-protein_state
free	I-protein_state
conformations	O
of	O
U2AF65	B-protein
and	O
/	O
or	O
structural	O
heterogeneity	O
introduced	O
by	O
tethering	B-experimental_method
of	O
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
to	O
the	O
slide	O
to	O
the	O
observed	O
distribution	B-evidence
of	I-evidence
FRET	I-evidence
values	I-evidence
,	O
we	O
reversed	B-experimental_method
the	I-experimental_method
immobilization	I-experimental_method
scheme	I-experimental_method
.	O

We	O
tethered	B-protein_state
the	O
AdML	B-gene
RNA	B-chemical
to	O
the	O
slide	O
via	O
a	O
biotinylated	B-chemical
oligonucleotide	I-chemical
DNA	I-chemical
handle	O
and	O
added	B-experimental_method
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
in	O
the	O
absence	B-protein_state
of	I-protein_state
biotin	B-chemical
-	I-chemical
NTA	I-chemical
resin	I-chemical
(	O
Fig	O
.	O
6g	O
,	O
h	O
;	O
Supplementary	O
Fig	O
.	O
7c	O
–	O
g	O
).	O

A	O
0	O
.	O
45	O
FRET	B-evidence
value	I-evidence
was	O
again	O
predominant	O
,	O
indicating	O
a	O
similar	O
RNA	B-protein_state
-	I-protein_state
bound	I-protein_state
conformation	O
and	O
structural	O
dynamics	O
for	O
the	O
untethered	B-protein_state
and	O
tethered	B-protein_state
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
).	O

We	O
examined	O
the	O
effect	O
on	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
conformations	O
of	O
purine	B-experimental_method
interruptions	I-experimental_method
that	O
often	O
occur	O
in	O
relatively	O
degenerate	O
human	B-species
Py	B-chemical
tracts	I-chemical
.	O

We	O
introduced	B-experimental_method
an	O
rArA	B-chemical
purine	B-chemical
dinucleotide	I-chemical
within	O
a	O
variant	O
of	O
the	O
AdML	B-gene
Py	B-chemical
tract	I-chemical
(	O
detailed	O
in	O
Methods	O
).	O

Insertion	B-experimental_method
of	O
adenine	B-chemical
nucleotides	I-chemical
decreased	O
binding	B-evidence
affinity	I-evidence
of	O
U2AF65	B-protein
to	O
RNA	B-chemical
by	O
approximately	O
five	O
-	O
fold	O
.	O

Nevertheless	O
,	O
in	O
the	O
presence	O
of	O
saturating	O
concentrations	O
of	O
rArA	B-chemical
-	O
interrupted	O
RNA	B-chemical
slide	B-protein_state
-	I-protein_state
tethered	I-protein_state
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
showed	O
a	O
prevalent	O
∼	O
0	O
.	O
45	O
apparent	O
FRET	B-evidence
value	I-evidence
(	O
Fig	O
.	O
6i	O
,	O
j	O
),	O
which	O
was	O
also	O
predominant	O
in	O
the	O
presence	O
of	O
continuous	O
Py	B-chemical
tract	I-chemical
.	O

Therefore	O
,	O
RRM1	B-structure_element
-	O
to	O
-	O
RRM2	B-structure_element
distance	O
remains	O
similar	O
regardless	O
of	O
whether	O
U2AF65	B-protein
is	O
bound	B-protein_state
to	I-protein_state
interrupted	O
or	O
continuous	O
Py	B-chemical
tract	I-chemical
.	O

The	O
inter	B-evidence
-	I-evidence
fluorophore	I-evidence
distances	I-evidence
derived	O
from	O
the	O
observed	O
0	O
.	O
45	O
FRET	B-evidence
state	I-evidence
agree	O
with	O
the	O
distances	O
between	O
the	O
α	O
-	O
carbon	O
atoms	O
of	O
the	O
respective	O
residues	O
in	O
the	O
crystal	B-evidence
structures	I-evidence
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
bound	B-protein_state
to	I-protein_state
Py	B-chemical
-	I-chemical
tract	I-chemical
oligonucleotides	I-chemical
.	O

It	O
should	O
be	O
noted	O
that	O
inferring	O
distances	O
from	O
FRET	B-evidence
values	I-evidence
is	O
prone	O
to	O
significant	O
error	O
because	O
of	O
uncertainties	O
in	O
the	O
determination	O
of	O
fluorophore	O
orientation	O
factor	O
κ2	O
and	O
Förster	O
radius	O
R0	O
,	O
the	O
parameters	O
used	O
in	O
distance	O
calculations	O
.	O

Nevertheless	O
,	O
the	O
predominant	O
0	O
.	O
45	O
FRET	B-evidence
state	I-evidence
in	O
the	O
presence	O
of	O
RNA	B-chemical
agrees	O
with	O
the	O
Py	B-protein_state
-	I-protein_state
tract	I-protein_state
-	I-protein_state
bound	I-protein_state
crystal	B-evidence
structure	I-evidence
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
.	O

Importantly	O
,	O
the	O
majority	O
of	O
traces	B-evidence
(∼	O
70	O
%)	O
of	O
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
bound	B-protein_state
to	I-protein_state
the	O
slide	O
-	O
tethered	O
RNA	B-chemical
lacked	O
FRET	O
fluctuations	O
and	O
predominately	O
exhibited	O
a	O
∼	O
0	O
.	O
45	O
FRET	B-evidence
value	I-evidence
(	O
for	O
example	O
,	O
Fig	O
.	O
6g	O
).	O

The	O
remaining	O
∼	O
30	O
%	O
of	O
traces	B-evidence
for	O
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
bound	B-protein_state
to	I-protein_state
the	O
slide	O
-	O
tethered	O
RNA	B-chemical
showed	O
fluctuations	O
between	O
distinct	O
FRET	B-evidence
values	I-evidence
.	O

The	O
majority	O
of	O
traces	B-evidence
that	O
show	O
fluctuations	O
began	O
at	O
high	O
(	O
0	O
.	O
65	O
–	O
0	O
.	O
8	O
)	O
FRET	B-evidence
value	I-evidence
and	O
transitioned	O
to	O
a	O
∼	O
0	O
.	O
45	O
FRET	B-evidence
value	I-evidence
(	O
Supplementary	O
Fig	O
.	O
7c	O
–	O
g	O
).	O

Hidden	B-experimental_method
Markov	I-experimental_method
modelling	I-experimental_method
analysis	I-experimental_method
of	O
smFRET	B-experimental_method
traces	B-evidence
suggests	O
that	O
RNA	B-protein_state
-	I-protein_state
bound	I-protein_state
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
can	O
sample	O
at	O
least	O
two	O
other	O
conformations	O
corresponding	O
to	O
∼	O
0	O
.	O
7	O
–	O
0	O
.	O
8	O
and	O
∼	O
0	O
.	O
3	O
FRET	B-evidence
values	I-evidence
in	O
addition	O
to	O
the	O
predominant	O
conformation	O
corresponding	O
to	O
the	O
0	O
.	O
45	O
FRET	B-evidence
state	I-evidence
.	O

Although	O
a	O
compact	O
conformation	O
(	O
or	O
multiple	O
conformations	O
)	O
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
corresponding	O
to	O
∼	O
0	O
.	O
7	O
–	O
0	O
.	O
8	O
FRET	B-evidence
values	I-evidence
can	O
bind	O
RNA	B-chemical
,	O
on	O
RNA	B-chemical
binding	O
,	O
these	O
compact	B-protein_state
conformations	O
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
transition	O
into	O
a	O
more	O
stable	O
structural	O
state	O
that	O
corresponds	O
to	O
∼	O
0	O
.	O
45	O
FRET	B-evidence
value	I-evidence
and	O
is	O
likely	O
similar	O
to	O
the	O
side	B-protein_state
-	I-protein_state
by	I-protein_state
-	I-protein_state
side	I-protein_state
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
-	O
arrangement	O
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
crystal	B-evidence
structures	I-evidence
.	O

Thus	O
,	O
the	O
sequence	O
of	O
structural	O
rearrangements	O
of	O
U2AF65	B-protein
observed	O
in	O
smFRET	B-experimental_method
traces	B-evidence
(	O
Supplementary	O
Fig	O
.	O
7c	O
–	O
g	O
)	O
suggests	O
that	O
a	O
‘	O
conformational	O
selection	O
'	O
mechanism	O
of	O
Py	B-chemical
-	I-chemical
tract	I-chemical
recognition	O
(	O
that	O
is	O
,	O
RNA	O
ligand	O
stabilization	O
of	O
a	O
pre	B-protein_state
-	I-protein_state
configured	I-protein_state
U2AF65	B-protein
conformation	O
)	O
is	O
complemented	O
by	O
‘	O
induced	O
fit	O
'	O
(	O
that	O
is	O
,	O
RNA	O
-	O
induced	O
rearrangement	O
of	O
the	O
U2AF65	B-protein
RRMs	B-structure_element
to	O
achieve	O
the	O
final	O
‘	O
side	B-protein_state
-	I-protein_state
by	I-protein_state
-	I-protein_state
side	I-protein_state
'	O
conformation	O
),	O
as	O
discussed	O
below	O
.	O

The	O
U2AF65	B-protein
structures	B-evidence
and	O
analyses	B-evidence
presented	O
here	O
represent	O
a	O
successful	O
step	O
towards	O
defining	O
a	O
molecular	O
map	O
of	O
the	O
3	B-site
′	I-site
splice	I-site
site	I-site
.	O

Several	O
observations	O
indicate	O
that	O
the	O
numerous	O
intramolecular	O
contacts	O
,	O
here	O
revealed	O
among	O
the	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
and	O
RRM1	B-structure_element
,	O
RRM2	B-structure_element
,	O
and	O
the	O
N	O
-	O
terminal	O
RRM1	B-structure_element
extension	I-structure_element
,	O
synergistically	O
coordinate	O
U2AF65	B-protein
–	O
Py	O
-	O
tract	O
recognition	O
.	O

Truncation	B-experimental_method
of	O
U2AF65	B-protein
to	O
the	O
core	B-protein_state
RRM1	B-structure_element
–	I-structure_element
RRM2	I-structure_element
region	I-structure_element
reduces	O
its	O
RNA	B-evidence
affinity	I-evidence
by	O
100	O
-	O
fold	O
.	O

Likewise	O
,	O
deletion	B-experimental_method
of	O
20	B-residue_range
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
residues	I-structure_element
significantly	O
reduces	O
U2AF65	B-protein
–	O
RNA	B-chemical
binding	O
only	O
when	O
introduced	O
in	O
the	O
context	O
of	O
the	O
longer	B-protein_state
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
construct	O
comprising	O
the	O
RRM	B-structure_element
extensions	I-structure_element
,	O
which	O
in	O
turn	O
position	O
the	O
linker	B-structure_element
for	O
RNA	B-chemical
interactions	O
.	O

Notably	O
,	O
a	O
triple	B-protein_state
mutation	I-protein_state
of	O
three	O
residues	O
(	O
V254P	B-mutant
,	O
Q147A	B-mutant
and	O
R227A	B-mutant
)	O
in	O
the	O
respective	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
,	O
N	B-structure_element
-	I-structure_element
and	I-structure_element
C	I-structure_element
-	I-structure_element
terminal	I-structure_element
extensions	I-structure_element
non	O
-	O
additively	O
reduce	O
RNA	B-evidence
binding	I-evidence
by	O
150	O
-	O
fold	O
.	O

Altogether	O
,	O
these	O
data	O
indicate	O
that	O
interactions	O
among	O
the	O
U2AF65	B-protein
RRM1	B-structure_element
/	O
RRM2	B-structure_element
,	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
,	O
N	B-structure_element
-	I-structure_element
and	I-structure_element
C	I-structure_element
-	I-structure_element
terminal	I-structure_element
extensions	I-structure_element
are	O
mutually	O
inter	O
-	O
dependent	O
for	O
cognate	O
Py	B-chemical
-	I-chemical
tract	I-chemical
recognition	O
.	O

The	O
implications	O
of	O
this	O
finding	O
for	O
U2AF65	B-protein
conservation	O
and	O
Py	B-chemical
-	I-chemical
tract	I-chemical
recognition	O
are	O
detailed	O
in	O
the	O
Supplementary	O
Discussion	O
.	O

Recently	O
,	O
high	B-experimental_method
-	I-experimental_method
throughput	I-experimental_method
sequencing	I-experimental_method
studies	I-experimental_method
have	O
shown	O
that	O
somatic	O
mutations	O
in	O
pre	B-protein_type
-	I-protein_type
mRNA	I-protein_type
splicing	I-protein_type
factors	I-protein_type
occur	O
in	O
the	O
majority	O
of	O
patients	O
with	O
myelodysplastic	O
syndrome	O
(	O
MDS	O
).	O

MDS	O
-	O
relevant	O
mutations	O
are	O
common	O
in	O
the	O
small	B-protein_state
U2AF	B-protein_type
subunit	I-protein_type
(	O
U2AF35	B-protein
,	O
or	O
U2AF1	B-protein
),	O
yet	O
such	O
mutations	O
are	O
rare	O
in	O
the	O
large	B-protein_state
U2AF65	B-protein
subunit	O
(	O
also	O
called	O
U2AF2	B-protein
)—	O
possibly	O
due	O
to	O
the	O
selective	O
versus	O
nearly	O
universal	O
requirements	O
of	O
these	O
factors	O
for	O
splicing	O
.	O

A	O
confirmed	O
somatic	O
mutation	O
of	O
U2AF65	B-protein
in	O
patients	O
with	O
MDS	O
,	O
L187V	B-mutant
,	O
is	O
located	O
on	O
a	O
solvent	B-site
-	I-site
exposed	I-site
surface	I-site
of	O
RRM1	B-structure_element
that	O
is	O
distinct	O
from	O
the	O
RNA	B-site
interface	I-site
(	O
Fig	O
.	O
7a	O
).	O

This	O
L187	B-residue_name_number
surface	O
is	O
oriented	O
towards	O
the	O
N	O
terminus	O
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
construct	O
,	O
where	O
it	O
is	O
expected	O
to	O
abut	O
the	O
U2AF35	B-site
-	I-site
binding	I-site
site	I-site
in	O
the	O
context	O
of	O
the	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
U2AF	B-protein
heterodimer	B-oligomeric_state
.	O

Likewise	O
,	O
an	O
unconfirmed	O
M144I	B-mutant
mutation	O
reported	O
by	O
the	O
same	O
group	O
corresponds	O
to	O
the	O
N	O
-	O
terminal	O
residue	O
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
,	O
which	O
is	O
separated	O
by	O
only	O
∼	O
20	O
residues	O
from	O
the	O
U2AF35	B-site
-	I-site
binding	I-site
site	I-site
.	O

As	O
such	O
,	O
we	O
suggest	O
that	O
the	O
MDS	O
-	O
relevant	O
U2AF65	B-protein
mutations	O
contribute	O
to	O
MDS	O
progression	O
indirectly	O
,	O
by	O
destabilizing	O
a	O
relevant	O
conformation	O
of	O
the	O
conjoined	O
U2AF35	B-protein
subunit	O
rather	O
than	O
affecting	O
U2AF65	B-protein
functions	O
in	O
RNA	B-chemical
binding	O
or	O
spliceosome	B-complex_assembly
recruitment	O
per	O
se	O
.	O

Our	O
smFRET	B-experimental_method
results	O
agree	O
with	O
prior	O
NMR	B-experimental_method
/	O
PRE	B-experimental_method
evidence	O
for	O
multi	O
-	O
domain	O
conformational	O
selection	O
as	O
one	O
mechanistic	O
basis	O
for	O
U2AF65	B-protein
–	O
RNA	B-chemical
association	O
(	O
Fig	O
.	O
7b	O
).	O

An	O
∼	O
0	O
.	O
45	O
FRET	B-evidence
value	I-evidence
is	O
likely	O
to	O
correspond	O
to	O
the	O
U2AF65	B-protein
conformation	O
visualized	O
in	O
our	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
crystal	B-evidence
structures	I-evidence
,	O
in	O
which	O
the	O
RRM1	B-structure_element
and	O
RRM2	B-structure_element
bind	O
side	B-protein_state
-	I-protein_state
by	I-protein_state
-	I-protein_state
side	I-protein_state
to	O
the	O
Py	B-chemical
-	I-chemical
tract	I-chemical
oligonucleotide	I-chemical
.	O

The	O
lesser	O
0	O
.	O
65	O
–	O
0	O
.	O
8	O
and	O
0	O
.	O
2	O
–	O
0	O
.	O
3	O
FRET	B-evidence
values	I-evidence
in	O
the	O
untethered	B-protein_state
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
experiment	O
could	O
correspond	O
to	O
respective	O
variants	O
of	O
the	O
‘	O
closed	B-protein_state
',	O
back	B-protein_state
-	I-protein_state
to	I-protein_state
-	I-protein_state
back	I-protein_state
U2AF65	B-protein
conformations	O
characterized	O
by	O
NMR	B-experimental_method
/	O
PRE	B-experimental_method
data	O
,	O
or	O
to	O
extended	B-protein_state
U2AF65	B-protein
conformations	O
,	O
in	O
which	O
the	O
intramolecular	O
RRM1	B-structure_element
/	O
RRM2	B-structure_element
interactions	O
have	O
dissociated	O
the	O
protein	B-protein
is	O
bound	B-protein_state
to	I-protein_state
RNA	B-chemical
via	O
single	B-protein_state
RRMs	B-structure_element
.	O

An	O
increased	O
prevalence	O
of	O
the	O
∼	O
0	O
.	O
45	O
FRET	B-evidence
value	I-evidence
following	O
U2AF65	B-protein
–	O
RNA	B-chemical
binding	O
,	O
coupled	O
with	O
the	O
apparent	O
absence	B-protein_state
of	I-protein_state
transitions	O
in	O
many	O
∼	O
0	O
.	O
45	O
-	O
value	O
single	O
molecule	O
traces	B-evidence
(	O
for	O
example	O
,	O
Fig	O
.	O
6e	O
),	O
suggests	O
a	O
population	O
shift	O
in	O
which	O
RNA	B-chemical
binds	O
to	O
(	O
and	O
draws	O
the	O
equilibrium	O
towards	O
)	O
a	O
pre	B-protein_state
-	I-protein_state
configured	I-protein_state
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
proximity	O
that	O
most	O
often	O
corresponds	O
to	O
the	O
∼	O
0	O
.	O
45	O
FRET	B-evidence
value	I-evidence
.	O

Notably	O
,	O
our	O
smFRET	B-experimental_method
results	O
reveal	O
that	O
U2AF65	B-protein
–	O
Py	B-chemical
-	I-chemical
tract	I-chemical
recognition	O
can	O
be	O
characterized	O
by	O
an	O
‘	O
extended	O
conformational	O
selection	O
'	O
model	O
(	O
Fig	O
.	O
7b	O
).	O

Examples	O
of	O
‘	O
extended	B-protein_state
conformational	O
selection	O
'	O
during	O
ligand	O
binding	O
have	O
been	O
characterized	O
for	O
a	O
growing	O
number	O
of	O
macromolecules	O
(	O
for	O
example	O
,	O
adenylate	B-protein_type
kinase	I-protein_type
,	O
LAO	B-protein_type
-	I-protein_type
binding	I-protein_type
protein	I-protein_type
,	O
poly	B-protein_type
-	I-protein_type
ubiquitin	I-protein_type
,	O
maltose	B-protein_type
-	I-protein_type
binding	I-protein_type
protein	I-protein_type
and	O
the	O
preQ1	B-protein_type
riboswitch	I-protein_type
,	O
among	O
others	O
).	O

Here	O
,	O
the	O
majority	O
of	O
changes	O
in	O
smFRET	B-experimental_method
traces	B-evidence
for	O
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
bound	B-protein_state
to	I-protein_state
slide	O
-	O
tethered	O
RNA	B-chemical
began	O
at	O
high	O
(	O
0	O
.	O
65	O
–	O
0	O
.	O
8	O
)	O
FRET	B-evidence
value	I-evidence
and	O
transition	O
to	O
the	O
predominant	O
0	O
.	O
45	O
FRET	B-evidence
value	I-evidence
(	O
Supplementary	O
Fig	O
.	O
7c	O
–	O
g	O
).	O

These	O
transitions	O
could	O
correspond	O
to	O
rearrangement	O
from	O
the	O
‘	O
closed	B-protein_state
'	O
NMR	B-experimental_method
/	O
PRE	B-experimental_method
-	O
based	O
U2AF65	B-protein
conformation	O
in	O
which	O
the	O
RNA	B-site
-	I-site
binding	I-site
surface	I-site
of	O
only	O
a	O
single	B-protein_state
RRM	B-structure_element
is	O
exposed	O
and	O
available	O
for	O
RNA	O
binding	O
,	O
to	O
the	O
structural	O
state	O
seen	O
in	O
the	O
side	B-protein_state
-	I-protein_state
by	I-protein_state
-	I-protein_state
side	I-protein_state
,	O
RNA	B-protein_state
-	I-protein_state
bound	I-protein_state
crystal	B-evidence
structure	I-evidence
.	O

As	O
such	O
,	O
the	O
smFRET	B-experimental_method
approach	O
reconciles	O
prior	O
inconsistencies	O
between	O
two	O
major	O
conformations	O
that	O
were	O
detected	O
by	O
NMR	B-experimental_method
/	O
PRE	B-experimental_method
experiments	O
and	O
a	O
broad	O
ensemble	O
of	O
diverse	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
arrangements	O
that	O
fit	O
the	O
SAXS	B-experimental_method
data	O
for	O
the	O
apo	B-protein_state
-	O
protein	B-protein
.	O

Similar	O
interdisciplinary	O
structural	O
approaches	O
are	O
likely	O
to	O
illuminate	O
whether	O
similar	O
mechanistic	O
bases	O
for	O
RNA	O
binding	O
are	O
widespread	O
among	O
other	O
members	O
of	O
the	O
vast	O
multi	O
-	O
RRM	B-structure_element
family	O
.	O

The	O
finding	O
that	O
U2AF65	B-protein
recognizes	O
a	O
nine	O
base	O
pair	O
Py	B-chemical
tract	I-chemical
contributes	O
to	O
an	O
elusive	O
‘	O
code	O
'	O
for	O
predicting	O
splicing	O
patterns	O
from	O
primary	O
sequences	O
in	O
the	O
post	O
-	O
genomic	O
era	O
(	O
reviewed	O
in	O
ref	O
.).	O

Based	O
on	O
(	O
i	O
)	O
similar	O
RNA	B-evidence
affinities	I-evidence
of	O
U2AF65	B-protein
and	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
,	O
(	O
ii	O
)	O
indistinguishable	O
conformations	O
among	O
four	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
in	O
two	O
different	O
crystal	O
packing	O
arrangements	O
and	O
(	O
iii	O
)	O
penalties	B-evidence
of	O
structure	B-experimental_method
-	I-experimental_method
guided	I-experimental_method
mutations	I-experimental_method
in	O
RNA	B-experimental_method
binding	I-experimental_method
and	I-experimental_method
splicing	I-experimental_method
assays	I-experimental_method
,	O
we	O
suggest	O
that	O
the	O
extended	B-protein_state
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
regions	I-structure_element
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
underlie	O
cognate	O
Py	B-chemical
-	I-chemical
tract	I-chemical
recognition	O
by	O
the	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
U2AF65	B-protein
protein	O
.	O

Further	O
research	O
will	O
be	O
needed	O
to	O
understand	O
the	O
roles	O
of	O
SF1	B-protein
and	O
U2AF35	B-protein
subunits	O
in	O
the	O
conformational	O
equilibria	O
underlying	O
U2AF65	B-protein
association	O
with	O
Py	B-chemical
tracts	I-chemical
.	O

Moreover	O
,	O
structural	O
differences	O
among	O
U2AF65	B-protein
homologues	O
and	O
paralogues	O
may	O
regulate	O
splice	B-site
site	I-site
selection	O
.	O

Ultimately	O
,	O
these	O
guidelines	O
will	O
assist	O
the	O
identification	O
of	O
3	B-site
′	I-site
splice	I-site
sites	I-site
and	O
the	O
relationship	O
of	O
disease	O
-	O
causing	O
mutations	O
to	O
penalties	O
for	O
U2AF65	B-protein
association	O
.	O

The	O
intact	B-protein_state
U2AF65	B-protein
RRM1	B-structure_element
/	O
RRM2	B-structure_element
-	O
containing	O
domain	O
and	O
flanking	O
residues	O
are	O
required	O
for	O
binding	O
contiguous	B-structure_element
Py	B-chemical
tracts	I-chemical
.	O

(	O
a	O
)	O
Domain	O
organization	O
of	O
full	B-protein_state
-	I-protein_state
length	I-protein_state
(	O
fl	B-protein_state
)	O
U2AF65	B-protein
and	O
constructs	O
used	O
for	O
RNA	B-chemical
binding	O
and	O
structural	O
experiments	O
.	O

An	O
internal	O
deletion	O
(	O
d	B-mutant
,	O
Δ	B-mutant
)	O
of	O
residues	O
238	B-residue_range
–	I-residue_range
257	I-residue_range
removes	O
a	O
portion	O
of	O
the	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
from	O
the	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
and	O
dU2AF651	B-mutant
,	I-mutant
2L	I-mutant
constructs	O
.	O

(	O
b	O
)	O
Comparison	O
of	O
the	O
apparent	O
equilibrium	B-evidence
affinities	I-evidence
of	O
various	O
U2AF65	B-protein
constructs	O
for	O
binding	O
the	O
prototypical	O
AdML	B-gene
Py	B-chemical
tract	I-chemical
(	O
5	B-chemical
′-	I-chemical
CCCUUUUUUUUCC	I-chemical
-	I-chemical
3	I-chemical
′).	I-chemical

The	O
flU2AF65	B-protein
protein	O
includes	O
a	O
heterodimerization	B-structure_element
domain	I-structure_element
of	O
the	O
U2AF35	B-protein
subunit	O
to	O
promote	O
solubility	O
and	O
folding	O
.	O

The	O
apparent	O
equilibrium	B-evidence
dissociation	I-evidence
constants	I-evidence
(	O
KD	B-evidence
)	O
for	O
binding	O
the	O
AdML	B-gene
13mer	O
are	O
as	O
follows	O
:	O
flU2AF65	B-protein
,	O
30	O
±	O
3	O
nM	O
;	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
,	O
35	O
±	O
6	O
nM	O
;	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
,	O
3	O
,	O
600	O
±	O
300	O
nM	O
.	O
(	O
c	O
)	O
Comparison	O
of	O
the	O
RNA	B-evidence
sequence	I-evidence
specificities	I-evidence
of	O
flU2AF65	B-protein
and	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
constructs	O
binding	O
C	B-structure_element
-	I-structure_element
rich	I-structure_element
Py	B-chemical
tracts	I-chemical
with	O
4U	O
'	O
s	O
embedded	O
in	O
either	O
the	O
5	O
′-	O
(	O
light	O
grey	O
fill	O
)	O
or	O
3	O
′-	O
(	O
dark	O
grey	O
fill	O
)	O
regions	O
.	O

The	O
KD	B-evidence
'	O
s	O
for	O
binding	O
5	B-chemical
′-	I-chemical
CCUUUUCCCCCCC	I-chemical
-	I-chemical
3	I-chemical
′	I-chemical
are	O
:	O
flU2AF65	B-protein
,	O
41	O
±	O
2	O
nM	O
;	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
,	O
31	O
±	O
3	O
nM	O
.	O
The	O
KD	B-evidence
'	O
s	O
for	O
binding	O
5	B-chemical
′-	I-chemical
CCCCCCCUUUUCC	I-chemical
-	I-chemical
3	I-chemical
′	I-chemical
are	O
:	O
flU2AF65	B-protein
,	O
414	O
±	O
12	O
nM	O
;	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
,	O
417	O
±	O
10	O
nM	O
.	O
Bar	O
graphs	O
are	O
hatched	O
to	O
match	O
the	O
constructs	O
shown	O
in	O
a	O
.	O
The	O
average	B-evidence
apparent	I-evidence
equilibrium	I-evidence
affinity	I-evidence
(	O
KA	B-evidence
)	O
and	O
s	O
.	O
e	O
.	O
m	O
.	O

The	O
purified	O
protein	O
and	O
average	B-evidence
fitted	I-evidence
fluorescence	I-evidence
anisotropy	I-evidence
RNA	I-evidence
-	I-evidence
binding	I-evidence
curves	I-evidence
are	O
shown	O
in	O
Supplementary	O
Fig	O
.	O
1	O
.	O

RRM	B-structure_element
,	O
RNA	B-structure_element
recognition	I-structure_element
motif	I-structure_element
;	O
RS	B-structure_element
,	O
arginine	B-structure_element
-	I-structure_element
serine	I-structure_element
rich	I-structure_element
;	O
UHM	B-structure_element
,	O
U2AF	B-structure_element
homology	I-structure_element
motif	I-structure_element
;	O
ULM	B-structure_element
,	O
U2AF	B-structure_element
ligand	I-structure_element
motif	I-structure_element
.	O

Structures	B-evidence
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
recognizing	O
a	O
contiguous	B-structure_element
Py	B-chemical
tract	I-chemical
.	O

(	O
a	O
)	O
Alignment	B-experimental_method
of	O
oligonucleotide	B-chemical
sequences	O
that	O
were	O
co	B-experimental_method
-	I-experimental_method
crystallized	I-experimental_method
in	O
the	O
indicated	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
.	O

The	O
regions	O
of	O
RRM1	B-structure_element
,	O
RRM2	B-structure_element
and	O
linker	B-structure_element
contacts	O
are	O
indicated	O
above	O
by	O
respective	O
black	O
and	O
blue	O
arrows	O
from	O
N	O
-	O
to	O
C	O
-	O
terminus	O
.	O

For	O
clarity	O
,	O
we	O
consistently	O
number	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
nucleotide	B-site
-	I-site
binding	I-site
sites	I-site
from	O
one	O
to	O
nine	O
,	O
although	O
in	O
some	O
cases	O
the	O
co	B-experimental_method
-	I-experimental_method
crystallized	I-experimental_method
oligonucleotide	B-chemical
comprises	O
eight	O
nucleotides	B-chemical
and	O
as	O
such	O
leaves	O
the	O
first	B-site
binding	I-site
site	I-site
empty	O
.	O

The	O
prior	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
nucleotide	B-site
-	I-site
binding	I-site
sites	I-site
are	O
given	O
in	O
parentheses	O
(	O
site	O
4	O
'	O
interacts	O
with	O
dU2AF65	B-mutant
RRM1	B-structure_element
and	O
RRM2	B-structure_element
by	O
crystallographic	O
symmetry	O
).	O

(	O
b	O
)	O
Stereo	O
views	O
of	O
a	O
‘	O
kicked	O
'	O
2	B-evidence
|	I-evidence
Fo	I-evidence
|−|	I-evidence
Fc	I-evidence
|	I-evidence
electron	I-evidence
density	I-evidence
map	I-evidence
contoured	O
at	O
1σ	O
for	O
the	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
,	O
N	O
-	O
and	O
C	O
-	O
terminal	O
residues	O
(	O
blue	O
)	O
or	O
bound	O
oligonucleotide	B-chemical
of	O
a	O
representative	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structure	O
(	O
structure	O
iv	O
,	O
bound	B-protein_state
to	I-protein_state
5	O
′-(	O
P	O
)	O
rUrUrUdUrUrU	O
(	O
BrdU	O
)	O
dUrC	O
)	O
(	O
magenta	O
).	O

Crystallographic	O
statistics	O
are	O
given	O
in	O
Table	O
1	O
and	O
the	O
overall	O
conformations	O
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
and	O
prior	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
/	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
structures	B-evidence
are	O
compared	O
in	O
Supplementary	O
Fig	O
.	O
2	O
.	O

BrdU	B-chemical
,	O
5	B-chemical
-	I-chemical
bromo	I-chemical
-	I-chemical
deoxy	I-chemical
-	I-chemical
uridine	I-chemical
;	O
d	B-chemical
,	O
deoxy	B-chemical
-	I-chemical
ribose	I-chemical
;	O
P	B-chemical
-,	I-chemical
5	B-chemical
′-	I-chemical
phosphorylation	I-chemical
;	O
r	B-chemical
,	O
ribose	B-chemical
.	O

Representative	O
views	O
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
interactions	O
with	O
each	O
new	O
nucleotide	B-chemical
of	O
the	O
bound	B-protein_state
Py	B-chemical
tract	I-chemical
.	O

New	O
residues	O
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
are	O
coloured	O
a	O
darker	O
shade	O
of	O
blue	O
,	O
apart	O
from	O
residues	O
that	O
were	O
tested	O
by	O
site	B-experimental_method
-	I-experimental_method
directed	I-experimental_method
mutagenesis	I-experimental_method
,	O
which	O
are	O
coloured	O
yellow	O
.	O

The	O
nucleotide	B-site
-	I-site
binding	I-site
sites	I-site
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
and	O
prior	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
structure	B-evidence
are	O
compared	O
in	O
Supplementary	O
Fig	O
.	O
3a	O
–	O
h	O
.	O
The	O
first	B-site
and	I-site
seventh	I-site
U2AF651	I-site
,	I-site
2L	I-site
-	I-site
binding	I-site
sites	I-site
are	O
unchanged	O
from	O
the	O
prior	O
dU2AF651	B-complex_assembly
,	I-complex_assembly
2	I-complex_assembly
–	I-complex_assembly
RNA	I-complex_assembly
structure	B-evidence
and	O
are	O
portrayed	O
in	O
Supplementary	O
Fig	O
.	O
3a	O
,	O
f	O
.	O
The	O
four	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structures	B-evidence
are	O
similar	O
with	O
the	O
exception	O
of	O
pH	O
-	O
dependent	O
variations	O
at	O
the	O
ninth	B-site
site	I-site
that	O
are	O
detailed	O
in	O
Supplementary	O
Fig	O
.	O
3i	O
,	O
j	O
.	O
The	O
representative	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structure	B-evidence
shown	O
has	O
the	O
highest	O
resolution	O
and	O
/	O
or	O
ribose	B-chemical
nucleotide	I-chemical
at	O
the	O
given	O
site	O
:	O
(	O
a	O
)	O
rU2	B-residue_name_number
of	O
structure	O
iv	O
;	O
(	O
b	O
)	O
rU3	B-residue_name_number
of	O
structure	O
iii	O
;	O
(	O
c	O
)	O
rU4	B-residue_name_number
of	O
structure	O
i	O
;	O
(	O
d	O
)	O
rU5	B-residue_name_number
of	O
structure	O
iii	O
;	O
(	O
e	O
)	O
rU6	B-residue_name_number
of	O
structure	O
ii	O
;	O
(	O
f	O
)	O
dU8	B-residue_name_number
of	O
structure	O
iii	O
;	O
(	O
g	O
)	O
dU9	B-residue_name_number
of	O
structure	O
iii	O
;	O
(	O
h	O
)	O
rC9	B-residue_name_number
of	O
structure	O
iv	O
.	O

(	O
i	O
)	O
Bar	O
graph	O
of	O
apparent	O
equilibrium	B-evidence
affinities	I-evidence
(	O
KA	B-evidence
)	O
of	O
the	O
wild	B-protein_state
type	I-protein_state
(	O
blue	O
)	O
and	O
the	O
indicated	O
mutant	B-protein_state
(	O
yellow	O
)	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
proteins	O
binding	O
the	O
AdML	B-gene
Py	B-chemical
tract	I-chemical
(	O
5	B-chemical
′-	I-chemical
CCCUUUUUUUUCC	I-chemical
-	I-chemical
3	I-chemical
′).	I-chemical

The	O
apparent	O
equilibrium	B-evidence
dissociation	I-evidence
constants	I-evidence
(	O
KD	B-evidence
)	O
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
mutant	B-protein_state
proteins	O
are	O
:	O
wild	B-protein_state
type	I-protein_state
(	O
WT	B-protein_state
),	O
35	O
±	O
6	O
nM	O
;	O
R227A	B-mutant
,	O
166	O
±	O
2	O
nM	O
;	O
V254P	B-mutant
,	O
137	O
±	O
10	O
nM	O
;	O
Q147A	B-mutant
,	O
171	O
±	O
21	O
nM	O
.	O
The	O
average	O
KA	B-evidence
and	O
s	O
.	O
e	O
.	O
m	O
.	O

The	O
average	O
fitted	O
fluorescence	O
anisotropy	O
RNA	B-evidence
-	I-evidence
binding	I-evidence
curves	I-evidence
are	O
shown	O
in	O
Supplementary	O
Fig	O
.	O
4a	O
–	O
c	O
.	O

The	O
U2AF65	B-protein
linker	B-structure_element
/	O
RRM	B-structure_element
and	O
inter	O
-	O
RRM	B-structure_element
interactions	O
.	O

(	O
a	O
)	O
Contacts	O
of	O
the	O
U2AF65	B-protein
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
linker	I-structure_element
with	O
the	O
RRMs	B-structure_element
.	O

A	O
semi	O
-	O
transparent	O
space	O
-	O
filling	O
surface	O
is	O
shown	O
for	O
the	O
RRM1	B-structure_element
(	O
green	O
)	O
and	O
RRM2	B-structure_element
(	O
light	O
blue	O
).	O

Residues	O
V249	B-residue_name_number
,	O
V250	B-residue_name_number
,	O
V254	B-residue_name_number
(	O
yellow	O
)	O
are	O
mutated	B-experimental_method
to	O
V249G	B-mutant
/	O
V250G	B-mutant
/	O
V254G	B-mutant
in	O
the	O
3Gly	B-mutant
mutant	I-mutant
;	O
residues	O
S251	B-residue_name_number
,	O
T252	B-residue_name_number
,	O
V253	B-residue_name_number
,	O
P255	B-residue_name_number
(	O
red	O
)	O
along	O
with	O
V254	B-residue_name_number
are	O
mutated	B-experimental_method
to	O
S251G	B-mutant
/	O
T252G	B-mutant
/	O
V253G	B-mutant
/	O
V254G	B-mutant
/	O
P255G	B-mutant
in	O
the	O
5Gly	B-mutant
mutant	I-mutant
or	O
to	O
S251N	B-mutant
/	O
T252L	B-mutant
/	O
V253A	B-mutant
/	O
V254L	B-mutant
/	O
P255A	B-mutant
in	O
the	O
NLALA	B-mutant
mutant	I-mutant
;	O
residues	O
M144	B-residue_name_number
,	O
L235	B-residue_name_number
,	O
M238	B-residue_name_number
,	O
V244	B-residue_name_number
,	O
V246	B-residue_name_number
(	O
orange	O
)	O
along	O
with	O
V249	B-residue_name_number
,	O
V250	B-residue_name_number
,	O
S251	B-residue_name_number
,	O
T252	B-residue_name_number
,	O
V253	B-residue_name_number
,	O
V254	B-residue_name_number
,	O
P255	B-residue_name_number
are	O
mutated	B-experimental_method
to	O
M144G	B-mutant
/	O
L235G	B-mutant
/	O
M238G	B-mutant
/	O
V244G	B-mutant
/	O
V246G	B-mutant
/	O
V249G	B-mutant
/	O
V250G	B-mutant
/	O
S251G	B-mutant
/	O
T252G	B-mutant
/	O
V253G	B-mutant
/	O
V254G	B-mutant
/	O
P255G	B-mutant
in	O
the	O
12Gly	B-mutant
mutant	I-mutant
.	O

Other	O
linker	B-structure_element
residues	O
are	O
coloured	O
either	O
dark	O
blue	O
for	O
new	O
residues	O
in	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
structure	O
or	O
light	O
blue	O
for	O
the	O
remaining	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
residues	O
.	O

The	O
central	O
panel	O
shows	O
an	O
overall	O
view	O
with	O
stick	O
diagrams	O
for	O
mutated	O
residues	O
;	O
boxed	O
regions	O
are	O
expanded	O
to	O
show	O
the	O
C	O
-	O
terminal	O
(	O
bottom	O
left	O
)	O
and	O
central	B-structure_element
linker	I-structure_element
regions	I-structure_element
(	O
top	O
)	O
at	O
the	O
inter	B-structure_element
-	I-structure_element
RRM	I-structure_element
interfaces	I-structure_element
,	O
and	O
N	O
-	O
terminal	O
linker	O
region	O
contacts	O
with	O
RRM1	B-structure_element
(	O
bottom	O
right	O
).	O

(	O
b	O
)	O
Bar	O
graph	O
of	O
apparent	O
equilibrium	B-evidence
affinities	I-evidence
(	O
KA	B-evidence
)	O
for	O
the	O
AdML	B-gene
Py	B-chemical
tract	I-chemical
(	O
5	B-chemical
′-	I-chemical
CCCUUUUUUUUCC	I-chemical
-	I-chemical
3	I-chemical
′)	I-chemical
of	O
the	O
wild	B-protein_state
-	I-protein_state
type	I-protein_state
(	O
blue	O
)	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
protein	O
compared	O
with	O
mutations	O
of	O
the	O
residues	O
shown	O
in	O
a	O
:	O
3Gly	B-mutant
(	O
yellow	O
),	O
5Gly	B-mutant
(	O
red	O
),	O
NLALA	B-mutant
(	O
hatched	O
red	O
),	O
12Gly	B-mutant
(	O
orange	O
)	O
and	O
the	O
linker	B-experimental_method
deletions	I-experimental_method
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
in	O
the	O
minimal	B-protein_state
RRM1	B-structure_element
–	I-structure_element
RRM2	I-structure_element
region	I-structure_element
(	O
residues	O
148	B-residue_range
–	I-residue_range
237	I-residue_range
,	O
258	B-residue_range
–	I-residue_range
336	I-residue_range
)	O
or	O
dU2AF651	B-mutant
,	I-mutant
2L	I-mutant
(	O
residues	O
141	B-residue_range
–	I-residue_range
237	I-residue_range
,	O
258	B-residue_range
–	I-residue_range
342	I-residue_range
).	O

The	O
apparent	O
equilibrium	B-evidence
dissociation	I-evidence
constants	I-evidence
(	O
KD	B-evidence
)	O
of	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
mutant	B-protein_state
proteins	O
are	O
:	O
wild	B-protein_state
type	I-protein_state
(	O
WT	B-protein_state
),	O
35	O
±	O
6	O
nM	O
;	O
3Gly	B-mutant
,	O
47	O
±	O
4	O
nM	O
;	O
5Gly	B-mutant
,	O
61	O
±	O
3	O
nM	O
;	O
12Gly	B-mutant
,	O
88	O
±	O
21	O
nM	O
;	O
NLALA	B-mutant
,	O
45	O
±	O
3	O
nM	O
;	O
dU2AF651	B-mutant
,	I-mutant
2L	I-mutant
,	O
123	O
±	O
5	O
nM	O
;	O
dU2AF651	B-mutant
,	I-mutant
2	I-mutant
,	O
5000	O
±	O
100	O
nM	O
;	O
3Mut	B-mutant
,	O
5630	O
±	O
70	O
nM	O
.	O
The	O
average	O
KA	B-evidence
and	O
s	O
.	O
e	O
.	O
m	O
.	O

The	O
fitted	O
fluorescence	O
anisotropy	O
RNA	B-evidence
-	I-evidence
binding	I-evidence
curves	I-evidence
are	O
shown	O
in	O
Supplementary	O
Fig	O
.	O
4d	O
–	O
j	O
.	O
(	O
c	O
)	O
Close	O
view	O
of	O
the	O
U2AF65	B-protein
RRM1	B-site
/	I-site
RRM2	I-site
interface	I-site
following	O
a	O
two	O
-	O
fold	O
rotation	O
about	O
the	O
x	O
-	O
axis	O
relative	O
to	O
a	O
.	O

U2AF65	B-protein
inter	O
-	O
domain	O
residues	O
are	O
important	O
for	O
splicing	O
a	O
representative	O
pre	B-chemical
-	I-chemical
mRNA	I-chemical
substrate	O
in	O
human	B-species
cells	O
.	O

(	O
a	O
)	O
Schematic	O
diagram	O
of	O
the	O
pyPY	B-chemical
reporter	O
minigene	O
construct	O
comprising	O
two	O
alternative	O
splice	B-site
sites	I-site
preceded	O
by	O
either	O
the	O
weak	O
IgM	O
Py	B-chemical
tract	I-chemical
(	O
py	B-chemical
)	O
or	O
the	O
strong	O
AdML	B-gene
Py	B-chemical
tract	I-chemical
(	O
PY	B-chemical
)	O
(	O
sequences	O
inset	O
).	O

(	O
b	O
)	O
Representative	O
RT	B-experimental_method
-	I-experimental_method
PCR	I-experimental_method
of	O
pyPY	B-chemical
transcripts	O
from	O
HEK293T	O
cells	O
co	B-experimental_method
-	I-experimental_method
transfected	I-experimental_method
with	O
constructs	O
encoding	O
the	O
pyPY	B-chemical
minigene	O
and	O
either	O
wild	B-protein_state
-	I-protein_state
type	I-protein_state
(	O
WT	B-protein_state
)	O
U2AF65	B-protein
or	O
a	O
triple	O
U2AF65	B-protein
mutant	B-protein_state
(	O
3Mut	B-mutant
)	O
of	O
Q147A	B-mutant
,	O
R227A	B-mutant
and	O
V254P	B-mutant
residues	O
.	O

(	O
c	O
)	O
A	O
bar	O
graph	O
of	O
the	O
average	O
percentage	O
of	O
the	O
py	B-chemical
-	O
spliced	O
mRNA	B-chemical
relative	O
to	O
total	O
detected	O
pyPY	B-chemical
transcripts	O
(	O
spliced	O
and	O
unspliced	O
)	O
for	O
the	O
corresponding	O
gel	O
lanes	O
(	O
black	O
,	O
no	O
U2AF65	B-protein
added	O
;	O
white	O
,	O
WT	B-protein_state
U2AF65	B-protein
;	O
grey	O
,	O
3Mut	B-mutant
U2AF65	B-protein
).	O

Protein	B-experimental_method
overexpression	I-experimental_method
and	O
qRT	B-experimental_method
-	I-experimental_method
PCR	I-experimental_method
results	O
are	O
shown	O
in	O
Supplementary	O
Fig	O
.	O
5	O
.	O

RNA	O
binding	O
stabilizes	O
the	O
side	B-protein_state
-	I-protein_state
by	I-protein_state
-	I-protein_state
side	I-protein_state
conformation	O
of	O
U2AF65	B-protein
RRMs	B-structure_element
.	O

(	O
a	O
,	O
b	O
)	O
Views	O
of	O
FRET	B-experimental_method
pairs	O
chosen	O
to	O
follow	O
the	O
relative	O
movement	O
of	O
RRM1	B-structure_element
and	O
RRM2	B-structure_element
on	O
the	O
crystal	B-evidence
structure	I-evidence
of	O
‘	O
side	B-protein_state
-	I-protein_state
by	I-protein_state
-	I-protein_state
side	I-protein_state
'	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
RRMs	B-structure_element
bound	B-protein_state
to	I-protein_state
a	O
Py	B-chemical
-	I-chemical
tract	I-chemical
oligonucleotide	I-chemical
(	O
a	O
,	O
representative	O
structure	O
iv	O
)	O
or	O
‘	O
closed	B-protein_state
'	O
NMR	B-experimental_method
/	O
PRE	B-experimental_method
-	O
based	O
model	O
of	O
U2AF651	B-mutant
,	I-mutant
2	I-mutant
(	O
b	O
,	O
PDB	O
ID	O
2YH0	O
)	O
in	O
identical	O
orientations	O
of	O
RRM2	B-structure_element
.	O

The	O
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
proteins	O
were	O
doubly	O
labelled	O
at	O
A181C	B-mutant
/	O
Q324C	B-mutant
such	O
that	O
a	O
mixture	O
of	O
Cy3	B-chemical
/	O
Cy5	B-chemical
fluorophores	B-chemical
are	O
expected	O
to	O
be	O
present	O
at	O
each	O
site	O
.	O

(	O
c	O
–	O
f	O
,	O
i	O
,	O
j	O
)	O
The	O
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
protein	O
was	O
immobilized	O
on	O
the	O
microscope	O
slide	O
via	O
biotin	B-chemical
-	I-chemical
NTA	I-chemical
/	I-chemical
Ni	I-chemical
+	I-chemical
2	I-chemical
(	O
orange	O
line	O
)	O
on	O
a	O
neutravidin	O
(	O
black	O
X	O
)-	O
biotin	O
-	O
PEG	O
(	O
orange	O
triangle	O
)-	O
treated	O
surface	O
and	O
imaged	O
either	O
in	O
the	O
absence	B-protein_state
of	I-protein_state
ligands	B-chemical
(	O
c	O
,	O
d	O
),	O
in	O
the	O
presence	O
of	O
5	O
μM	O
AdML	B-gene
Py	B-chemical
-	I-chemical
tract	I-chemical
RNA	I-chemical
(	O
5	B-chemical
′-	I-chemical
CCUUUUUUUUCC	I-chemical
-	I-chemical
3	I-chemical
′)	I-chemical
(	O
e	O
,	O
f	O
),	O
or	O
in	O
the	O
presence	O
of	O
10	O
μM	O
adenosine	B-residue_name
-	O
interrupted	O
variant	O
RNA	B-chemical
(	O
5	B-chemical
′-	I-chemical
CUUUUUAAUUUCCA	I-chemical
-	I-chemical
3	I-chemical
′)	I-chemical
(	O
i	O
,	O
j	O
).	O

The	O
untethered	B-protein_state
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
protein	O
(	O
1	O
nM	O
)	O
was	O
added	O
to	O
AdML	B-gene
RNA	B-chemical
–	I-chemical
polyethylene	I-chemical
-	I-chemical
glycol	I-chemical
-	I-chemical
linker	I-chemical
–	I-chemical
DNA	I-chemical
oligonucleotide	I-chemical
(	O
10	O
nM	O
),	O
which	O
was	O
immobilized	O
on	O
the	O
microscope	O
slide	O
by	O
annealing	O
with	O
a	O
complementary	O
biotinyl	B-chemical
-	I-chemical
DNA	I-chemical
oligonucleotide	I-chemical
(	O
black	O
vertical	O
line	O
).	O

Typical	O
single	B-experimental_method
-	I-experimental_method
molecule	I-experimental_method
FRET	I-experimental_method
traces	B-evidence
(	O
c	O
,	O
e	O
,	O
g	O
,	O
i	O
)	O
show	O
fluorescence	O
intensities	O
from	O
Cy3	B-chemical
(	O
green	O
)	O
and	O
Cy5	B-chemical
(	O
red	O
)	O
and	O
the	O
calculated	B-evidence
apparent	I-evidence
FRET	I-evidence
efficiency	I-evidence
(	O
blue	O
).	O

Additional	O
traces	B-evidence
for	O
untethered	B-protein_state
,	O
RNA	B-protein_state
-	I-protein_state
bound	I-protein_state
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
are	O
shown	O
in	O
Supplementary	O
Fig	O
.	O
7c	O
,	O
d	O
.	O
Histograms	B-evidence
(	O
d	O
,	O
f	O
,	O
h	O
,	O
j	O
)	O
show	O
the	O
distribution	B-evidence
of	I-evidence
FRET	I-evidence
values	I-evidence
in	O
RNA	B-protein_state
-	I-protein_state
free	I-protein_state
,	O
slide	B-protein_state
-	I-protein_state
tethered	I-protein_state
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
(	O
d	O
);	O
AdML	B-gene
RNA	B-protein_state
-	I-protein_state
bound	I-protein_state
,	O
slide	B-protein_state
-	I-protein_state
tethered	I-protein_state
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
(	O
f	O
);	O
AdML	B-gene
RNA	B-protein_state
-	I-protein_state
bound	I-protein_state
,	O
untethered	B-protein_state
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
(	O
h	O
)	O
and	O
adenosine	O
-	O
interrupted	O
RNA	B-protein_state
-	I-protein_state
bound	I-protein_state
,	O
slide	B-protein_state
-	I-protein_state
tethered	I-protein_state
U2AF651	B-mutant
,	I-mutant
2LFRET	I-mutant
(	O
Cy3	B-chemical
/	O
Cy5	B-chemical
)	O
(	O
j	O
).	O

N	O
is	O
the	O
number	O
of	O
single	O
-	O
molecule	O
traces	B-evidence
compiled	O
for	O
each	O
histogram	B-evidence
.	O

Schematic	O
models	O
of	O
U2AF65	B-protein
recognizing	O
the	O
Py	B-chemical
tract	I-chemical
.	O

(	O
a	O
)	O
Diagram	O
of	O
the	O
U2AF65	B-protein
,	O
SF1	B-protein
and	O
U2AF35	B-protein
splicing	O
factors	O
bound	B-protein_state
to	I-protein_state
the	O
consensus	O
elements	O
of	O
the	O
3	B-site
′	I-site
splice	I-site
site	I-site
.	O

A	O
surface	O
representation	O
of	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
is	O
shown	O
bound	B-protein_state
to	I-protein_state
nine	O
nucleotides	B-chemical
(	O
nt	O
);	O
the	O
relative	O
distances	O
and	O
juxtaposition	O
of	O
the	O
branch	B-site
point	I-site
sequence	I-site
(	O
BPS	B-site
)	O
and	O
consensus	O
AG	B-chemical
dinucleotide	I-chemical
at	O
the	O
3	B-site
′	I-site
splice	I-site
site	I-site
are	O
unknown	O
.	O

MDS	O
-	O
relevant	O
mutated	O
residues	O
of	O
U2AF65	B-protein
are	O
shown	O
as	O
yellow	O
spheres	O
(	O
L187	B-residue_name_number
and	O
M144	B-residue_name_number
).	O

(	O
b	O
)	O
Following	O
binding	O
to	O
the	O
Py	B-chemical
-	I-chemical
tract	I-chemical
RNA	I-chemical
,	O
a	O
conformation	O
corresponding	O
to	O
high	B-evidence
FRET	I-evidence
and	O
consistent	O
with	O
the	O
‘	O
closed	B-protein_state
',	O
back	B-protein_state
-	I-protein_state
to	I-protein_state
-	I-protein_state
back	I-protein_state
apo	B-protein_state
-	O
U2AF65	B-protein
model	O
resulting	O
from	O
PRE	B-experimental_method
/	O
NMR	B-experimental_method
characterization	O
(	O
PDB	O
ID	O
2YH0	O
)	O
often	O
transitions	O
to	O
a	O
conformation	O
corresponding	O
to	O
∼	O
0	O
.	O
45	O
FRET	B-evidence
value	I-evidence
,	O
which	O
is	O
consistent	O
with	O
‘	O
open	B-protein_state
',	O
side	B-protein_state
-	I-protein_state
by	I-protein_state
-	I-protein_state
side	I-protein_state
RRMs	B-structure_element
such	O
as	O
the	O
U2AF651	B-mutant
,	I-mutant
2L	I-mutant
crystal	B-evidence
structures	I-evidence
.	O

Alternatively	O
,	O
a	O
conformation	O
of	O
U2AF65	B-protein
corresponding	O
to	O
∼	O
0	O
.	O
45	O
FRET	B-evidence
value	I-evidence
can	O
directly	O
bind	O
to	O
RNA	B-chemical
;	O
RNA	B-chemical
binding	O
stabilizes	O
the	O
‘	O
open	B-protein_state
',	O
side	B-protein_state
-	I-protein_state
by	I-protein_state
-	I-protein_state
side	I-protein_state
conformation	O
and	O
thus	O
shifts	O
the	O
U2AF65	B-protein
population	O
towards	O
the	O
∼	O
0	O
.	O
45	O
FRET	B-evidence
value	I-evidence
.	O

RRM1	B-structure_element
,	O
green	O
;	O
RRM2	B-structure_element
,	O
pale	O
blue	O
;	O
RRM	B-structure_element
extensions	I-structure_element
/	O
linker	B-structure_element
,	O
blue	O
.	O

